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1. Whether or not compounds activate AhR in vitro, does not say anything about their 
physiological relevance in vivo.  
(this thesis) 
2. Microbial metabolites are more important for intestinal health than the (non-pathogenic) 
gut microbiota.  
(this thesis) 
3. In science, deductive and inductive reasoning are equally important and should be 
combined to build new knowledge. 
4. For healthy individuals, personalised nutrition is overrated. 
5. Multidisciplinary research opens doors but covers deep lakes. 
6. If a sneeze can set off a fire alarm, safety is not assured.  
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1 Introduction to the thesis
Recent insights have shown that there is a triangular relationship between the diet, immune 
system and intestinal microbiome, in which the gut microbiota is a substantial contributor 
to human metabolism and health1. Therefore, increased interest exists in the relationship 
between the fields of nutrition, immunology and microbiology. Not only can the diet influence 
the composition of the gut microbiota, but the microbiota and its products can, in turn, also have 
profound effects on the biology of the host2-4. However, the relationship between microbiota 
and health is highly complex and does not only require understanding of specific microbial 
interactions via metabolites or other factors (including the pathogenic traits of pathobionts) 
but also detailed knowledge on host physiology, in particular intestinal homeostasis and mucosal 
immunity5 (Figure 1). The fraction of food that is not digested and absorbed by the host, serves 
as nutrients for the microbiota. Despite progress in predicting the effects of fibres on microbial 
composition and short-chain fatty acid (SCFA) production1,6, we do not yet understand the full 
complexity of dietary effects on the microbiota and keystone species that play a major role in 
shaping individual microbiota ecosystems. This understanding is a critical step in developing 
rational therapeutic interventions to modify microbiota composition and activity to promote 
health and prevent or treat diseases. 
Figure 1. Schematic overview of the contribution of diet to the interactions between microbiota and host, 
and its impact on immunomodulation.
Previous studies showed that a high fibre diet resulted in a different microbiota composition 
and increased production of SCFAs than in a diet low in fibres1,6. This was the first evidence 
of the relationship between diet and microbiome. Dietary changes towards a Western style 
diet, rich in fat and protein and low in fibres, fruit and vegetables, lead to an increased risk for 
chronic immune diseases such as inflammatory bowel disease (IBD), allergies and autoimmune 
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diseases1,7,8. Microbial fermentation of complex carbohydrates that are not digested by the 
host in the small intestine, results in the production of SCFAs, which are known to directly and 
indirectly affect the immune system9-11. Another class of bacterial metabolites that impact on 
intestinal homeostasis and immunity are the tryptophan metabolites, which can activate the 
Aryl hydrocarbon Receptor (AhR)12. 
A better understanding of the relationship between diet, including food processing, and the 
activity of metabolites produced by the gut microbiota and their effect on the host, is an essential 
step in designing food that benefits human health. The nutrient composition of a diet is obviously 
of importance to health, but also the way food is designed plays an important role in how much 
reaches compounds the colon where it is metabolised by the microbiota13. Food design, both 
industrial food processing and domestic food preparation, can therefore be a tool to influence 
the nutrients that reach the lower gut and impact intestinal health. However, more insight is 
needed into the modulatory effect of digestion and microbial fermentation on the interactions 
between dietary components and the gut immune system. Therefore, this thesis describes the 
effects of different dietary components (fibre, tryptophan, glucosinolates and polyphenols) on 
immune modulation, mainly focussing on activation of the Aryl hydrocarbon Receptor (AhR), 
during human digestion and fermentation. The results described in this thesis give insight into 
the effects of food preparation and microbial fermentation on the potential health properties 
of food compounds.
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2 Immunomodulation: effects of dietary fibre 
and microbiota on the host
The mammalian immune system is complex, having multiple systems and mechanisms to protect 
the host from invading microbes, parasites and viruses. In the intestine, various types of cells, 
such as innate and adaptive immune cells and epithelial cells, are involved in the gut immune 
system14. Together, all immune cells related to intestinal associated lymphoid tissue are about 
the size of the brain15, reflecting their importance in human biology. The human intestine 
harbours more than 1015 commensal bacteria, most of which are located in the large bowel. 
The microbiota has numerous symbiotic functions including vitamin production, maximising 
energy harvest, host immune functioning, tissue development and colonisation resistance 
against pathogens1,16,17. Dietary compounds can modulate the immune system either directly as 
parent compounds or indirectly by metabolites formed from the parent compounds. Indirectly, 
dietary fibres, i.e. components of plant cell walls that are resistant to human digestion18,19, are 
fermented by microbiota in the colon to produce SCFA. SCFAs have important effects on health 
through various mechanisms20-22, and play a role in gut homeostasis and induction of colonic 
T-regulatory cells23. Additionally, SCFAs can lower the colonic pH, thereby inhibiting pathogenic 
growth24. Dietary fibres are also utilised as prebiotics to promote the growth of specific genera 
and species of the intestinal microbiota25,26. 
Apart from their indirect effects on the microbiota and SCFA production, several fibres have 
been reported to have immune-stimulatory effects on immune cells27. The mechanisms involved 
in immunomodulatory effects of fibres are poorly understood with the exception of β-1,3-linked 
glucans, which are components of the cell walls of fungi. These glucans signal through binding 
to the C-type lectin receptor (CLR) Dectin-1, which is important for antifungal immunity28-30. 
Other fibres that are reported to have immune-stimulatory effects are pectin-derived arabinans, 
like linear or branched arabinan27. Pectins are the main compound of the middle lamella in the 
plant primary cell wall, and consist of homogalacturonan (HG), rhamnogalacturonan I and II 
(RG I and II) and xylogalacturonan (XGA)31. Arabinans are the side chains of RG I and were able 
to directly bind mouse dendritic cells (DC)27. In this thesis, both direct and indirect effects by 
dietary compounds on immune modulation were investigated.
|   Chapter 1
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3 Diet-microbiota influence 
on the AhR-immune axis
Another important connection between host, diet and microbiota is the AhR-immune axis. 
AhR is a cytosolic receptor expressed by many cells in the human body and previously known 
to bind, amongst others, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), contributing to its 
detoxification32. However, recent studies have demonstrated that AhR also participates in 
the establishment and maintenance of intestinal homeostasis, including maintaining epithelial 
barrier integrity, protection from pathogens and regulation of commensal gut microbiota12,16,33. 
The diet can influence AhR-dependent mechanisms by providing a source of potential AhR 
ligands. In addition, the microbiota can produce AhR ligands through metabolism of tryptophan. 
AhR can be considered as an important anti-inflammatory receptor which combines dietary, 
microbial, metabolic and endogenous signals to activate immune response and alter the gut 
microbiota composition1. AhR is expressed by a number of immune cells, and thus, AhR signalling 
provides a molecular pathway that integrates the effects of the environment and metabolism 
on the immune response34.
3.1 AhR pathway
AhR consists of a basic helix-loop-helix (bHLH) protein belonging to the Per-Arnt-Sim (Pas) 
family35. The receptor resides in the cytosol and it is ligand-activated. Several domains and 
regions are functionally important within the AhR protein complex. At the amino terminal 
part, the bHLH-Pas region is a key player in the interaction with hsp90, binding of DNA and 
dimerisation with AhR nuclear translocator (Arnt). Arnt is also involved in translocation of the 
receptor to the nucleus, involving a nuclear localisation signal (NLS) and a nuclear export signal 
(NES). Additionally, AhR has a Pas domain, which contains two structural repeats: Pas A and 
Pas B. While Pas A is involved in the dimerisation of AhR with Arnt, Pas B binds the ligands and 
interacts with hsp90. The Pas domain is not only important at the amino terminal, but also at the 
carboxy terminal part where it is involved in the interaction of AhR with XAP2, an AhR associated 
protein. The carboxy terminal consists of a transactivation domain with three subdomains. The 
total AhR has a size of 95 to 125 kDa, varying amongst different species36-38.
When AhR ligands enter the cell, they pass the plasma membrane and bind the receptor39 
(Figure 2). At that moment, AhR is present as an inactive complex consisting of multiple proteins 
and resides in the cytosolic compartment. It contains 2 hsp90 molecules: XAP2 and P2340-42. 
Hsp90 in the cytoplasm has the function to localize AhR in the absence of a ligand, where it 
protects its degradation and transformation. XAP2 minimises the degradation of AhR and 
plays a role in the regulation of the translocation of AhR to the nucleus. Moreover, it boosts 
AhR signalling when it is joined with hsp9043,44. P23 is involved in the stabilisation of the AhR 
complex45.
General introduction   |
13
Upon ligand binding to AhR, the receptor changes its conformation, exposes the NLS and enters 
the nucleus. After being translocated into the nucleus, AhR binds Arnt and subsequently binds 
to dioxin or xenobiotic responsive elements (DRE or XRE), which are target gene promoters 
to induce expression of AhR-responsive genes such as CYP1A1 and CYP1b146. As a result, the 
transcription of adjacent genes is activated, one of which is IL-2247-49. This pathway interacts 
with some other pathways, for example the estrogen, NF-κB and cAMP pathway1,50. As a result 
of the transformation and activation events, a variety of proteins are expressed, including drug-
metabolising enzymes.
Figure 2. AhR signalling pathway. Aryl hydrocarbon Receptor (AhR), AhR repressor (AhRR), AhR nuclear 
translocator (Arnt), cytochrome P450 1A1 (Cyp1a1), cytochrome P450 1B1 (Cyp1b1), dioxin response 
element (DRE), glutathione-S-transferase A (GSTA), heat shock protein 90 (hsp90), interleukin 22 (IL-22), 
HBV X-associated protein 2 (XAP2). Adapted from Lamas et al.39.
3.2 AhR activation by ligands
AhR is known to mediate the toxic effects of halogenated aromatic hydrocarbons (HAHs). Apart 
from HAHs, a number of ligands for the AhR have been reported in the scientific literature, 
including exogenous diet-derived compounds such as polycyclic aromatic hydrocarbons (PAHs), 
aromatic amines and phytochemicals, as well as endogenous bacterial metabolites (Figure 3)1,51. 
|   Chapter 1
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The main exogenous ligands for AhR are derived from edible plant tissues, i.e. vegetables, fruits, 
teas and herbs32,35. Several studies showed that especially polyphenols can exert an agonistic or 
antagonistic effect on AhR transduction pathways52-58. Moreover it is stated that at physiological 
conditions, polyphenols are antagonists rather than agonists, as the agonistic effects induced 
by polyphenols often require higher concentrations52,58-62. 
Besides food derived compounds, also endogenous microbial metabolites can act as AhR ligands. 
Examples of microbial metabolites that can activate AhR are tryptophan metabolites from e.g. 
Lactobacilli12, microbial pigments phenazines and naphthoquinone produced by respectively 
Pseudomonas aeruginosa and Mycobacterium tuberculosis, and 1,4-dihydroxy-2-naphthoic acid, a 
vitamin K2 precursor, metabolised by Propionibacterium freudenreichii1. Additionally, AhR senses 
bacterial pigments, thereby controlling some antibacterial responses63. 
Figure 3. Several identified AhR ligands, originating from diet, tryptophan metabolism, or cell metabolism. 
Adapted from Lamas et al.39. 
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AhR activation can be measured in different ways, for example in vivo by using mice models 
comparing AhR-/- with wild type mice, or by dietary intervention studies with AhR ligands and 
measuring gene expression of AhR or the downstream CYP1a1 gene. AhR activation can also 
be measured in vitro, by using various cell lines. In this thesis we used two different in vitro cell 
lines, first the CALUX cell line (BioDetection Systems), where rat liver cells (H4Luc03) were 
transfected with the pGudLuc1.1 plasmid luciferase gene and responsiveness is conferred by 
DRE sequences64. In our last study (Chapter 5), we used the recently developed human Hep-G2 
Lucia AhR reporter assay (Promega), which has the same principle as the CALUX cells, but in 
human liver cells.
In this thesis, we investigated the fate of dietary AhR ligands during digestion and colonic 
fermentation. Results lead to knowledge on how to increase the delivery of potential AhR ligands 
to the lower gut and the potential role of food in the establishment and maintenance of a healthy 
gut. In the next sections, the most important classes of diet-derived AhR ligands (polyphenols, 
glucosinolates and tryptophan metabolites) are discussed in more detail. 
3.2.1  Polyphenols
Polyphenols are secondary metabolites from plants and have been widely studied for their 
antioxidant properties to inhibit oxidation and protection against reactive oxygen species65,66. 
Recently it became clear that polyphenols are active in several other mechanisms and the 
health effects of polyphenols include more complex interactions with the host, including 
anti-inflammatory and antimicrobial capacities66,67. Polyphenols can be grouped based on 
their chemical structure, i.e. the number of phenol (aromatic) rings and the way the rings are 
connected in phenolic acids, flavonoids and non-flavonoid polyphenols (stilbenes and lignans)68. 
Several studies investigated the capacity of individual polyphenols to activate AhR32,62,69-71. These 
showed that mainly flavonoids are potent AhR ligands. Furthermore, the number of hydroxyl 
groups and planar conformation are important factors that determine the AhR activation 
capacity72. 
Flavonoids consist of a basic core structure with a C6-C3-C6 flavone skeleton. The C3 portion 
of this skeleton is often cyclised with an oxygen molecule and can vary in location of unsaturation 
and oxidation73. At least 5000 different plant-derived flavonoids have been discovered and 
isolated from a wide variety of plants74,75. Flavonoids can be further divided into six groups: 
flavonols, flavones, flavanones, flavanols, isoflavones and anthocyanidins68. The degree of 
hydroxylation, substitutions, conjugations and degree of polymerisation determines the 
chemical nature and therefore the structural class of flavonoids. Often these occur in the plant 
as glycosides76. The biochemical activity of flavonoids depends on the chemical structure and 
relative orientation of the molecule. Naturally, flavonoids are found in almost all parts of plants, 
and are particularly abundant in the external tissues like coats or skin. Therefore, flavonoids 
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form an integral part of the human diet76. Depending on their size and structure, polyphenols can 
be absorbed in the small intestine but the bioavailable fraction is typically small (approximately 
5 - 10 %). Most of the polyphenols reach the colon unchanged where they are fermented by the 
gut microbiota66,67. In the colon, polyphenols are converted into low molecular weight phenolic 
metabolites by cleavage of glycosidic linkages and breakdown of the heterocyclic backbone of 
the resulting aglycon, thereby facilitating absorption in the gut (Figure 4)66,67.
Figure 4. Schematic presentation of flavanone metabolism in the small and large intestine as an example 
of polyphenols fate in the human superorganism66.
3.2.2  Glucosinolates
Beneficial health effects of vegetables of the genus Brassica (e.g. broccoli and cabbage) have been 
partly linked to glucosinolates (GLS), which are secondary metabolites77. The GLS structure 
consists of a β-D-thioglucose group, a sulfonated oxime group, and a side chain derived from 
amino acids78. Over 130 GLS have been identified and these can be divided into three classes: 
indole GLS, aliphatic GLS and aromatic GLS. Brassica vegetable tissue contains myrosinase 
and high amounts of glucosinolates. Myrosinase, an endogenous plant enzyme, can hydrolyse 
glucosinolates into an array of breakdown products with a variety of physiological effects78. 
The study of Hubbard et al., demonstrated that the beneficial aspects of dietary broccoli (Brassica 
oleracea) upon intestinal health are associated with an increase in AhR activation79. When 
glucobrassicin, a GLS, is hydrolysed, compounds such as isothiocyanates (ITC) are formed and 
those can be converted into AhR ligands16,80-82. Glucosinolates and myrosinase are physically 
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segregated from each other in intact vegetable tissues. Food preparation and chewing of the 
vegetables results in the loss of compartmentalisation in the vegetable tissue, and glucosinolates 
and myrosinase can come into contact with each other, which catalyses the enzymatic hydrolysis 
of glucosinolates83. One of the degradation products of enzymatic hydrolysis of glucobrassicin 
is indole-3-carbinol (I3C). I3C exhibits several biological functions, including reduction of DNA-
adduct formation, induction of apoptosis and inhibition of tumour growth84,85. I3C is unstable 
and can undergo acid-catalysed oligomerisation at low pH, for example in the stomach. The 
oligomerisation of I3C results in a mixture of products, like 2-(indol-3-yl methyl)-indol-3-yl]
indol-3-methane (LTr-1), indolo[3,2-b]carbazole (ICZ) and 3,3-diindolylmethane (DIM)86. I3C 
is a ligand of the AhR and can bind weakly to the receptor, whereas the products of the acid-
catalysed oligomerisation have a higher affinity for this receptor87. 
3.2.3  Tryptophan
Tryptophan (Trp) is an essential amino acid and abundant in protein-rich foods like beans 
and nuts, cheese, meat, fish, and eggs88. The daily intake of Trp in the average Western diet 
is approximately 600 - 900 mg89, of which 70 - 95 % is absorbed depending on the source. 
Of the absorbed fraction, around 30% is used for energy89,90 and the remaining Trp can be 
metabolised in the body by endogenous enzymes indoleamine 2,3-dioxygenase (IDO) and 
L-tryptophan 2,3-dioxygenase (TDO) in the kynurenine pathway of the host (Figure 5)12,91-95. 
Furthermore, Trp is a precursor in the serotonin and melatonin pathways94,96. A fraction of Trp 
ends up in the skin, where it can be converted into 6-formylindolo[3,2-b]carbazole (FICZ) by 
UVB irradiation. FICZ can also be formed by a reaction between Trp and H
2
O
2
, rearrangement 
of indole-3-acetaldehyde (IAAId) and by yeasts present on the skin (Malessezia species)97. FICZ 
has a high binding affinity for AhR, but undergoes rapid degradation, so its effects on the host 
may be limited98,99.
The fraction of Trp that escapes absorption ends up in the colon and can there be metabolised 
by the gut microbiota into AhR active indole derivatives. The bacteria Lactobacillus reuteri12,100, 
L. murinus and L. taiwanensis100, and Clostridium sporogenes101,102 can all produce indoles from 
Trp. Lactobacilli are able to produce the AhR ligands indole-3-acetic acid (IAA)100 and indole-
3-aldehyde (IAId)12. The C. sporogenes metabolise Trp into indole-3-propionic acid (IPA)101 and 
3-methyl indole (or skatole)102,103. IPA is able to stimulate the AhR but not in a dose-dependent 
manner while 3-methyl indole can activate the AhR in a dose-dependent manner103. After 
absorption by the colon epithelium, the Trp metabolites may be further metabolised in the 
host tissues. For instance, indole can be metabolised into oxindole by mammalian oxidases104. 
Oxindole (or 2-oxindole) and also indole itself were shown to activate AhR in a dose-dependent 
manner105.
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Figure 5. Tryptophan metabolism. Trp that is absorbed in the small intestine is used for energy, or 
metabolised into serotonin or kynurenine. The remaining Trp is metabolised by the microbiota. Adopted 
from Agus et al.95.
3.3 Gut microbiota and AhR
As stated before, the intestinal immune system comes into contact with many antigens, such as 
from pathogens, food and commensals. Various species of the gut microbiota have been shown 
to influence metabolic pathways in human hosts106. For instance, Clostridium and Eubacterium 
genera are known to metabolise phenolic compounds into bioactive metabolites that are taken 
up by the host107. Furthermore, the intestinal microbiota produces metabolites that can induce 
an immune response. It was suggested that Trp metabolites play a role in the immune response 
via AhR. In line with this, it has been shown that culture supernatants of Trp metabolising L. 
reuteri and Allobaculum species activate AhR100. When using Trp as the major energy source in 
the diet of mice, the relative abundance of Lactobacilli producing indole-3-aldehyde increased. 
This resulted in a higher production of IL-22, which in turn affected the microbiota and provided 
resistance against colonisation with Candida albicans and consequently gut inflammation108. 
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Zelante et al. showed that L. reuteri can produce IAAId, an AhR agonist, showing an additional 
manner in which microbiota can contribute to AhR stimulation12. Takamura et al. showed that 
certain heat-killed Lactobacillus strains activated the AhR using an AhR reporter assay, but 
whether this was the bacterium itself or its metabolites remained unclear108. 
It was demonstrated that a divergence in microbiota composition between AhR genotypes in 
mice resulted in differences in metabolite abundance and host gene expression. 16S rDNA 
gene sequencing was performed to find differences in microbiota between AhR-/+ and AhR-/- 
mice109. There was no significant difference between Bacteroidetes and Firmicutes, the two 
most dominant phyla in mice and humans, but there were significant changes in the other phyla 
abundance. This suggests that AhR expression influences the composition of the microbiota, but 
only the lower abundant phyla. Overall, results obtained in multiple studies indicate that AhR 
plays a role in maintaining the balance in the microbiome, possibly indirect through the effect 
on the IL-22 pathway12,108-110.
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4 In vitro fermentation
In order to study the relationship between host, diet and the microbiome, fermentation studies 
are necessary. However, in vivo studies in humans are expensive, time-consuming and ethically 
restricted, thereby limiting research possibilities. Furthermore, sampling of specific locations 
along the digestive tract comes with practical difficulties. Another option would be to use animal 
models, in which for example rats or pigs can be used as a model for humans. However, animal 
models require ethical justification and ‘live’ sampling during digestion and fermentation is 
practically very challenging. Furthermore, intrinsic differences exist between human and murine 
core gut microbiota, which bring into question the capability of mouse models to recapitulate 
effects of diet on the human gut microbiota111. As an alternative to animal experiments several 
in vitro fermentations models have been developed, in which fermentation with human faecal 
microbiota can be mimicked112.
Static (or batch) fermentation models use a closed anaerobic vessel incubated at 37 ºC and are 
inoculated with faecal sample, microbial growth medium and the substances to be fermented113. 
It is a simplified fermentation method, high throughput and relatively inexpensive. Fermentation 
time can be up to 48 hours, and generally no new substrate is added. Dynamic fermentation 
models are more complex, can be long term and may comprise of multiple connected vessels 
kept within a specific pH range and fixed volume. Several dynamic models exist114,115, for example, 
the TNO In Vitro Model of the Colon (TIM-2), the Dynamic Gastrointestinal Simulator (SIGMI) 
and the Simulator of the Human Intestinal Ecosystem (SHIME), which was used in this thesis. 
The main advantage of the SHIME model is that it is possible to study the effects of long-term 
feeding on the microbiota, over several weeks. Another advantage is that the conditions found 
in each main segment of the colon are mimicked in different vessels. Samples can be taken at any 
time point and location during digestion, with the major advantage being the separation of the 
colon segments. A limitation is the lack of nutrient or compound absorption, lack of peristaltic 
movements and the semi-static nature of the system (Chapter 6, General discussion). The 
SIGMI does include peristaltic movements, but only those of the stomach. In contrast, the TIM-2 
mimics peristaltic movements of the large intestine, as an alternative to mixing by stirrers as in 
the SHIME. Stirrers can be unfavourable for certain food products, as these can mechanically 
break certain cell wall structures, thereby influencing food accessibility for the microbiota116,117. 
Moreover, TIM-2 includes a dialysis component. The disadvantage however is that usually there 
is only a proximal colon mimicked and experiments are performed for only a few days114.
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5 Aims and order of research chapters
Previous research on the relationship between diet, gut immunity and microbiota has mainly 
focussed on SCFAs as microbial metabolites, while other metabolites that are likely to be 
important for human health have received little attention. The role of microbiota variation 
among individuals in the production of metabolites is also poorly understood. Lastly, the 
modulating effect of a food matrix compared to isolated compounds is often not taken into 
account. Therefore, the aim of this thesis was to study the effects of different foods or food 
components on immune modulation, mainly focussing on activation of the Aryl hydrocarbon 
Receptor (AhR), and the role of human digestion and metabolism by the microbiota (Figure 6).
Figure 6. Visual representation of the thesis.
Chapter 2 describes the ability of the dietary fibre arabinan to bind human dendritic cells, and 
studies the effects of a (food) matrix sugar beet and apple during fermentation of arabinan. In 
Chapter 3, the effect of oregano, containing the polyphenol luteolin, on AhR activation during 
in vitro fermentation was studied. As a continuation, Chapter 4 describes the importance 
of microbial metabolites from tryptophan on AhR activation during in vitro fermentation. 
In Chapter  5, we investigated the effects of cooking on the health compounds in broccoli, 
glucosinolates, and the differences in AhR activation during digestion, both in vitro and in vivo. 
Finally, Chapter 6 discusses the results from the different research chapters, as well as some 
limitations in the methods used and describes future research opportunities.
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Abstract
Dietary fibres such as pectin-derived arabinans are fermented in the colon resulting in bacterial 
production of short-chain fatty acids (SCFAs), which play a role in gut homeostasis. Additionally, 
linear arabinan (LA) originating from sugar beet has been reported to strongly activate mouse 
dendritic cells in a Spleen Tyrosine Kinase (SYK)-dependent manner, suggesting involvement 
of immune receptor tyrosine-based activating motif (ITAM)-containing C-type lectin receptors 
(CLR). The aim of this study was to investigate whether LA was immune-stimulatory for human 
dendritic cells (DCs) and identify the CLR involved. Purified lipopolysaccharide (LPS)-free LA 
bound specifically to human dendritic cells in a calcium dependent manner with involvement of 
SYK. Stimulation of human DCs with LA resulted in strong induction of IL-6, IL-10 and TNFα 
and these responses were reduced after SYK-inhibition. Studies with competitive inhibitors, 
blocking antibodies and siRNA knockdown ruled out the involvement of Dectin-1, Dectin-2, DC-
SIGN, Mincle and the Mannose Receptor in immune activation by LA. Additionally, we fermented 
sugar beet (SB), apple (A) and sugar beet pectin (SBP) with human faecal microbiota in vitro to 
investigate the potential biological relevance of pectin fermentation and immune activity of 
the glycans in vivo. Filtered supernatants from SB and A fermentation increased production of 
IL-6 and TNFα in BMDCs from TLR4/2 knockout mice compared to ‘microbiota-only’ controls. 
However, fermentation of isolated SBP only had a small effect on the immune stimulatory 
activity compared to SB, suggesting an important role for the natural matrix. In conclusion, LA 
is immune-stimulatory for human DCs in a calcium and SYK-dependent manner, which suggests 
involvement of a CLR other than the CLRs targeted in this study.
Keywords: Dendritic cells, Immunomodulation, Dietary fibres, Sugar beet, Apple
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1 Introduction
Dietary fibres are components of plant cells that are resistant to human digestion1,2. They are 
fermented by the microbiota in the colon to produce short-chain fatty acids (SCFA). The SCFA 
have important effects on health through various mechanisms3-5, ranging from the induction of 
regulatory T cells in the colon6-10, barrier protection11, energy metabolism12-16, and entero-endocrine 
function17,18. Dietary fibre fermentation also promotes the growth of specific genera and species 
of the intestinal microbiota19,20, which are associated with health benefits, i.e. they have a prebiotic 
effect. Apart from their indirect effects on microbiota and SCFA production, several fibres have 
been reported to have immune-stimulatory effects in immune cells21. The mechanisms involved 
in immunomodulatory effects of fibres are poorly understood with the exception of β-1,3-linked 
glucans, which are components of the cell walls of certain fungi. These signal through binding to 
the C-type lectin receptor (CLR) Dectin-1, which is important for antifungal immunity22-24. 
Several CLRs are present on immune cells, such as dendritic cells (DCs) and macrophages, where 
they play a role in innate immunity and immune regulation25. CLRs belong to the superfamily of 
C-type lectins which contain a common protein fold known as the carbohydrate recognition domain. 
Several membrane CLRs signal through the immune receptor tyrosine-based activating motif (ITAM) 
or hemi-ITAM motif signalling domains, which signal through recruitment of spleen tyrosine kinase 
(SYK). Recruitment of SYK then leads to activation of the CARD9/Bcl10/Malt-1 module to promote 
NF-κB signalling and expression of inflammatory genes. Dectin-1 is an example of a hemi-ITAM, 
which requires ligand-induced dimerization of Dectin-1 and bridging the two ITAM domains to 
recruit SYK26,27. Some CLRs possess the immunoreceptor tyrosine-based inhibitory signalling 
motif (ITIM), which negatively regulates heterologous inflammatory signalling pathways through 
recruitment of tyrosine phosphatases such as SHP-1 or SHP-2. Several CLRs do not possess ITAM 
or ITIM motifs in their cytoplasmic tails. One example is DC-SIGN, where ligand binding leads to 
the formation of a signalling complex containing LSP1, KSR1, and CNK and the kinase Raf-1 that 
modulates inflammatory signalling through its acetylation of the p65 subunit of NF-kB. 
CLRs can recognise glycosylated self-antigens and microbe-associated glycans, but the 
specificity and binding mode has only been characterised for a few receptors. Dectin-1 binds 
to b-1,3 glucans found in fungal cell walls and plays an important role in antifungal immunity22-24. 
Dectin-2, an ITAM-containing CLR, recognises a-mannan in fungal cell walls, mannose-capped 
lipoarabinomannan of Mycobacterium tuberculosis and mannosylated O-antigens of Gram-
negative bacterial lipopolysaccharides. Mincle, another ITAM containing CLR, is expressed on 
monocytes, macrophages, dendritic cells and neutrophils. Mincle can bind to a broad range 
of bacterial pathogens through glycolipids28. DC-SIGN is mainly expressed by myeloid and 
monocyte-derived DCs and binds preferentially to high mannose structures and fucose-
terminated glycan structures29.
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Several CLRs are expressed in the colon23, but, with the exception of Dectin-1, the relevance 
of other CLR-fibre interactions in the gut are poorly understood. Recently, Dectin-1 was 
shown to be expressed in primary colonic enterocytes and induce chemokine secretion upon 
ligand binding to β1,3-linked glucans23. Binding of dietary fibres to the epithelial associated 
subsets of macrophages or dendritic cells may also impact intestinal immunity. Evidence that 
Dectin-1 signalling is indeed important in the gut, comes from the finding that a loss of function 
polymorphism in Dectin-1 are associated with severe, intractable forms of ulcerative colitis 
resulting from fungal microorganisms in the intestine. 
Recently, bone marrow-derived dendritic cells (BMDCs) from TLR2/4 knockout mice were 
shown to be a reliable approach to analyse the immunomodulatory properties of a diverse 
range of dietary fibres, by avoiding immune cell activation due to contaminating Microbe-
Associated Molecular Patterns (MAMPs). Several of the 44 tested dietary fibre preparations 
induced cytokine responses in BMDCs from TLR2/4 KO mice21. Particulate fractions of linear 
arabinan (LA) and branched arabinan (BA) from sugar beet pectin were shown to be strongly 
immune-stimulatory with LA being more immune-stimulatory than BA. Moreover, enzymatic 
debranching of BA increased its immune-stimulatory activity, possibly due to increased particle 
formation by the alignment of debranched linear arabinan. Mechanistic studies showed that 
immune stimulation was SYK-dependent but independent of Dectin-1, suggesting recognition 
of the LA and BA via an unknown C-type lectin receptor21.
Here we produced lipopolysaccharide (LPS) and MAMP free LA to investigate whether it was 
immune-stimulatory for human dendritic cells. To investigate which CLRs might be binding to LA, 
we coupled LA to fluorescent beads and tested binding to human dendritic cells in presence or 
absence of blocking antibodies and known CLR ligands. Additionally, we tested whether in vitro 
fermentation by the microbiota of sugar beet (SB), sugar beet pectin (SBP), and apple (A) could 
generate immune-stimulatory LA when LA was incorporated in a natural matrix. 
Fermentation and immune-stimulatory binding of linear arabinan to dendritic cells   |
33
2 Materials and Methods
2.1 Substrates
Linear (1,5)-α-L-Arabinan (LA, originating from sugar beet) was purchased from Megazyme 
(Ireland). Raw sugar beet was kindly provided by Wageningen farm and Elstar apples were 
purchased at the local market (Wageningen, The Netherlands).
2.2 Receptor ligand specificity assays
A flow cytometry-based bead-binding assay to measure receptor-ligand specificity was used 
as previously described by Sprokholt et al., 2016 (methods 3.2.3; 30). Fluorescent beads were 
coated with lyophilised rat monoclonal protein-G affinity purified antibody specific for (1-5)-α-L-
Arabinan (LM6, Plantprobes, UK). Lewis Y (LeY) antigen (Lectinity, Russia) was used as positive 
control for binding. 
2.3 Lipopolysaccharide removal and TLR signalling assays
In order to assure that linear arabinan was free of any LPS contamination, alkaline treatment 
was used to remove LPS according to Govers et al., 2016 31. Next, HEK293-hTLR2, HEK293-
hTLR4 and HEK293-hTLR5 cells transfected with pNifty2 vector containing the firefly 
luciferase gene under control of the NF-kB promoter (Invivogen, France) were used in reporter 
assays to detect any contamination with LPS or other MAMPs. The HEK293 cell lines were 
grown in DMEM growth medium with 10 % fetal bovine serum and 1 % penicillin/streptomycin 
(All Gibco, USA). The cells were plated on opaque clear bottom plates (Corning, USA) at a 
concentration of 6 x 104 cells per well and grown overnight before 3 hour stimulation with 
400 µg/mL LA (Megazyme) and specific TLR agonists: 1 µg/mL LPS, 25 ng/mL PAM2CSK4, 
40 ng/mL flagellin and 2.5 ng/mL TNFα (all Invivogen). 120 µL cell supernatant was collected 
and 100 µL Bright-Glo substrate (Promega, USA) was added. The plates were shaken for 5 
min at 500 rpm after which the luminescence was measured (Spectramax M5, Molecular 
Devices, USA).
2.4 Cytokine secretion assays with isolated BMDCs from TLR2/4 KO mice 
Frozen aliquots of BMDC from 3 to 5 months old TLR2/4 knock out female mice were 
thawed and stimulated with the carbohydrate fractions as previously described21. Cells were 
plated in a concentration of 4 x 104 per well and grown for a week in RPMI growth medium 
with 10 % fetal calf serum, 1 % penicillin/streptomycin (all Gibco), 20 ng/mL recombinant 
mouse granulocyte macrophage colony-stimulating factor (GM-CSF, R&D systems, USA) and 
0.5 µL/mL β-mercaptoethanol (Invitrogen, The Netherlands). After a confluent cell layer was 
formed, cells were stimulated for 24 hours with particulate LA and the following TLR ligands 
as controls: 10 and 100 ng/mL LPS, 10 ng/mL, Pam2CSK4 (a synthetic diacylated lipopeptide 
ligand of TLR2 and TLR2/6) and 100 ng/mL Pam3CSK4 (a synthetic triacylated lipopeptide 
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ligand of TLR2 and TLR2/1). As an additional control depleted zymosan, a ligand for Dectin-1, 
was added at a concentration of 20 µg/mL. After 24 h, the cell culture supernatant was 
collected and cytokines IL-12p70, TNFα, IL-10, IL-6, IL-1β and IL-8 were measured using 
the BD™ Cytometric Bead Array System (CBA, BD Biosciences, USA), and flow cytometry 
(Cytoflex Beckman Coulter, USA).
2.5 Cytokine mRNA expression in human dendritic cells 
Peripheral blood monocytes from healthy donors were isolated as previously described by 
Sprokholt et al., 201729. Monocytes were differentiated into immature dendritic cells (DCs) by 
addition of 500 U/mL IL-4 and 800 U/mL GM-SCF (Invitrogen) for 1 week in RPMI supplemented 
with 10 % fetal calf serum, 10 U/mL penicillin, 10 mg/mL streptomycin (all Invitrogen) and 2 mM 
L-glutamine (Lonza, Switzerland). Immature DCs were plated with 1 x 105 cells per well in a 
U-bottom plate (Corning). Antibodies to Dectin-1, DC-SIGN or a control antibody of the same 
immunoglobulin isotype were added and incubated for 2 hours, and silencing with siMincle (small 
inhibitory RNA for macrophage inducible C-type lectin) or siMCL (small inhibitor macrophage 
C-type lectin) were incubated for 48 hours, after which the stimuli were added and incubated 
for another 6 hours. Positive controls were used to validate blocking by antibodies as described 
previously by Gringhuis et al.32,33. The cells were lysed and mRNA purified using an mRNA capture 
kit (Roche, Switzerland). cDNA was synthesized using the reverse transcriptase kit (Promega), 
followed by RT-PCR in the ABI 7500 Fast PCR detection system (Applied Biosystems). Data 
analysis was performed with 7500 Fast Dx software.
2.6 Pectin extraction from sugar beet 
The sugar beet was washed, peeled and sliced into pieces of approximately 4 x 3 x 0.3 cm (L*W*H). 
Then it was immersed in boiling 96 % (v/v) ethanol at 80 °C for 20 min and oven-dried at 40 °C 
for 24 h. The dried sugar beet was milled using a freeze milling (model 6875D, SPEX Sample 
Prep, USA) and passed through a 0.25 mm sieve. To extract the pectin, the powder was mixed 
with water in a ratio of 1/50 (w/v). The solution was sonicated (Sonation, Germany) for 30 min 
after which it was added to 0.5 M NaOH in a concentration of 40 mL/g sugar beet. The mixture 
was microwaved for 5 min at 0.9 kW and cooled in a water bath34,35. After cooling, the mixture 
was centrifuged (ThermoFisher, Germany) at 3494 g for 20 min. The pH of the supernatant was 
adjusted to pH 5.5 with 8 M HCL. Then, the filtrate was coagulated with 96 % ethanol in a volume 
ratio of 1:1.5 and incubated for 6 hours at room temperature. After incubation, the coagulated 
pectin was centrifuged at 3494 g for 10 min and dispersed in two volumes of 96 % ethanol and 
dried at 50 °C in an incubator (BINDER, Germany). The dried sugar beet pectin was milled by 
Fritsch Mill (FRITSCH, Germany) and stored in a sealed container at room temperature until 
further experiments.
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2.7 Sugar composition
The sugar composition of digested (Section 2.8) sugar beet (SB), digested apple (A), and sugar beet 
pectin (SBP), was determined by high-performance anion-exchange chromatography (HPAEC), 
using an ICS-3000 ion chromatography high-performance liquid chromatography (HPLC) 
system equipped with a CarboPac PA-1 column (2 × 250 mm) in combination with a CarboPac 
PA guard column (2 × 25 mm) and a pulsed electrochemical detector in pulsed amperometric 
detection mode (Dionex, Sunnyvale, USA). First, duplicate samples were hydrolysed in sulphuric 
acid to generate monomeric sugars according to Seaman et al.36, then hydrolysed for 1 h in 72 % 
w/w H
2
SO
4
 at 30 °C and finally diluted with distilled water to a final concentration of 1M H
2
SO
4
. 
The mixture was incubated for 3 h at 100 °C, then cooled on ice and then briefly centrifuged. The 
supernatants were diluted until 1 mL volume was reached, and 2.5 µL 0.1% (w/v) bromophenol 
blue in ethanol was added. The pH was adjusted with barium carbonate until a clear blue colour 
was obtained (pH > 4.6). The remaining solution was filtrated using a 0.45 µm PFTE filter. The 
amount of monomeric sugars was measured according to the method of Gilbert-López et al., 
with the following modifications37. A flow rate of 0.25 mL/min was used and the column was 
equilibrated with H
2
O. Elution was performed as follows: 0-35 min H
2
O, 35-50 min 0-40 % 1 
M sodium acetate in 100 mM NaOH, 50-55 min 1 M sodium acetate in 100 mM NaOH, 55-60 
min 150 mM NaOH, 70-85 min H
2
O. Monomeric sugars eluted from the CarboPac PA guard 
column were detected after addition of 0.5 M sodium hydroxide (0.15 mL/min). The monomeric 
sugars were quantified using a calibration curve generated with standards in the range of 0 – 0.1 
mg/mL. Deoxy-galactose was used as internal standard and the column temperature maintained 
at 20 °C. 
2.8 In vitro fermentation with human faecal microbiota
In vitro batch fermentation of fibres by human faecal microbiota was performed as previously 
described38. SB and A were first incubated in 0.9 % (w/v) pancreatin (Sigma) at 37°C overnight 
in order to remove any free sugars. After incubation, the samples were centrifuged and the 
pellets were freeze-dried and milled into powder. Sterile penicillin bottles were filled with 43 mL 
sterilised colon growth medium (5.22 g/L K
2
HPO
4
,
 
16.32 g/L KH
2
PO
4
, 2 g/L NaHCO
3
, 2 g/L 
yeast extract, 2 g/L peptone, 1 g/L mucin, 0.5 g/L L-cysteine HCL and 2 mL/L tween-80) and 
with 20 mL of each substrate in sterilised demi-water: digested sugar beet (0.8 g; SB), digested 
apple (1.3 g; A) or sugar beet pectin (0.2 g; SBP). The bottles were closed with rubber caps 
and made anaerobic by flushing with nitrogen. The human faecal inoculums were prepared as 
described by Van den Abbeele et al.38, in a phosphate buffer (8.8 g/L K
2
HPO
4
, 6.8 g/L KH
2
PO
4
 and 
0.1 g/L sodium thioglucolate) using separate faecal samples from 2 healthy, non-smoking, donors 
ageing from 25 – 30 years. To start the fermentation, 7 mL faecal inoculum was injected into the 
penicillin bottles. Microbiota-free control bottles were prepared with each substrate, growth 
medium and phosphate buffer without faecal inoculum. Additionally, a control containing only 
growth medium and faecal inoculum in phosphate buffer was included for each faecal donor. The 
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bottles were incubated at 37 °C with constant shaking (300 rpm) for 48 h. After 0 h, 4 h, 8 h, 24 
h and 48 h, 3 mL samples were collected, centrifuged at 9000 g for 5 min, filtered using a 0.2 µm 
RC filter (Phenomenex) and stored at -20 °C until further analysis. The supernatants (10 % final 
volume) were incubated with BMDCs from TLR2/4 KO mice for 24 h and secreted cytokines 
quantified as described in section 2.4 above. As controls, BMDCs were stimulated with (100 ng/
mL LPS, 10 ng/mL Pam2CSK4, 100 ng/mL Pam3CSK4 or 20 µg/mL depleted zymosan).
2.9 Statistical analyses
GraphPad Prism 5 (La Jolla, USA) was used for the statistical analyses. Results are shown as 
mean ± SEM. One-way ANOVA followed by a Tukey post-hoc test was used to analyse the data 
for NF-κB activation in TLR 2, 4 and 5 reporter cells and cytokine measurements. Student’s 
t-test was used to test the difference between bead binding with and without the addition of 
potential binding inhibitors. Two-way ANOVA was used to analyse qPCR data on the relative 
expression of cytokines in the presence or absence of piceatannol and blocking antibodies. A 
repeated measures two-way ANOVA was used for the differences in IL-6 production between 
the substrates during in vitro fermentation over time, followed by a Bonferroni post-hoc test. For 
probability values of *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 the null hypothesis 
was considered true. 
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3 Results 
Previously, LA was shown to activate BMDCs from mouse TLR2/4 knockout mice which avoided 
potential effects of contaminants such as bacterial LPS, lipoproteins and lipotechoic acids. In 
order to investigate the potential immunomodulatory effect of LA (from sugar beet) on human 
DCs, it was necessary to remove MAMPs such as LPS and TLR2 agonists, which would activate 
the NF-kB pathway through TLR signalling. The alkali-treated LA gave only background levels of 
NF-kB activity in TLR luciferase reporter cell lines, which were not significantly different to the 
medium negative control (p < 0.05; Figure 1). The responsiveness of the different TLR-reporter 
cell lines was verified using their specific ligands and TNFa as a TLR-independent activator of 
the NF-kB pathway. Control HEK293 cells containing the pNiFTy reporter but not expressing 
TLRs were, as expected, not responsive to the TLR ligands (data not shown). We also verified 
that the alkali-treated LA still activated BMDCs from TRL2/4 KO mice and induced cytokine 
secretion (Figure 2).
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Figure 1. NF-κB activation (RLU) after stimulation of HEK293-hTLR2, HEK293-hTLR4 and HEK293-
hTLR5 pNifty2 cells with the controls LPS (1 µg/mL), PAM2CSK4 (25 ng/mL), flagellin (40 ng/mL) and 
TNFα (2.5 ng/mL), and linear arabinan (LA, 400 µg/mL) before and after LPS removal. n = 3. Different 
letters above bars represent statistically significant differences between responses to each compound.
3.1  Specific binding of LA to human DCs 
To study if purified LA would bind to human monocyte-derived DCs, we immobilized LA on 
fluorescent beads coated with protein-G affinity purified antibody specific for (1-5)-α-L-Arabinan. 
The beads coated with LA bound specifically to DCs with approximately 40 % of bead positive cells. 
This was similar as the binding of LeY-coated beads, which are known to strongly bind to DCs via the 
DC-SIGN receptor (Figure 3). In contrast, no binding of the uncoated control beads was detected 
indicating a specific interaction between DCs and the LA glycans. Moreover, binding of LA-coated 
beads to DCs was significantly decreased in presence of egtazic acid (EGTA), indicating a calcium-
dependent mode of binding. In agreement with previous studies on calcium-dependence of DC-
SIGN-ligand interactions39, EGTA also decreased binding of the beads coated with LeY to DCs. 
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Figure 2. Cytokine production after stimulation of bone marrow derived dendritic cells from TLR2/TLR4 
KO mice with medium control (RPMI), depleted zymosan (20 µg/mL), LPS (10 and 100 ng/mL), PAM2 
(10 ng/mL), PAM3 (100 ng/mL) or linear arabinan (LA, 400 µg/mL). n = 3. Different letters above bars 
represent statistically significant differences between responses to each compound. 
Blocking antibodies against Dectin-1, Dectin-2, combination of Dectin-1 and 2, mannose 
receptor (MR), or the immunoglobulin isotype control antibody, did not inhibit the binding of 
LA-coated beads, suggesting that LA binds to a different CLR (Figure 3). Mannan, a competitive 
inhibitor of mannose-binding receptors, significantly reduced binding of LeY-coated but not 
LA-coated beads to DCs, indicating that the CLR interacting with LA does not interact with 
high mannoses (Figure 3).
3.2  LA activation of human immature DCs 
Addition of purified LPS-free LA to human DCs of two individual donors induced expression of 
cytokines IL-6, IL-10 and TNFα as shown for BMDCs (Figure 2). Addition of piceatannol (40 µM) 
significantly reduced transcription of IL-6 and IL-10 suggesting that the signalling induced by LA 
may be SYK-dependent (Figure 4a). The cytokine induction by curdlan was effectively blocked 
by anti-Dectin-1 (positive control, data not shown). The induction of cytokine expression by 
LA was not blocked by antibodies to Dectin-1 or DC-SIGN compared to a non-specific control 
antibody of the same immunoglobulin isotype (Figure 4b), providing further evidence that CLRs 
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Dectin-1, DC-SIGN or the mannose receptor were not responsible for the signalling and immune 
activation by LA. Additionally, siRNA silencing of Macrophage (inducible) C-type lectin (MCL and 
Mincle) did not attenuate expression of cytokines induced by LA (Figure 4c).
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Figure 3. Bead binding assay using beads coated with control (-), linear arabinan (LA) or lewis Y (LeY, 
positive control) after stimulation of human dendritic cells with EGTA, mannan, isotype, several Dectin 
antibodies and mannose receptor antibody (a-MR). n =2. *p < 0.05, **p < 0.01.
3.3  Arabinan from faecal microbiota fermentation of sugar beet and apple in vitro 
3.3.1 Sugar composition of sugar beet, apple and sugar beet derived pectin
The sugar composition of pancreatin treated SB, A and SBP was presented in Table 1. In all 
the arabinose substrates, the major sugars present were glucose and arabinose, followed by 
galactose, galacturonic acid, rhamnose, xylose, mannose and N-acetyl glucosamine. The highest 
content in galacturonic acid, 12 % ± 0.81 % was found in SBP. The arabinose content was 35 % 
± 0.05 % in SBP which was significant higher (p < 0.05) than in SB (23 % ± 0.47 %).
3.3.2 Immune-stimulatory activity of fermented apple, sugar beet and extracted sugar 
beet pectin (SBP) 
An in vitro batch model was used to simulate human colon microbiota fermentation of the 
pancreatic pre-digested SB and A, and extracted SBP. Fermenter supernatants were collected 
at intervals over 48 h, filtered and added to BMDCs from TLR2/4 KO mice to assess their 
immune-stimulatory activity by measurement of secreted cytokines (Figure 5). Microbiota-
free control bottles were prepared with each substrate, growth medium and phosphate buffer 
without faecal inoculum. Additionally, a “no-substrate control”, containing only growth medium 
and faecal inoculum in phosphate buffer was included for each faecal donor.
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Figure 4. Relative mRNA cytokine levels of IL-6, IL-10 and TNFα after stimulation of human DCs with 
control (-) or linear arabinan (LA), with the addition of (a) DMSO or Piceatannol, (b) isotype control, anti-
Dectin-1, anti-DC-SIGN or anti-Mannose receptor (a-MR) or (c) silencing of Macrophage (inducible) 
C-type lectin (MCL and Mincle). n = 2 donors. **p < 0.01, and ****p < 0.0001.
Table 1. Sugar composition (% w/w) of the total amount of polysaccharides in sugar beet, apple and sugar 
beet pectin.
Glucose Arabinose Galactose Galacturonic acid Rhamnose Xylose Mannose N-acetyl 
glucosamine
Sugar beet 50 ± 0.65 23 ± 0.47 10 ± 00.3 7 ± 0.3 2 ± 0.04 2 ± 0.03 2 ± 0.03 3 ± 0.22
Sugar beet pectin 36 ± 0.06 35 ± 0.05 8 ± 0.03 12 ± 0.81 3 ± 0.12 1 ± 0.01 1 ± 0.04 4 ± 0.81
Apple 50 ± 0.75 14 ± 0.15 11 ± 0.23 7 ± 0.02 2 ± 0.1 7 ± 0.12 3 ± 0.01 5 ± 0.12
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Figure 5. Cytokine production after stimulation of bone marrow derived dendritic cells from TLR2/TLR4 
KO mice with batch fermentation supernatant of nonbacterial control (control), non-bacterial control 
sugar beet (control sugar beet), sugar beet, non-bacterial control sugar beet pectin (control sugar beet 
pectin), sugar beet pectin, non-bacterial control apple (control apple) or apple during in vitro fermentation. 
n = 2 donors. **p < 0.001.
Table 1. Sugar composition (% w/w) of the total amount of polysaccharides in sugar beet, apple and sugar 
beet pectin.
Glucose Arabinose Galactose Galacturonic acid Rhamnose Xylose Mannose N-acetyl 
glucosamine
Sugar beet 50 ± 0.65 23 ± 0.47 10 ± 00.3 7 ± 0.3 2 ± 0.04 2 ± 0.03 2 ± 0.03 3 ± 0.22
Sugar beet pectin 36 ± 0.06 35 ± 0.05 8 ± 0.03 12 ± 0.81 3 ± 0.12 1 ± 0.01 1 ± 0.04 4 ± 0.81
Apple 50 ± 0.75 14 ± 0.15 11 ± 0.23 7 ± 0.02 2 ± 0.1 7 ± 0.12 3 ± 0.01 5 ± 0.12
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Fermentation of sugar beet induced a higher IL-6 production by DCs after 48 h of fermentation 
than the no-substrate control (SB control, Figure 5; p < 0.001). Besides, after fermentation of 
SB for 48 h, there was a significant increase in IL-6 compared to SBP fermentation (Figure 5; p < 
0.001). TNFα secretion was significantly higher in the microbiota-free SB control compared 
to the no-substrate control or SBP after 48h (p < 0.001). During A fermentation, there was a 
significant increase in TNFα production induced by A compared to the SBP and the no-substrate 
(faecal microbiota only) control. No statistically significant increase in IL-10 production was 
found for any of the substrates. Furthermore, no differences were observed between a substrate 
and its corresponding control without bacteria (SB, A or SBP control). 
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4 Discussion
Immune-modulation by dietary polysaccharides has received increasing interest in recent 
years31,40,41. However, many fibres are contaminated with bacterial MAMPs such as LPS, 
which are difficult to remove, making it hard to screen for immune activation by human cells31. 
Recently, several dietary fibres were shown to activate BMDCs from TLR2/4 KO mice, that 
are not responsive to LPS, suggesting that, similar to 1,3-β-glucan, they interact with CLRs to 
induce immune signalling responses21. Here we verified that LA activates BMDCs from TLR2/4 
KO mice and induces cytokine secretion in amounts comparable to that previously reported 
(Figure 2). The amounts of secreted cytokines produced after stimulation with 400 µg/mL LA 
in our study are comparable to those reported by Meijerink et al.21, despite having used frozen 
aliquots of BMDCs in our study.
To investigate whether LA would also activate human DCs, we used a recently developed method 
for removing LPS and other MAMPs from dietary fibres31. LPS-free LA lacked NF-kB inducing 
activity in TLR4, 2, and 5 reporter cell assays but still activated BMDCs from TLR4/2 knockout 
mice. Incubation of LA with human DCs led to activation and cytokine secretion showing that 
the mechanism of immune activation is also present in human immune cells (Figure 4). 
To characterize the human receptor for LA, LPS-free LA was coupled to fluorescent beads with 
a monoclonal antibody and incubated with human DCs in the presence of different inhibitors, 
competitors and CLR blocking antibodies. LA binding to human DCs was blocked by the 
addition of EGTA, indicating that LA binding to DCs is calcium dependent. Ligand binding to 
the carbohydrate recognition domain of several CLRs is known to be calcium-dependent42. 
Furthermore, DC activation and cytokine secretion was blocked by addition of piceatannol, a 
SYK inhibitor. The first known SYK coupled C-type lectin was Dectin-1, which functions during 
fungal infections, but recently other CLRs that signal via SYK have been identified43. The finding 
that LA signals through SYK in a calcium-dependent manner provides evidence for possible 
involvement of a CLR43,44. However, we were unable to identify the CLR recognising LA using 
CLR blocking antibodies or siRNAs inhibiting the expression of specific CLR. LA bead binding 
to human DC was not blocked by antibodies against Dectin-1, Dectin-2, a combination of 
Dectin-1 and Dectin-2, or the mannose receptor, indicating that none of these CLRs interacts 
with LA. Besides binding, the induction of cytokines was not lowered by antibodies to Dectin-1, 
Dectin-2, DC-SIGN, a control isotype, and mannose receptor, confirming that LA is recognized 
by a different C-type lectin receptor. Silencing of Mincle and MCL also did not decrease the 
cytokine production by LA, suggesting that LA binding to DCs signals to an unknown other 
CLR (like) receptor. 
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To study the effect of the food matrix and microbiota fermentation on LA release and immune 
response, pectin-rich matrices such as SB, A and SBP were fermented in vitro by faecal 
microbiota from two different donors and the supernatants were tested for their capacity to 
activate cytokine secretion in TLR2/4 KO mice BMDCs. Controls were included where the 
pectin-rich substrates were dissolved in the growth medium without bacteria to separately 
check for the effect of soaking and dissolution of potentially active fractions from the substrates. 
Our hypothesis was that the observed effect of LA to induce cytokine production by DCs would 
be different when LA is provided in a purified form, when provided still attached to the pectin 
backbone, and when pectin itself is naturally embedded in the plant cell wall material. The pectin 
extraction aimed to retain the highest amount of arabinan. As shown in Table 1, the arabinose 
content in % w/w was significantly increased in the SBP compared to the SB. This indicates 
that the pectin extraction was successful and that the SBP probably contains a relatively higher 
amount of (linear) arabinan.
The major cytokines that were produced by DCs upon stimulation of the supernatants were 
IL-6 and TNFα. Overall, both SB and A gave a significantly higher cytokine production than the 
non-substrate bacteria-only control, therefore indicating their potential to induce an immune 
response. During the fermentation of SB, only a slight increase of IL-6 and TNFα was found over 
time. Interestingly, the sugar beet control, where no bacterial inoculum was added to the batch 
fermentation, did not induce a different cytokine production compared to the supernatants from 
fermented sugar beet. This indicates that the production of cytokines is not, or not prominently, 
modulated by microbial utilization of sugar beet dietary fibre. It must be stressed here that the 
BMDCs were stimulated with supernatant of the batch fermentation only, which is expected to 
contain only the water-soluble fraction of sugar beet and apple to avoid adding intact bacteria 
which might be phagocytosed. To study the effect of fermentation on the full potential of LA 
to bind DCs, it would be interesting to study also the insoluble pellet, because the particulate 
fraction of LA is better able to bind DCs21. It is also noteworthy to mention that SB and A have 
been extensively digested overnight before fermentation, to remove all the possible non-dietary 
fibre (DF) compounds from the plant matrix. However, it is possible that the comparatively 
longer incubation for 48 h at 37 °C may have facilitated further solubilisation of fibre from 
the matrix. In such a scenario, the cytokine response observed at different fermentation times 
would be the result of a complex interplay between release of pectin from the matrix, release of 
LA molecules from pectin, release of other potentially active compounds from the plant matrix 
and the metabolism of all by microbial fermentation. After 48 h, SBP induced a significantly 
lower amount of IL-6 than SB, a trend observed at all-time points, indicating that in SBP LA was 
probably metabolised during fermentation resulting in a lower IL-6 production. The study of 
Tuncil et al., showed that fermentation of soluble fibres was faster when fermented individually 
as compared to when fermented in a mixture45. This indicates that SBP was probably fermented 
faster than the SB, therefore resulting in a rapid loss of LA and less cytokine production by DCs.
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Compared to SB, fermentation of A resulted in less IL-6 production. The observed differences 
may be due to a difference in the amount of (linear) arabinans in apple pectin, as the amount of 
substrate supplied in the batch fermentation was calculated based on the arabinose content 
which might not relate exactly to the amount of LA. However, the difference in the supplied 
amounts of sugar beet and apple cannot account for the difference in IL-6 production during 
fermentation. Thus, immunomodulatory fibres such as linear arabinan might be present in 
greater amounts in A compared to SB. Overall, both SB and apple elicited significantly increased 
production of cytokines than the non-substrate bacteria-only control, indicating their potential 
to induce an immune response.
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5 Concluding remarks
LA induces cytokine production in human DCs which was not due to contamination with LPS 
or other MAMPs. Through binding assays with blocking antibodies, competitive ligands as well 
as siRNA knockdown experiments in human DCs we ruled out the involvement of several well 
characterised CLRs including Dectin-1/Dectin-2, Mincle, DC-SIGN and the mannose receptor. 
However, activation of DCs was calcium-dependent supporting the notion that LA interacts 
with one of the CLRs with a calcium-dependent carbohydrate binding domain. Additionally, 
activation of DCs and cytokine secretion appeared to be SYK-dependent suggesting the CLR 
involved contains an ITAM motif or hemi-ITAM motif. 
During fermentation of SB and A, mainly IL-6 and TNFα were produced by mice DCs. SBP did not 
induce higher amounts of cytokine secretion than SB and A after 48 hours of fermentation. This 
may be due to more rapid microbial metabolism of LA or branched arabinans in isolated pectin.
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Figure S1. Cytokine production after stimulation of bone marrow derived dendritic cells from TLR2/TLR4 
KO mice with controls: medium, LPS, depleted zymosan, PAM2 or PAM 3. n = 5. 
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Abstract
Many dietary phytochemicals have been reported to promote gut health. Specific dietary 
phytochemicals, such as luteolin, as well as specific microbial metabolites of tryptophan are 
ligands of the Aryl hydrocarbon Receptor (AhR), which plays a role in immunity and homeostasis 
of the gut barrier. Here, the fate of luteolin during colonic fermentation and the contribution of 
tryptophan metabolites to AhR activity in different parts of the colon are investigated. Several 
polyphenols are screened for AhR activation and oregano, containing the ligand luteolin, is added 
to batch cultures of human microbiota from the distal colon. Luteolin is rapidly metabolized, 
with no measurable increase in AhR activity. In the second experiment using the Simulator 
of the Human Intestinal Microbial Ecosystem (SHIME), not all luteolin is metabolized in the 
ascending colon, but disappears rapidly in the transverse colon. The greatest AhR activity is due 
to microbiota-derived metabolites of tryptophan, particularly in the descending colon. Luteolin 
in food is rapidly metabolized in the transverse colon. Tryptophan metabolism by the microbiota 
in the colon contributes substantially to the pool of lumen metabolites that can activate the AhR.
Keywords: Aryl hydrocarbon Receptor, SHIME, Microbiota, Luteolin, Tryptophan
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1 Introduction
The Aryl hydrocarbon Receptor (AhR) is best known for its role in detoxification of halogenated 
aromatic hydrocarbons such as polycyclic aromatic hydrocarbons (PAHs) and dioxins. Of these 
exogenous compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the most potent activator 
and it induces diverse toxicological and biological effects1,2. Perspectives on the biological role 
of AhR have changed due to the establishment of a link between dietary or microbial agonists 
of the AhR and maintenance of host-microbe homeostasis in the intestine3-5. Activation of AhR 
in the gut is essential for maintenance of intraepithelial lymphocytes (IELs) and IL-22 producing 
innate lymphoid cells (ILC3s), which enhance the gut barrier functions and control the microbial 
load and composition5,6. Therefore, AhR is considered as a sensor that connects the outside 
environment with cellular processes with consequences for immune functioning5,7,8.
The AhR consists of a basic helix-loop-helix (bHLH) protein and belongs to the Per-Arnt-Sim 
(PAS) superfamily9. The receptor is an intracellular, ligand-activated transcription factor. In the 
cytosol, AhR forms a complex with two heat shock protein 90 molecules, an X-associated protein 
2, prostaglandin E synthase 3 (p23), AhR interacting protein (AIP) and AhR-activated 9 (ARA9)10. 
Upon ligand binding to AhR, AIP is released leading to a conformational change, exposure of the 
nuclear location signal and translocation to the nucleus. In the nucleus, HSP90 is assumed to 
dissociate from the complex allowing interaction with ARNT and binding to the dioxin/xenobiotic 
response elements (DRE/XRE), leading to expression of AhR-regulated genes11.
Certain dietary compounds like polyphenols, mainly flavonoids, and tryptophan derivatives 
have been reported as AhR ligands8,9,12. Recent studies showed the major significance of dietary 
compounds like tryptophan and phytochemicals like indole-derivatives in both intestinal and 
microbial homeostasis in relation to AhR in mouse colitis models13,14. As little is known about 
how metabolism of these compounds by microbes alters the AhR-mediated signaling activity, 
we sought to study the kinetics of their release and the ability to activate the AhR using the 
Simulator of the Human Intestinal Microbial Ecosystem (SHIME), simulating the ascending (AC), 
transverse (TC), and descending (DC) colon15. The aim of our research was to study the effects of 
dietary ligands on AhR and the effect of microbial fermentation of food matrix on the evolution 
of the formed ligands. Additionally, we investigated the relative contribution of microbiota-
derived tryptophan metabolites to the overall AhR activity in different parts of the colon. 
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2 Materials and Methods
2.1 Chemicals
All chemicals used were purchased from Sigma-Aldrich (St. Louis, MO), unless stated otherwise. 
The tested polyphenols were: apigenin, baicalein, catechin, caffeic acid, 4-O-caffeoylquinic 
acid, chrysin, chlorogenic acid, curcumin (Indofine Chemicals (Hillsborough, NJ)), daidzein, 
epicatechin, epigallocatechin gallate, formononetin, hesperetin, kaempferol, luteolin (Indofine 
Chemicals), myricetin, naringenin, quercetin, resveratrol (Indofine Chemicals) and rutin (Indofine 
Chemicals). Two different batches of dried oregano (Origanum vulgare) were purchased on the 
local marked and used for the batch and SHIME experiments.
2.2 Luteolin extraction from oregano
To determine the luteolin concentration in oregano, duplicate samples of 50 mg of milled dried 
oregano were mixed with 5 mL of 70% (v/v) methanol and sonicated for 60 min at 40 kHz, 100 W 
(HBM Machines B.V., Moordrecht, The Netherlands). The temperature during sonication ranged 
from 22 to < 48 ºC. After sonication, the extract was centrifuged at 1363 g for 15 min and the 
supernatant was passed through a 0.20 µm cellulose filter (Phenomenex, Torrance, CA) and 
stored in the dark at room temperature. 
2.3 Batch SHIME
SHIME (ProDigest, Belgium) was used to mimic the distal colon of three different donors. 
Microbial inoculum was first stabilized over a period of 2 weeks to adapt to the proximal and 
distal colon respectively as previously described16. Fresh fecal samples were used to inoculate 
the TRIPLESHIME setup, consisting of a proximal and distal colon for three different donors. 
The two male and one female fecal stool donors were nonsmoking adults, between 25 and 35 
years of age, with no prior history of antibiotic and probiotic use for at least 6 months and 3 
weeks respectively. For each donor, three double-jacketed vessels were used, simulating one 
combined stomach/small intestine, a proximal (pH 5.6 - 5.9) and a distal colon (pH 6.6 - 6.9). 
Every 8 h, 70 mL fresh liquid feed (pH 2) entered the stomach vessel for each donor with a stable 
feed composition (1.2 g/L arabinogalactan, 2.0 g/L pectin, 0.5 g/L xylan, 0.4 g/L glucose, 3.0 g/L 
yeast extract, 1.0 g/L special peptone, 3.0 g/L mucin, 0.5 g/L L-cysteine-HCl and 4.0 g/L starch16). 
After 90 min, 30 mL of pancreatic juice (12.5 g/L NaHCO
3
; 6 g/L Oxgall, BD Biosciences, The 
Netherlands; 0.9 g/L pancreatin from porcine ≥ 3 * USP) was added. After 90 minutes of the 
small intestinal phase, the total volume was transferred to the proximal colon connected in 
series to the distal colon. The vessel volumes, pH and retention times were kept constant at 
all times15,17. 
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Freshly donated fecal sample was stored in a collection box with an anaerobic AnaeroGen™ 
bag (Oxoid, UK), at 4 °C for less than 8 hours. A 20 % (w/v) solution of the fecal sample was 
homogenized with phosphate buffer for 10 min using a stomacher 400 circulator (Seward, UK). 
The sterilized phosphate buffer consisted of 8.8 g/L K
2
HPO
4
 (Merck KGaA, Germany), 6.8 g/L 
KH
2
PO
4
 (Merck KGaA) and 0.1 g sodium thioglycolate in demi-water. The pH was adjusted to 
7 and 15 mg sodium thionite (VWR, The Netherlands) was added before use. After mixing, the 
inoculum was centrifuged for 2 min at 500 x g and added in a concentration of 5 mL per 100 mL 
vessel volume. After the 2 weeks stabilization period, the microbiota was collected and stored 
with 50 % sterilized cryoprotectant (a final concentration of 42 % glycerol, 0.5 g/L cysteine HCl, 
10 g/L trehalose and 3 g/L tryptic soy broth (Oxoid)) at -80 °C for further experiments.
The SHIME set-up was modified to study oregano and luteolin fermentation in the distal colon. 
Three distal colon vessels were used, originating from the three different donors, inoculated 
with 4 mL of the frozen stabilized microbiota added to 400 mL feed per vessel. The microbiota 
was grown anaerobically overnight, with pH controlled in the range 6.6 - 6.9, followed by a 
3-day program with simulated feedings every 8 h. The experiment included three treatment 
days, with daily addition of 0.75 grams milled and sieved (< 0.250 mm) dried oregano (Greek) 
per donor to the stomach phase. The concentration of luteolin in oregano was 6.4 ± 0.3 mg per 
100 g. Samples were taken during fermentation and immediately centrifuged for 5 min at 9000 
x g at a temperature of 4 °C. After centrifugation, the supernatants were filtered using a 0.20 
µm cellulose filter and stored at -20 °C until further analyses. The three donors were used as 
biological replicates. 
2.4 TWINSHIME
To simulate a complete microbial fermentation, including an ascending (pH 5.6 - 5.9, 250 mL), 
transverse (pH 6.15 - 6.4, 400 mL) and descending colon (pH 6.6 - 6.9, 300 mL), the TWINSHIME 
was used. Fecal inoculation was performed similarly to the batch SHIME experiment, including 
a 2-week stabilization period. After stabilization, the microbiota suspension was frozen as 
described above. The experimental procedure consisted of addition of 1.5 g dried oregano per 
donor to the stomach phase, followed by a time series of sampling during fermentation at 10, 
20, 30, 60 and 300 min in all colon parts. This batch of oregano contained 9.7 ± 0.3 mg luteolin 
per 100 gram oregano. Individual donors were used as biological duplicates.
2.5 AhR activation
Luciferin transfected Dr Chemical Activated LUciferase gene eXpression (CALUX) reporter cells 
(BioDetection Systems, The Netherlands, mycoplasma free), HepG2 cells and Caco-2 cells were 
used to measure the AhR activation. 
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2.5.1 Chemical Activated LUciferase gene eXpression
The reporter cells were grown in α-MEM growth medium (Gibco, USA) with 1 % penicillin/
streptomycin (Gibco) and 10 % heat inactivated fetal calf serum (Gibco), harvested by trypsin/
EDTA and added to white clear bottom 96-wells plate (Corning, USA) at a final concentration 
of 7.5 x 104 cells per well. After 24 h incubation, the cells were stimulated with triplicate 
samples of the polyphenols listed in the chemicals section or controls and incubated for 24 
hours before performing the assay. All polyphenols and the positive control were dissolved in 
DMSO (Merck KGaA, Germany) and 1 % final volume was added to the CALUX reporter cells to 
measure AhR activation. The microbial culture supernatant was added as 20 % of final volume. 
After stimulation, the cells were washed twice with 200 µL per well PBS, lysed using 20 µL per 
well reporter lysis buffer (Promega, USA), followed by addition of 100 µL per well luciferase 
assay buffer (Promega). The luminescence was measured immediately after adding the assay 
buffer using a Spectramax M5 (Molecular devices, USA). The results of the AhR activation 
were expressed as a percentage of the activity obtained with the positive control consisting of 
5 µM β-naphthoflavone in DMSO18. All results were corrected for the corresponding negative 
controls incubated with medium or DMSO (n = 3).
2.5.2 CYP1A1 gene expression
The HepG2 cells (DSMZ, Germany) were grown in RPMI medium (Gibco) and Caco-2 cells (ATCC, 
USA) in DMEM medium (Gibco), both with 1 % penicillin/streptomycin and 10 % heat inactivated 
fetal calf serum. The HepG2 cells were seeded in 12 well plates (Corning) at a density of ≈ 7 x 105 
and used 24 hours after seeding. The Caco2 cells were seeded at a density of 1.5 x 105 in 12 well 
plates and grown for 2 weeks with regular medium refreshments to allow for differentiation. The 
cells were stimulated with microbial culture supernatant in a 20% final volume concentration. 
After 6 hours incubation, mRNA was extracted using a RNA isolation kit (Qiagen RNeasy mini 
kit, Germany) including an on-column DNase treatment (Qiagen) and cDNA was synthesized 
of 1ug mRNA (qScript, QuantaBio, USA). Quantitative PCR (qPCR) was performed using a 
Rotorgene machine (Qiagen) and SYBRgreen master mix (Promega, USA), to which 5 µl diluted 
(1:20) cDNA was added. The primers used were Cyp1A1 fw 5’GACCACAACCACCAAGAAC3’; 
rv 5’AGCGAAGAATAGGGATGAAG3’, GAPDH fw 5’TGCACCACCAACTGCTTAGC3’; rv 
5’GGCATGGACTGTGGTCATGAG3’, and β-actin fw 5’GGACTTCGAGCAA GAGATGG3’; rv 
5’AGCACTGTGTTGGCGTACAG3’. The program used was 95 °C for 2 minutes, followed by 40 
cycles of 95 °C for 3 seconds and 60 °C for 30 seconds. This was followed by a melt curve. The 
expression of Cyp1A1 was compared to both housekeeping genes and the results were similar 
following standardization to either gene. “-RT” and non-template controls were performed in 
every experiment and no amplification above background was detected. The results are shown 
as fold-changes (2-ΔΔCt) calculated via the ΔΔCt method19.
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2.6 Luteolin analysis
Luteolin concentration was monitored according to Ferracane et al. with some modifications20. 
Flavone was separated using an Ultimate 3000 U-HPLC (Thermo Scientific, Bremen, Germany) 
equipped with a C18 column (XBridge, 100 x 2.1 mm, 2.6 µm Waters, UK) and a guard column 
of the same phase, both thermostated at 30 ºC. The binary solvent system consisted of 0.1 % 
v/v formic acid (solvent A) and 0.1 % v/v formic acid acetonitrile (solvent B). The gradient elution 
was (min/%B): (0/20), (3/20), (7/80), and (9/80). The flow rate was 300 µl/min and the injection 
volume 10 µl. The U-HPLC was interfaced with a TSQ Quantum tandem mass spectrometer 
equipped with a heated electrospray source (HESI-I, Thermo). Positive selected reaction 
monitoring (SRM) mode with the following conditions was used: spray voltage 3000V, sheath 
gas pressure 10 psi, auxiliary gas pressure 5 psi and capillary temperature 260 ºC. Luteolin was 
analyzed by using the mass transitions and collision energy (CE) given in parentheses, in bold 
the quantitative transition: (m/z [M+H]+ 287/89, CE: 42 V; 287/153, CE: 31 V). Luteolin was 
quantified using a linear calibration curve with the external standard technique and the results 
were reported in ng/mL.
2.7 Tryptophan metabolites
Samples were centrifuged (21700 g, 10 min, 4 °C) and diluted five times in 0.1 % formic acid 
and passed through a 0.22 µm cellulose filter (Phenomenex) before high resolution mass 
spectrometry (HRMS) analysis. Chromatographic separation of tryptophan and tryptophan 
metabolites was achieved by using an Accela 1250 U-HPLC (Thermo) equipped with a Luna 
Polar C18 column (50 x 2.1 mm, 1.6 µm, Phenomenex) and a guard column of the same phase, 
both at 40 ºC. Mobile phases consisted of 0.1 % v/v formic acid (A) and 0.1 % v/v formic acid 
in acetonitrile (B) with the following gradient (min/%B): (0/2), (0.50/2), (9.5/70), and (12/70). 
The flow rate was 200 µl/min, the column temperature was 40 °C and 5 µl was injected. The 
U-HPLC system was interfaced to an Exactive Orbitrap HRMS (Thermo) and the analytes were 
detected through a heated electrospray interface (HESI-II) in positive mode. The current ion of 
each analyte listed in Table S1 was scanned in the m/z range of 50 – 400. The resolving power 
was set to 75000 full width at half maximum (FWHM, m/z 200) resulting in a scan time of 1s. The 
interface parameters were: spray voltage 4.8 kV, capillary voltage 20.0 V, capillary temperature 
295 °C, heater temperature 250 °C, and sheath gas flow and auxiliary gas flow were 30 and 9 
arbitrary units, respectively. HRMS conditions were optimized by infusing a mixture of indole, 
indole-3-acetic acid, tryptophan and l-kynurenine (20 µg/mL) at a flow rate of 3 µl/min. Analyte 
concentrations were monitored by using the external standard technique while mass tolerance 
was set to 5 ppm. Three sets of calibration curves for tryptophan, indole, indole-3-propionic 
acid, indole-3-carboxyaldehyde, indole-3-acetic acid, l-kynurenine, kynurenic acid, tryptamine, 
3-hydroxyanthranilic acid, anthranilic acid and 6-formylindolo(3,2-b)carbazole (FICZ) were built 
in the range 0.455 - 911 ng/mL. Intraday and interday assays were performed by monitoring 
three sets of calibration curves within the same day and in three different days. The slope among 
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the calibration curves was compared to each replicate and the results were expressed as relative 
standard deviation RSD (%). Each sample was analyzed in triplicate and the concentrations given 
in nM. A summary of the analytical performances of the method is reported in the supporting 
information (Table S1), while the repeatibility and reproducibility tests were always below 10 
% in the linearity range.
2.8 Microbial analysis
16S sequencing of the V3-V4 region was performed by BaseClear (Leiden, The Netherlands) and 
the results were analyzed using the CLC bio genomics workbench (Qiagen, The Netherlands), 
Microbial Genomics Toolbox. The SILVA 16S v128 99 % database was used as reference 
database. Results show the relative abundances at phylum level for the three different donors.
2.9 Statistical analyses
The statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, La Jolla, 
CA). Results are shown as mean ± standard error of the mean (SEM). *p < 0.05, **p < 0.01 
and ***p < 0.001 are considered statistical differences. Letters above bars represent classes 
of statistically significant different responses compared to each concentration. Each graph 
bar with the same letter is not statistically different. The AhR activation data and luteolin 
concentrations between the different fermentation time points were tested using a one-way 
ANOVA followed by a Tukey post-hoc analysis. A first order kinetics model was fitted to the 
luteolin degradation data in order to determine the rate constants for luteolin degradation on 
each of the three days using the Solver tool in Excel. Differences between days in fermentation 
rates were analyzed using a one-way repeated measures ANOVA followed by a Tukey post-hoc 
analysis. Differences between AC, TC and DC in AhR activation were tested using repeated 
measures two-way ANOVA followed by a Bonferroni multiple comparisons test. The qPCR data 
was analyzed with ANOVA followed by a Tukey post-hoc analysis using the ddCt values. The 
heat map was calculated using OMICs (XLSTAT, Addinsoft, NY). Dendrograms were built by the 
agglomerative hierarchical clustering algorithm considering the concentrations (nM) of each 
tryptophan metabolite21. 
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3 Results and Discussion
3.1  Screening dietary phenolic compounds for AhR activation 
Among all polyphenols listed in the chemical section tested for AhR activation, only luteolin, 
baicalein and 4-O-caffeoylquinic acid showed a dose dependent AhR activation with an optimal 
concentration of 80, 320 and 40 µM, respectively (Figure 1). Interestingly, quercetin did not 
activate AhR, and actually reduced AhR activation by luteolin, suggesting an antagonistic effect 
of quercetin on AhR activation. When luteolin was combined with the ligand β-naphthoflavone 
(Figure 1f), no differences in AhR activation were found, suggesting that luteolin does not show 
antagonistic effects on AhR when combined with another agonist. Chlorogenic acid also did not 
activate AhR, unlike its isomer 4-O-caffeoylquinic acid. Several studies have reported conflicting 
results on the capacity of polyphenols to activate AhR12,22-25, most likely due to use of different 
cell types in the reporter assay26. Baicalein has been reported to activate AhR using different 
cell lines, but quercetin is often reported as either a (weak) ligand or antagonist27, consistent 
with our results (Figure 1e).
Figure 1. AhR activation measured with the CALUX reporter assay with luciferase production as readout, 
expressed as percent of the positive control (β-naphthoflavone, 5 µM). (a) Luteolin; (b) Baicalein; (c) 
4-O-caffeoylquinic acid; (d) Quercetin (e) Luteolin combined with an equivalent concentration of 
quercetin; (f) Luteolin combined with 5 µM β-naphthoflavone. Letters above the bar represent classes 
of statistically significant different responses compared to each concentration. Bars with the same letter 
are not statistically different.
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Luteolin and baicalein belong to a sub-class of flavonoids named flavones. In their most stable 
conformation, flavone conformers can take on a planar structure, which is thermodynamically 
unfavorable to flavonols, because of the presence of a hydroxyl group at C3 position of the 
C carbon ring. Based on these observations and the fact that several known AhR ligands are 
planar (e.g. β-naphthoflavone dioxin, FICZ), we speculate that a planar structure is an important 
structural feature of AhR ligands. Despite the fact that quercetin differs from luteolin by a single 
hydroxyl group, on C3 of the C ring, quercetin did not activate the AhR receptor in our assay. This 
is consistent with the fact that the most energetically stable conformer of quercetin is not a planar 
structure. Clearly, structural features other than the planar conformation are important for the 
activation of AhR because other flavones such as apigenin, which possesses a planar structure, did 
not activate AhR. The structure-dependent AhR activation by flavonoids is also described by Jin et 
al., where they show that the number of hydroxyl groups plays an important role in AhR activity26.
Among the compounds which activate AhR, luteolin has dietary relevance as it is being found 
in several food sources such as oregano and parsley28. Baicalein has been found in the roots of 
the Scutellariae baicalensis. This root is not consumed as a food, but frequently used in Chinese 
herbal medicine29, while 4-O-caffeoylquinic acid is present in foods but its relative capacity to 
activate AhR is low. For these reasons, we decided to use oregano in our batch fermentation 
study because it is a rich source of luteolin.
3.2 Batch fermentation of oregano
To study the metabolic fate of luteolin in oregano during distal colon fermentation, a batch 
fermentation was performed where 0.75 grams of oregano per donor was added to the stomach 
phase of the digestion. The batch fermentation used in this experiment is a more physiological 
representation of human fermentation in vivo than conventional batch fermentation studies. 
After 10 min, the entire content of the small intestinal vessel was transferred directly to a vessel 
containing the microbiota of the distal colon. Results in Figure 2a indicated that, immediately 
after transfer, luteolin was rapidly metabolized by the microbiota of all donors. The luteolin 
bioaccessibility on day 1 was 179 %, followed by 122 % at day 2 and 149 % at day 3. This showed 
that luteolin was readily and fully bio-accessible from the finely grounded plant matrix that was 
used. After 60 min of fermentation, almost all luteolin was metabolized. Significant differences 
were observed in the rate of degradation of luteolin from oregano on different days (Figure 2b).
On day 3, luteolin was more rapidly degraded than on day 1 (p < 0.05, Table 1), which may be 
due to a metabolic adaptation or a shift in the microbiota composition at the lower taxonomic 
levels, in response to daily addition of polyphenols. Labib et al. performed a batch fermentation 
of luteolin with pig microbiota, where luteolin was broken down and the single metabolite 
3-(3-hydroxyphenyl)-propionic acid was formed30. Given its structural similarity to caffeic acid, 
there is no indication that the metabolite can activate AhR. In their study, the rate of luteolin 
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degradation was lower than that measured in our human colon fermentation model. This might 
be due to differences in microbial density or composition, fermentation conditions or different 
concentrations of luteolin31. 
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Figure 2. (a) Luteolin concentration in distal colon supernatants over 300 min on three consecutive days of 
oregano feeding, n=3 donors. (b) Rate of luteolin breakdown rate as percentage of starting concentration 
on three consecutive days of oregano feeding, n = 3 donors. (c-e) AhR activation in the distal colon on each 
day of consecutive oregano feeding, measured with the CALUX reporter assay using luciferase production 
as readout. Results are expressed as percent of the positive control (β-naphthoflavone, 5 µM), n = 3 
donors. Data are expressed as mean of three donors ± SEM, with *p < 0.05, **p < 0.01, and ***p < 0.001.
Interestingly, a similar breakdown kinetics of luteolin and AhR activation capacity was found in 
all three donors so their microbial composition was compared. The microbial composition in the 
distal colons after the stabilization period of the three different donors is depicted in Figure 3. 
Donor 2 shows a different Firmicutes/Bacteroidetes ratio (1.33 compared to 0.32 and 0.39 
for resp. donor 1 and 3). Donor 2 also shows a higher relative abundance in Actinobacteria 
compared to donor 1 and 3. The relative abundance of Proteobacteria was similar for all donors. 
Differences of this magnitude are typical of the normal variation observed between individuals, 
including differences due to gender32. In our study, the use of a standardized diet in the system 
throughout the stabilization period and experiments could have reduced the variability. 
However, even after a 2 weeks stabilization period with this diet, the microbial communities 
between donors preserve the original differences (data not shown). 
|   Chapter 3
64
Table 1. Rate constants (min-1) of luteolin degradation over three consecutive days of oregano feeding.
Day 1 Day 2 Day 3
Donor 1 0.0516 0.0785 0.1138
Donor 2 0.0413 0.0689 0.1236
Donor 3 0.0559 0.0695 0.0789
Data of Figure 2c-e showed that supernatants from the colon fermentation have a significant capacity 
to activate AhR (between 20 and 30 % of the reference). However, AhR activity does not change for 
up to 60 minutes after oregano addition, at which point the luteolin has been completely degraded 
(see Figure 2a), suggesting that at this concentration luteolin does not significantly contribute to the 
AhR activity present in the supernatants. Indeed, similar results were obtained with the microbial 
supernatant from the fermenter to which no oregano was added (Time 0, Figure 2c-e), demonstrating 
that substantial amounts of AhR ligands were being produced by the fecal microbiota. 
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Figure 3. Microbiota composition at phylum level (relative abundance) for the three different donors 
used in the distal colon batch fermentation. Microbiota composition was determined after the 2-week 
stabilization period in the SHIME and before addition of oregano.
3.3 TWINSHIME fermentation oregano
To assess the metabolic fate of dietary luteolin in connection to AhR activation in the different 
parts of the lower gut, a SHIME fermentation study on oregano was performed. 1.5 g of 
oregano per donor was added to the stomach/small intestinal phase, after which the content 
of the stomach/small intestinal vessel was automatically transferred in series to the vessels 
simulating the AC, TC and DC. The two different donors used in the SHIME study showed 
a different microbial composition (Figure S1) with comparable functionality, similar to the 
previous experiment. Therefore, results are shown as biological duplicates. 
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Figure 4 shows the luteolin concentration over time in the AC (Figure 4a), TC (Figure 4b) and DC 
(Figure 4c). The most interesting finding was the limited metabolism of luteolin in the AC after 
60 minutes (20.5 %, p > 0.05), which was reduced to 53.3 % after 300 min (p < 0.01). In contrast, 
a rapid decrease of luteolin was observed in the TC. The concentration of luteolin observed in 
the TC was initially lower than in the AC due to dilution upon transfer to the TC vessel, reaching 
a peak value of ≈ 100 ng/mL at 30 min, when the transfer was complete, after which it rapidly 
decreased. In the DC, low amounts of luteolin were present at 30 min due to its degradation 
in the TC and dilution upon transfer. Overall, these results suggest that breakdown of luteolin 
occurs primarily in the TC. The differential luteolin breakdown ability of the microbiota in the 
different part of the gut is a new finding that could have various biological implications. This 
evidence could be likely extended also to other polyphenols. In fact, the recent study of Wu et 
al. showed that absorption of polyphenols is influenced by location in the colon, with generally 
more absorption in the DC. Their data showed high recovery of polyphenols in the AC, whereas 
in the TC this is limited33. 
Supernatants from each colon condition were tested for their capacity to activate AhR during 
the 300 min fermentation of oregano (Figure 4d). All supernatants strongly activated AhR with 
highest activity in the DC where no luteolin was present. These results are comparable to the 
qPCR data where the Cyp1A1 gene expression is higher in the DC compared to the TC and AC 
in both human liver (HepG2) and intestinal (Caco-2) cells (Figure 5). It should be noted that the 
concentration of luteolin found in all the SHIME compartments is too low to account for the 
AhR signaling activity. The maximum recovered luteolin concentration was about 2 µM in the 
AC, which is about 20 times lower than what is needed to measure a significant AhR activation. 
The fermentation medium alone had no AhR activity and the luteolin released from oregano 
makes only a minor contribution to the total activity, indicating that the microbiota produces 
AhR activating ligands from other sources. 
Figure 6 shows the AhR activation in the AC. The basal activation is much lower than in the 
DC and a significant increase was observed after oregano feeding compared to a non-oregano 
feeding control. Oregano induces AhR activation in the AC, which is comparable to the base 
level AhR activation in the DC (Figure 4d). These results suggested that food components 
contribute to the total amount of AhR agonists present in the proximal part of the colon but 
the vast majority of AhR ligands present in the TC and DC are produced by the microbiota. We 
can hypothesize that there is an optimal production of microbial-derived AhR ligands along the 
colon and other AhR activators are needed when the microbial metabolites are not sufficiently 
present. This gap can be filled by dietary compounds34. Which exact compounds trigger the AhR 
receptor in the AC in this case remains unknown, but luteolin alone cannot be responsible for 
this effect.
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Figure 4. (a-c) The luteolin concentration after feeding oregano to the SHIME system, presenting a 
partially-dynamic system of ascending (a), transverse (b) and descending (c) colon connected in series. 
n = 2 donors. (d) AhR activation measured with the CALUX reporter assay in the ascending, transverse 
and descending colon during fermentation after addition of 1.5 g oregano per donor (n = 2 donors), using 
luciferase production as readout, expressed as percent of the positive control (β-naphthoflavone, 5 µM). 
Data are expressed as mean of two donors ± SEM, with *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 5. QPCR of Cyp1A1 gene expression as fold change compared to housekeeping gene GAPDH 
after stimulation of (a) HepG2 and (b) Caco-2 cells with SHIME samples from ascending colon (AC), 
transverse colon (TC) and descending colon (DC) of donor 1 and 2. The experiment was repeated twice 
for both donors, with *p < 0.05, **p < 0.01, and ***p < 0.001.
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Figure 6. AhR activation in the ascending colon for a control fermentation compared to oregano 
fermentation, measured with the CALUX reporter assay using luciferase production as readout, expressed 
as percent of the positive control (β-naphthoflavone, 5 µM), n = 2 donors. Data are expressed as mean of 
two donors ± SEM, with *p < 0.05, **p < 0.01, and ***p < 0.001.
3.4 Role of tryptophan derivatives in AhR activation
We hypothesized that a microbial source of AhR agonists in the SHIME supernatants were 
derived from the metabolism of tryptophan in the SHIME basal feed. The metabolism of 
tryptophan by certain gut bacteria has been shown to generate indole metabolites that 
exhibit both AhR agonistic and partial antagonistic activities8,35-38. Furthermore, tryptophan 
supplementation in the diet of mice resulted in the production of tryptophan metabolites which 
attenuated colitis in an AhR-dependent fashion14.
Results of measuring tryptophan metabolites (Table S1, Supporting Information) in fermentation 
supernatants are summarized in Figure 7 and their concentrations are given in Figure S2, 
Supporting Information. Ward’s method was used to scale, center and cluster data in order 
to depict hierarchical relationship between microbiota and the compounds formed21. Colon 
sections of the two donors were grouped together as revealed by the horizontal dendrogram, 
confirming the similar metabolic capacity of microbiota of different donors. Metabolites were 
clustered into three main groups according to the concentration in the three different sections. 
Anthranilic acid, tryptamine and 3-(2-hydroxyethyl)indole exhibited a constant concentration 
through the sections, while the other metabolites showed increased or decreased concentrations 
through the sections. In the bottom left corner of the dendrogram (AC1 AC2; colored red), the 
metabolites with highest concentration in the AC were tryptophan, L-kynurenine, indole-3-
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aldehyde, 3-hydroxyanthranilic acid, 3-methylindole and indole-3-acetic acid. However, these 
were measured in substantially lower amounts in the DC supernatants suggesting ongoing 
metabolism or degradation as they move through the colon. Oxindole, indole, kynurenic acid, 
indole-3-acetaldehyde and indole-3-propionic acid were present at a higher concentration in 
the DC than in the AC supernatants. The tryptophan concentration changed from 3417 ± 100 
nM in the AC, to a concentration of 372 ± 26 and 291 ± 0.9 nM in the TC and DC, respectively, 
while for instance indol-3-acetaldehyde increases from 3 ± 0.4 nM in the AC to 14 ± 0.0 and 16 
± 0.0 nM in the TC and DC, respectively. The tryptophan derivatives, kynurenine, tryptamine, 
indole-3-acetaldehyde, indole-3-acetic acid and indole-3-aldehyde are known AhR ligands8, 
explaining why the greatest AhR activation is found in the DC supernatants (Figure 4b).
Figure 7. Heat map of tryptophan and tryptophan derivatives, from yellow (lower concentration) to red 
(higher concentration). Ascending colon (AC), transverse colon (TC) and descending colon (DC) of donor 
1 and 2. The concentrations (nM) are reported in Figure S2, Supporting Information.
An intrinsic limitation of the SHIME model system is that it does not model the intestinal 
absorption16. As the intermediate tryptophan derivatives are not constantly removed as happens 
in vivo, an overestimation of AhR activity in the lumen of the human colon is expected because 
high levels of tryptophan are usually not reached in the distal colon. Besides lack of absorption, 
there is a discontinuous flow of liquids between colon sections in the system, resulting in a 
stricter cut-off between colon sections compared to in vivo where there is a continuous flow of 
material along the AC, TC and DC39.
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4 Concluding remarks
Our results with the food component oregano demonstrated that AhR activity in the large 
intestine can be modulated by dietary compounds. Polyphenols with a planar structure were 
generally found to be good AhR ligands. Luteolin, an AhR agonist present in oregano, is unlikely to 
achieve significant AhR activation along the entire colon due to its rapid degradation. However, 
other dietary AhR ligands in oregano were shown to activate AhR in the ascending colon. 
Tryptophan metabolites generated by the microbiota are found in relatively high concentration 
in all colon parts in our fermentation model, some of which are potent AhR ligands. Overall, it 
can be concluded that there is a dynamic formation of AhR ligands originating from dietary 
tryptophan by the gut microbiota and that other dietary AhR ligands can act as complementary 
AhR activators in the ascending colon.
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Supporting information
Table S1. HRMS performances. RT (retention time, min); TM (theoretical mass); EM (experimental mass, 
[M+H]+); error (Δ ppm). The following compounds were quantified using chemical similarities toward the 
analytes in parenthesis (SciFinder, ACS 2018): 3-(2-hydroxyethyl)indole (indole-acetic acid), oxindole 
(indole), 3-methyl indole (indole), indole-3-acetaldehyde (indole-3-aldehyde).
Compound Name RT Elemental 
Composition
TM EM Δ ppm
l-kynurenine 2.3 C10H12N2O3 209.09207 209.09275 3.3
indole-3-acetaldehyde 2.6 C10H9NO 160.07569 160.07549 -1.2
3-hydroxyanthranilic acid 3.2 C7H7NO3 154.04987 154.04991 0.3
tryptophan 4.1 C11H12N2O2 205.09715 205.09754 1.9
3-methyl indole 4.3 C9H9N 132.08078 132.08028 -3.8
tryptamine 4.4 C10H12N2 161.10732 161.10719 -0.8
kynurenic acid 4.6 C10H7NO3 190.04987 190.04963 -1.3
anthranilic acid 4.9 C7H7NO2 138.05496 138.05490 -0.4
indole-3-aldehyde 5.5 C9H7NO 146.06004 146.05990 -1.0
indole-3-acetic acid 5.6 C10H9NO2 176.07061 176.07021 -2.3
3-(2-hydroxyethyl)indole 5.8 C10H11NO 162.09134 162.09155 1.3
indole-3-propionic acid 6.2 C11H11NO2 190.08626 190.08611 -0.8
indole 6.7 C8H7N 118.06513 118.06509 -0.3
oxindole 6.8 C8H7NO 134.06004 134.06022 1.3
6-formylindolo(3,2-b)carbazole 8.6 C19H12N2O 285.10224 285.10199 -0.9
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Figure S1. Relative abundance of microbiota used in the TWINSHIME fermentation of 2 different donors 
before oregano treatment given in phylum level, analyzed by 16S sequencing. AC1/AC2 represents 
ascending colon donor 1/2; TC1/TC2 represents transverse colon donor 1/2; DC1/DC2 represents 
descending colon donor 1/2.
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Figure S2. Concentration of tryptophan and tryptophan derivatives in ascending (AC), transverse (TC) 
and descending (DC) colon, n = 2 donors. 
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Abstract
The gut microbiome has been shown to influence metabolic pathways in mice and humans. 
The Aryl hydrocarbon Receptor (AhR) plays an important role in intestinal homeostasis and 
some microbial metabolites of tryptophan are known AhR agonists. The aim of this study was to 
assess the impact of tryptophan supplementation on the formation of tryptophan metabolites, 
AhR activation and microbiota composition in the Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME). AhR activation, microbial composition, and tryptophan metabolites were 
compared during high tryptophan supplementation (4 g/L tryptophan), control and wash-
out periods. During tryptophan supplementation, the concentration of several tryptophan 
metabolites was increased compared to the control and wash-out period, but AhR activation 
by fermenter supernatant was significantly decreased. This was due to the higher levels of 
tryptophan, which was found to be an antagonist of AhR signalling. Tryptophan supplementation 
induced most microbial changes in the transverse colon including increased relative abundance 
of Lactobacillus, which are known to produce AhR agonists from the metabolism of tryptophan. 
We conclude that tryptophan supplementation leads to increased formation of AhR agonists in 
the colon. Although tryptophan itself was found to be an antagonist of AhR activation, its impact 
on AhR activation in vivo is unknown due to uptake and transport by intestinal epithelial cells. 
Keywords: Aryl hydrocarbon Receptor, SHIME, Microbiota, Tryptophan, Tryptophan 
metabolites
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1 Introduction
Species of the human gut microbiota produce numerous metabolites, including those 
generated by the metabolism of dietary compounds1,2. Metabolite signalling through the 
Aryl hydrocarbon Receptor (AhR) is an example of an interaction that can have strong effects 
on the immune system and intestinal homeostasis3-5. AhR is expressed in many different cell 
types in the body and is involved in many complex physiological processes, in particular the 
regulation of xenobiotic metabolising enzymes4,6-8. 
AhR agonists can be found as such in the diet (e.g. certain polyphenols), they can be generated 
during digestion in the small intestine from dietary precursors (e.g. 3,3’-diindolylmethane 
from glucobrassicin) or they can be generated by microbial metabolism of tryptophan 
by specific species9-11. Tryptophan (Trp) is abundant in protein-rich foods like beans and 
nuts, cheese, meat, fish, and eggs12. The daily intake of Trp in the average ‘Western’ diet is 
approximately 600-900 mg13, of which approximately 30 % is used for protein synthesis13,14. 
Trp supplementation is used to treat sleep disorders and other neurological disorders linked 
to reduced secretion of serotonin because it is a precursor in the serotonin and melatonin 
pathways15. Trp is also metabolised by endogenous enzymes indoleamine 2,3-dioxygenase 
(IDO) and l-tryptophan 2,3-dioxygenase (TDO) in the kynurenine pathway of the host, 
or metabolised by the gut microbiota9,16-20 to produce agonists of AhR. The metabolism 
of Trp to kynurenine and other AhR agonists or antagonists by microbiota is therefore 
of considerable interest in relation to host immune regulation. Kynurenine metabolites 
promote immunological tolerance through their activity on dendritic cells, T-cell anergy and 
apoptosis, and proliferation of Treg and Th17 cells21. Microenvironmental factors regulate 
the kynurenine pathway to maintain immune homeostasis.
AhR agonists produced by the microbiota have been shown to be crucial for antifungal 
immunity in mouse infection models9. IBD patients with polymorphisms in CARD9, leading 
to loss of function, have an altered microbiota that is deficient in producing AhR agonists, 
contributing to dysfunctional intestinal homeostasis10. In turn, microbiota composition and 
metabolism are affected by Trp availability in the diet. It leads to an increase of Lactobacilli, 
mainly L. reuteri, which subsequently affects the local immune response through the 
production of indole-3-aldehyde from Trp9. Given the mounting evidence connecting gut 
Trp metabolism to health, there is interest in supporting human health through dietary 
supplementation with Trp. However, the effects of such supplementation on Trp metabolism 
and the production of different AhR agonists in the human intestine are currently yet 
unknown. 
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The aims of this study were to assess the impact of Trp supplementation on the formation 
of Trp metabolites by the human microbiota using the Simulator of the Human Intestinal 
Microbial Ecosystem (SHIME), and to assess the activity of the individual and pooled 
metabolites on the AhR signalling pathway. 
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2 Material and Methods
2.1  Chemicals
All chemicals were purchased from Sigma-Aldrich (USA) unless stated otherwise. Trp metabolites 
screened for AhR activation were tryptamine, indole-3-aldehyde, anthranilic acid, kynurenic 
acid, indole-3-propionic acid, 3-hydroxy-anthranilic acid, oxindole, indole, l-kynurenine and l-Trp 
in concentrations ranging from 0.1 – 100 µM.
2.2  AhR activation
To measure the AhR activation, Luciferin transfected Dr. Chemical Activated Luciferase gene 
eXpression (CALUX) reporter cells (BioDetection Systems, The Netherlands, mycoplasma free) were 
used as previously described23. In brief, cells were grown in α-MEM growth medium (Gibco, USA) 
with 10 % heat-inactivated fetal calf serum (Gibco) and 1 % penicillin/streptomycin (Gibco). The cells 
were grown in 96-wells white clear-bottom plates (Corning, USA) at a concentration of 7.5 x  104 cells 
per well for 24 hours before stimulation. The cells were stimulated for 24 hours in triplicate with 
Trp and its derivatives dissolved in DMSO (Merck KGaA, Germany) or with 20 % final volume of 
microbial supernatant. After stimulation, the cells were lysed with 20 µL lysis buffer (Promega, USA) 
per well and 100 µL luciferase assay buffer was added (Promega). The luminescence was measured 
using a Spectramax M5 (Molecular Devices, USA) immediately after the addition of the assay buffer. 
The results were expressed as a percentage of the positive control, 5 µM β-naphthoflavone.
2.3  In vitro human fermentation
The SHIME was used to simulate the human intestinal tract, as previously described23. The 
TWINSHIME set-up was used where two faecal samples, each from an independent donor, were 
used to inoculate two sets of 4 vessels in parallel. Each set of vessels simulated a combined stomach 
and small intestine, followed by an ascending (AC, pH 5.6 – 5.9), transverse (TC, pH 6.15 – 6.4) and 
descending (DC, pH 6.6 – 6.9) colon part for each donor. The donors of the faecal sample were 
healthy and did not take antibiotics or prebiotics for 6 and 3 months before donation, respectively. 
Every 8 hours, a new feeding cycle was started with a stomach phase, where 140 mL feed with 
pH 2 (1.2 g/L arabinogalactan, 2 g/L pectin, 0.5 g/L xylan, 0.4 g/L glucose, 3 g/L yeast extract, 1 g/L 
special peptone, 3 g/L mucin, 0.5 g/L L-cysteine-HCl and 4 g/L starch; pH 1.8 – 2.2) was incubated 
for 1.5 hours, after which 60 mL of pancreatic juice was added (12.5 g/L NaHCO
3
, 6 g/L Oxgall, 
0.9 g/L pancreatin; pH 7). After a further 1.5 hours, the feed was transferred to the AC, TC and 
DC connected in series. The experimental design consisted of 3 weeks, including a 1-week control 
period with the standard feed, a 1-week Trp supplementation period where 4 g/L L-tryptophan 
was added to the feed and a 1-week wash-out period where the standard feed was provided again. 
Fermented samples were taken every day and immediately centrifuged at 9000 g at 4 ºC, after 
which the supernatant was filtered using a 0.2 µm RC filter (Phenomenex, Torrance, CA). The 
samples were stored at -20 ºC until further analysis. 
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2.4  SCFA analysis
Gas chromatography coupled with a flame-ionization detector (GC-FID, Shimadzu, Kyoto, Japan) 
was used to determine short-chain fatty acid (SCFA) composition in each sample. The samples 
and calibration standards were mixed in a ratio of 2:1 with an internal standard containing 0.45 
mg/mL 2-ethylbutyric acid in 0.3 M HCl and 0.9 M oxalic acid. Subsequently, the solutions were 
centrifuged for 4 min at 20000 g. 1 µL of the supernatant was injected spitless in a Restek 
Stabilwax-DA column (30 m x 0.32 mm x 1 µm, T
max
 240 ºC, Restek, USA). Nitrogen was used 
as carrier gas, with a flow rate of 2.51 mL/min. The makeup gasses were nitrogen, hydrogen, 
and air with respective flow rates of 40 mL/min, 30 mL/min and 400 mL/min. The temperature 
was initially held at 100 ºC. After injection, the temperature was increased first to 180 ºC and 
then to 240 ºC and both temperatures were held for 2 min. The samples were compared to 6 
calibration standard solutions containing acetic acid, propionic acid, butyric acid, valeric acid, 
isovaleric acid, and isobutyric acid. The results were processed using Chromeleon Edition 7 
(Thermo Scientific, San Jose, CA).
2.5  Tryptophan metabolites
Tryptophan metabolites were analysed according to Koper et al.,23. Samples were centrifuged 
(21700 g, 10 min, 4°C) and diluted in 0.1 % formic acid, followed by filtration using a 0.22 µm 
cellulose filter (Phenomenex) and high-resolution mass spectrometry (HRMS) analysis. A 
silica modified Luna Polar C18 column (50 x 2.1 mm, 1.6 µm, Phenomenex) was used for the 
chromatographic separation of Trp and tryptophan metabolites. The mobile phases consisted 
of water (A) and acetonitrile (B) both with 0.1% v/v of formic acid and the following gradient 
(min/%B) was used: (0/2), (0.50/2), (9.5/70), (12/70). The flow rate was 200 µL/min, the column 
temperature was 40 °C and 5 µL was injected. The U-HPLC system (Accela 1250, Thermo 
Fisher, Bremen, Germany) was interfaced to an Exactive Orbitrap HRMS (Thermo) and the 
analytes were detected through a heated electrospray interface (HESI-II) in positive mode by 
scanning the ions listed in Table S1 in the m/z range of 50–400. Analytical performances, mass 
spectrometry optimization and linearity range were monitored according to Koper et al.,23. Each 
sample was analysed in duplicate and the concentrations are given in µM.
2.6  Microbial analysis
DNA extraction of the microbial pellets was performed using the QIAmp PowerFecal DNA Kit 
(Qiagen, USA). 16S ribosomal RNA sequencing of the V3-V4 region was performed by Novogene 
(Hong Kong). The results were analysed using the CLC bio genomics workbench (Qiagen, The 
Netherlands), Microbial Genomics Toolbox with the SILVA 16S v132 99 % as reference database. 
Further analysis and statistics were performed using the online MicrobiomeAnalyst tool 
(www.microbiomeanalys.ca), with filtering steps: minimal count 4, prevalence 10 % and removal 
of 2 % standard deviation. The Ward clustering analysis was shown as a heat map using Euclidean 
distance measurement at family level.
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2.7  Statistical analysis
The statistical analyses were performed using GraphPad Prism 5 (La Jolla, USA). Results are 
shown as mean  ±  SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 were considered statistical 
differences. AhR activation was tested using one-way ANOVA followed by a Tukey post hoc 
analysis for the tryptophan derivatives and a repeated-measures ANOVA followed by a 
Tukey post hoc analysis for the fermentation samples. Different letters above bars represent 
statistically significant differences between responses to each concentration.
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3 Results and Discussion
3.1  AhR activation during colonic fermentation
To study the effects of a high Trp diet in SHIME, 4 g/L l-tryptophan, corresponding to 560 
mg per feeding, was added to the standard SHIME feed for 1 week in all feeding cycles. The 
amount of Trp was based on dietary supplementation in human intervention studies, taking 
into account absorption in the small intestine22. Each day, one sample was collected from each 
SHIME vessel just prior to the new feeding cycle. In the control period (i.e. 1-week before the 
Trp supplementation period), AhR activity of the samples remained constant in each part of the 
colon (Figure 1). The highest AhR activation was measured in the DC, followed by the TC and 
AC, which is in line with previous findings23. Surprisingly, AhR activation decreased in all parts 
of the colon during the 1-week of Trp supplementation, with the largest decrease in the DC 
(Figure 1c). Finally, after the wash-out period, the AhR activation returned to the level measured 
in the control period in the AC and DC samples. However, on the last day of the wash-out period 
AhR activity in the TC was significantly higher (p < 0.001) than in the control period (Figure 1b).
Figure 1. AhR activation of a) ascending, b) transverse and c) descending colon, where each data point 
represents the AhR activity at each day of the control, tryptophan supplementation and wash-out period. 
Measured with the CALUX reporter assay, expressed as percent of the positive control (β-naphthoflavone, 
5 µM) using luciferase production as readout. Data are expressed as mean of 2 donors ± SEM.
3.2  Tryptophan metabolites in control and supplemented diet
Trp and its metabolites were quantified in all sample supernatants and as expected, Trp and 
all its metabolites increased during the Trp supplementation period (Figure 2). Trp reached a 
concentration of 995 µM, 765 µM and 363 µM in the AC, TC, and DC, respectively. Theoretically, 
the concentration of Trp in the AC after the supplementation should have been 3917 µM, meaning 
that approximately 75 % of the Trp was metabolised by the microbiota. Trp supplementation 
increased the combined amount of Trp metabolites in AC, TC, and DC compared to the control 
(Figure 3). From Figure 3 it is also evident that Trp supplementation increased the conversion 
of Trp into its metabolites especially in AC and TC but to a lesser extent in the DC. The largest 
increase of Trp metabolites was measured in the TC (p < 0.0001), indicating the importance 
of the TC for Trp metabolism. After the wash out period the total amount of Trp metabolites 
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measured in the AC decreased to 0.7 µM, which is similar to the concentration present in the 
control period before Trp supplementation (0.5 µM). The same holds true for the concentration 
of Trp metabolites formed in the TC after the wash-out period indicating that the production of 
Trp metabolites by the microbiota is directly related to the amount of available Trp.
The main metabolite formed during the Trp supplementation period was the AhR ligand oxindole, 
which was at highest concentration (34 µM) in the TC, had fluctuating concentrations (3.5 to 
25 µM) in the DC and was absent in the AC (Figure 2). The second most abundant metabolite 
formed was 3-methylindole, with highest concentrations of 17 µM in the AC, 14 µM in the TC 
and 2 µM in the DC. At the end of the wash-out period, Trp and most of its metabolites decreased 
to similar concentrations measured before Trp supplementation (control period in Figure 2). 
The concentrations of some metabolites, namely tryptophol, indole-3-acetic acid, indole-3-
acetaldehyde, and tryptamine were higher on the last day of the wash-out period than in the 
control period. Indole and anthranilic acid had higher concentrations during and after the wash-
out in both the TC and DC compared to the beginning of the wash-out period.
As can be seen in Figure 2, we measured a larger increase of 3-methylindole, oxindole and indole 
than the other Trp metabolites during Trp supplementation. This may be due to a higher rate 
of conversion for the reactions catalysed by tryptophanase and pyruvate amino transferase 
compared to those catalysed by arylformidase and transglutaminase, which are required for 
formation of kynurenine and xanthurenic acid24,25. Alternatively, this may be due to the presence 
of bacterial species with different pathways for metabolism of Trp. 
Of the metabolites formed (Figure 2), tryptamine, kynurenine, indole-3-acetaldehyde, indole-
3-acetic acid and indole-3-aldehyde, indole, 3-methylindole, and oxindole have been reported 
as AhR ligands9,26. Several Trp metabolites produced during colonic fermentation in the SHIME 
system (tryptamine, indole-3-aldehyde, anthranilic acid, kynurenic acid, indole-3-propionic acid, 
3-hydroxy-anthranilic acid, oxindole, indole, l-kynurenine, and l-tryptophan) were screened 
for their capacity to activate AhR. Of these, only tryptamine induced a relatively high dose-
dependent AhR activation (approx. 28 % of the positive control) after stimulation with 80 and 
100 µM (Figure 4a). l-kynurenine, oxindole and indole induced significant but low levels of AhR 
activation (Figure 4b-d). Trp itself did not activate AhR in the range between 1 and 1000 µM. 
This is in line with other reports of AhR activation by Trp and its metabolites27,28.
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Figure 2. Evolution of Tryptophan and tryptophan metabolites concentration during control, tryptophan 
supplementation and wash-out period, in the ascending (AC), transverse (TC) and descending colon (DC) 
during in vitro SHIME fermentation. n = 2 donors. Each data point represents the concentration at each 
day of the Trp supplementation and wash-out period. Only the last day of the control period is reported 
(first data point in the graph).
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Figure 3. Cumulative concentration of tryptophan metabolites quantified using Orbitrap during control, 
tryptophan supplementation and wash-out period, in the ascending (AC), transverse (TC) and descending 
colon (DC) during in vitro SHIME fermentation. n = 2 donors. Each data point represents the concentration 
at each day of the Trp supplementation and wash-out period. Only the last day of the control period is 
reported (first data point in the graph). *p < 0.05.
Figure 4. AhR activation of a) tryptamine, b) l-kynurenine, c) oxindole, d) indole and e) tryptophan, 
measured with the CALUX reporter assay, expressed as percent of the positive control (β-naphthoflavone, 
5 µM) using luciferase production as readout. Data are expressed as mean of 3 replicates ± SEM, and 
different letters above the bar represent statistically significant different responses compared to each 
concentration.
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The AhR ligand indole-3-acetaldehyde29 had a higher concentration in the TC after the wash-
out period than in the control and Trp supplementation period (Figure 2). This change may 
partly explain the higher AhR activity in the TC after the wash-out period (Figure 1b). This may 
involve the interconversion between tryptophol (which is not an AhR agonist) and indole-3-
acetaldehyde27. Again, this implies a relevant role of the TC regarding the production of AhR 
ligands that are formed further down the Trp metabolism pathway. 
Liang et al. studied supplementation of Trp in pigs and although they did not discriminate 
between different colon parts, they found different levels of Trp metabolites in colonic 
content of pigs with different Trp treatments (control, 0.2 % Trp and 0.4 % Trp)30. Indole-3-
acetic acid was increased the most in the cecal content after Trp supplementation but no 
increase was measured in the colonic content. In our study, Trp supplementation elevated 
the amount of Trp available to microbiota in the AC, TC and DC by 46, 31 and 21 times 
respectively, even though the total amount of Trp metabolites was not proportionally higher 
compared to control (Figure 3). 
Figure 5. AhR activation measured with the CALUX reporter assay, expressed as percent of the positive 
control (β-naphthoflavone, 5 µM) using luciferase production as readout. With a) different concentrations 
of tryptophan combined with 5 µM β-naphthoflavone and b) different concentrations of tryptophan 
combined with 80 µM tryptamine. n = 3. Data are expressed as mean ± SEM, and different letters above 
the bar represent statistically significant different responses compared to each concentration.
To explain the fact that AhR activity was lower than the control during Trp supplementation 
(Figure 4), we hypothesized that Trp itself might have an antagonistic effect on AhR signalling. 
Indeed, we found that above concentrations of 200 µM, Trp inhibits AhR activation by 
β-naphthoflavone (Figure 5a) and tryptamine (Figure 5b), one of the most potent microbial-
derived AhR agonists. In the AC, Trp supplementation increased concentrations to above 
200 µM which would account for the decreased AhR activity in AC compared to control. This 
is, as far as we know, the first time Trp has been reported to antagonise AhR signalling by other 
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ligands. In vivo, the antagonist effect of Trp on AhR activation in mucosal tissues may also be 
relevant but it is difficult to predict because Trp is transported across the epithelium by amino 
acid transporters31 and the concentrations found in intestinal mucosa have to our knowledge 
not been assessed. 
3.3  Effects of Trp supplementation on microbial composition and SCFA production
SCFAs and the microbial composition were analysed in order to determine whether there was 
a change in microbial composition and fermentation leading to an altered production of SCFA. 
Figure 6 shows that the total production of SCFA was highest in the DC and lowest in the AC, 
which is in accordance with Van den Abbeele et al.32. Overall, the SCFAs concentrations in all 
parts of the colon remained at similar levels independently of Trp supplementation. This is in 
accordance with the findings of Liang et al., who did not find any differences in SCFA production 
with different amounts of Trp supplementation in vivo30. Also, Van den Abbeele et al., showed 
that the SHIME microbiota is stable over time without changed fermentation conditions like 
SCFAs32. Recently, it was shown that butyrate can activate the AhR pathway in vitro, in a dose-
dependent manner at concentrations above 1 mM33. Although the butyrate concentrations in 
our AhR activation assay reached < 1 mM, butyrate may be important for AhR activation in 
vivo. However, butyrate is found in scarce amounts in the blood, suggesting its metabolism by 
epithelial cells, which makes its effect largely restricted to cells in the intestinal epithelium34,35.
Figure 6. SCFA profile (mM) for the (a) ascending colon, (b) transverse colon and (c) descending colon, 
after a control, tryptophan supplementation and wash-out period of 5 days. Each data point represents 
the SCFA profile at each day of the control, Trp supplementation and wash-out period. n = 2 donors. 
The microbiota was compared between the donors and in the different colon compartments 
over the period of supplementation and wash-out. The microbiota of the two human donors 
was stable but differed in composition during the control period (Figure 7a, p < 0.019). As 
anticipated, the physiological conditions in each simulated colon compartment altered the 
composition, independently of the donor (Figure 7b, p < 0.001). No significant differences were 
measured in the alpha diversity during the Trp supplementation compared to the control and 
wash-out period (Figure 7c).
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Figure 7. (a-b) Beta diversity at OTU level, using the Bray-Curtis PCoA index, showing the effects of donor 
(a) and colon part (b) on the overall microbial composition. (c) Alpha-diversity of the control vs tryptophan 
supplementation vs wash-out period at OTU level using the Shannon index. 
The effect of Trp supplementation on phylum level composition was analysed for both donors 
in each simulated colon compartment. In the AC of donor 1 (AC1), the relative abundance of 
Firmicutes phylum increased from 53% in the control period to 65% after the high Trp and 70% 
after the wash-out period (Figure 8). This coincided with a decreased relative abundance of the 
Bacteroidetes phylum, from 31 % to 20 % and 17 % during the control, Trp supplementation and 
wash-out periods respectively. However, an increase in Firmicutes was not observed in AC of 
donor 2 (AC2) during the Trp supplementation and wash-out period. Instead the AC2 showed 
a small but significant decrease in abundance of Actinobacteria phylum during the Trp (16 %) 
and wash-out period (14 %) compared to the control (21 %). 
Trp supplementation induced similar changes in the microbiota composition of the TC and DC 
compartments of both donors. For donor 1, the Verrucomicrobia (mainly Akkermansia) decreased 
during and after the Trp period (from 16 % to 2 and 3 % in TC1 and from 11 % to 5 and 3 % in 
DC1). The decrease in Verrucomicrobia coincided with an increase in Bacteroidetes (from 18 % 
to 33 %) in TC1 and in Actinobacteria in DC1 (from 7 to 13 %). In donor 2, Verrucomicrobia also 
decreased in the TC and DC compartments although to a lesser extent. Akkermansia muciniphyla, 
the only species of the phylum Verrucomicrobia is indicated to be beneficial in maintaining 
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intestinal integrity36. For this reason the big decrease observed in the TC and DC of both donors 
(Table S2) might indicate intestinal imbalance, although our in vitro system does not represent 
the full intestinal complexity. Particularly it lacks the mucous layer and A. muciniphyla is a mucin-
degrading species. The Bacteroidetes in DC1 were highest in abundance after the Trp period 
(40 %) compared to the control (32 %) and wash-out period (29 %). In donor 2, a small increase 
in Firmicutes was observed during the Trp supplementation in both the TC and DC (TC2 from 
55 to 62 % and DC2 from 41 to 51 %).
Figure 8. Relative abundance of 16S rRNA sequencing at phylum level for donor 1 and donor 2, in the 
ascending (AC1/2), transverse (TC1/2) and descending (DC1/2) colon at control period (Ctrl), tryptophan 
supplementation period (Trp) and wash-out period (WO).
The microbiota differences between donors and colon parts are shown in more in detail in a heat 
map cluster analysis at the family level of taxonomy for the two donors in all colon compartments 
after the control, Trp supplementation and wash-out period (Figure 9, Table S2). 
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Figure 9. Heat map of the 16S rRNA microbial analysis at family level of donor 1 and donor 2, ascending 
(AC1/2), transverse (TC1/2) and descending (DC1/2) colon at control period (Ctrl), tryptophan 
supplementation period (Trp) and wash-out period (WO). Red indicates a higher abundance and blue a 
lower abundance. 
There was a higher abundance of Peptococcacea, Peptostreptococcaceae, Staphylococcaceae, 
Clostridiacaea, Eggerthellaceae, Enterococcaceae and Lactobacillacae in the AC of donor 
1 in the wash out period. This was also observed in the AC of donor 2, but the increase in 
abundance of Lactobacillacae was less. Some donor-specific changes in the composition of 
the microbiota were also evident, for example, the large increase of Planococcaceae in the 
AC of donor 1 in the wash out period. Some of these families are symbiotic and produce 
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bioactives with anti-inflammatory effects, for example Eggerthellacacae, which are well 
known to metabolize ellagitannins into urolithins37.
A major increase in Lactobacillacae and Enterococcaceae was found in TC2 after 
Trp supplementation. Besides, Trp supplementation increased relative abundance of 
Corynebacteriaceae (uncultured species) and Rhodospirillales (uncultured) in DC2. In donor 1, 
the abundance of these species was not significantly altered, but Trp supplementation led to 
an increase in several families of the Clostridiales order in both the TC and DC. There was 
also a decrease in Akkermansiaceae in TC1 after the Trp supplementation period compared 
to the control period (from 16 to 2 %), which is consistent with changes at the phylum level 
(Figure 8). In the TC and DC of both donors, there was a major increase in Lachnospiraceae 
after the Trp supplementation, which includes butyrate-producing species38 that have beneficial 
roles in the intestine39,40. At the end of the wash-out period, the Lachnospiraceae were still 
increased in abundance in the TC and DC and also increased in the AC of both donors compared 
to the control period. The increase in Lachnospiraceae in both donors indicates that the Trp 
supplementation had an effect on butyrate producers and can play a role in anti-inflammatory 
properties after supplementation. 
Lactobacillacae and Peptococcacea are reported to be able to produce AhR ligands. Besides, 
an increase in Lactobacillacae in a high Trp diet is confirmed by several studies9,41,42. Further 
analysis of Lactobacillacae and Enterococcaceae on species level, as found in TC2 after Trp 
supplementation, appear to be mainly an increased abundance of Enterococcus faecalis (from 
0.2 to 0.4 to 0.1 %), Lactobacillus reuteri and Lactobacillus murinus (0.02 to 0.09 to 0.02 %), 
which are all known to be AhR ligand producers42. The differences in microbiota after the Trp 
supplementation found between the two donors, combined with having a similar AhR activity, 
suggest that probably not only the Lactobacillacae and Peptococcacea are important when 
converting Trp in AhR ligands. Besides, as only relative abundance was measured, there might 
be differences in absolute amount of e.g. Lactobacillacae and a different amount of AhR ligands 
produced. Although the microbiota composition differs between donors, the AhR activation 
and the SCFA production were not significantly different. It can be hypothesized that different 
microbial species can exert similar metabolism, thereby maintaining a balanced microbial 
ecosystem.
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4 Concluding remarks
This is the first time that an intestinal model of the human microbiota ecosystem has been used 
to investigate the detailed profile of Trp metabolites generated in different parts of the colon 
and the effect of Trp supplementation on the microbial composition. Despite the fact that Trp 
supplementation increased the amount of Trp metabolites in the fermenter supernatants, the 
overall AhR activity was lower than in the control period. This was due to an antagonistic effect 
of Trp on AhR activation. However, Trp and its metabolites are unlikely to accumulate in the 
lumen of the large intestine in vivo as they do in the fermenter, and little is known on their 
relative transport rate across the colon epithelium. This means that the relative concentration 
of tryptophan compared to AhR ligands obtained thereof that we measured in our in vitro 
fermenter, may not fully represent the concentration ratios occurring within the colon cells.
Most Trp metabolites were produced in the TC where the largest effect of Trp on the 
microbiota composition was observed. In the TC, the AhR ligand producers Enterococcus faecalis, 
Lactobacillus reuteri and Lactobacillus murinus were increased as a result of Trp supplementation. 
Overall, these findings indicate that Trp supplementation can increase Trp metabolism and the 
production of AhR agonists.
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Supporting information
Table S1. High resolution mass spectrometry performances, RT (retention time, min), EC (elemental 
composition), TM (theoretical mass, [M+H]+), EM (experimental mass, [M+H]+), Δ ppm (mass accuracy). 
Compound Name EC RT TM TE Δ ppm
l-kynurenine C
10
H
12
N
2
O
3
2.3 209.09207 209.09241 1.6
Indole-3-acetaldehyde C
10
H
9
NO 3.2 160.07569 160.07533 -2.2
Kynurenic acid C
10
H
7
NO
3
3.8 190.04987 190.04899 -4.6
Indole-3-pyruvate C
11
H
9
NO
3
4.0 204.06552 204.06533 -0.9
Xanthurenic acid C
10
H
7
NO
4
4.1 206.04478 206.04428 -2.4
Tryptophan C
11
H
12
N
2
O
2
4.2 205.09715 205.09722 0.3
Indole-3-aldehyde C
9
H
7
NO 4.2 146.06004 146.06047 2.9
3-methylindole C
9
H
9
N 4.3 132.08078 132.08066 -0.9
Tryptamine C
10
H
12
N
2
4.4 161.10732 161.10711 -1.3
Anthranilic acid C
7
H
7
NO
2
4.8 138.05496 138.05512 1.2
Oxindole C
8
H
7
NO 5.2 134.06004 134.06044 3.0
Tryptophol C
10
H
11
NO 5.8 162.09134 162.09151 1.0
Indole-3-acetic acid C
10
H
9
NO
2
5.8 176.07061 176.07033 -1.6
Indole-3-propionic acid C
11
H
11
NO
2
6.3 190.08626 190.08629 0.2
Indole C
8
H
7
N 6.8 118.06513 118.06488 -2.1
Table S2. Relative abundance as percentage of the 16S rRNA microbial analysis at family level.
Treatment Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO
Colon part AC AC AC AC AC AC TC TC TC TC TC TC DC DC DC DC DC DC
Donor 1 1 1 2 2 2 1 1 1 2 2 2 1 1 1 2 2 2
Acidaminococcaceae 0.12 0.13 0.10 0.11 0.11 0.12 0.22 0.17 0.19 0.24 0.18 0.12 0.29 0.14 0.14 0.22 0.12 0.12
Akkermansiaceae 0.77 0.32 0.66 0.26 0.47 0.84 16.23 2.83 2.40 4.39 1.83 3.30 10.71 4.62 2.65 5.04 1.68 3.21
Atopobiaceae 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.03 0.03 0.00 0.00 0.01 0.01 0.02 0.06
Bacillaceae 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00
Bacteroidaceae 30.85 19.67 15.64 19.49 18.80 23.27 17.16 30.32 31.44 23.30 20.63 33.57 30.34 38.65 27.39 32.08 27.11 27.51
Barnesiellaceae 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.02 0.03 0.01 0.01 0.00 0.02 0.02 0.02 0.00 0.01 0.00
Bifidobacteriaceae 9.59 9.11 7.33 20.05 15.22 12.89 5.99 6.52 8.07 13.54 10.80 12.02 7.31 8.12 11.48 16.81 14.55 14.87
Burkholderiaceae 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.06 0.03 0.04 0.08 0.05 0.04 0.05 0.05 0.04 0.09 0.08
Christensenellaceae 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.02 0.01 0.02 0.00 0.01 0.01
Clostridiaceae1 0.01 0.02 1.59 0.16 0.06 0.65 1.31 0.02 0.08 0.32 0.02 0.02 0.05 0.02 0.04 0.02 0.29 0.11
ClostridialesvadinBB60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00
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Table S1. High resolution mass spectrometry performances, RT (retention time, min), EC (elemental 
composition), TM (theoretical mass, [M+H]+), EM (experimental mass, [M+H]+), Δ ppm (mass accuracy). 
Compound Name EC RT TM TE Δ ppm
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10
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12
N
2
O
3
2.3 209.09207 209.09241 1.6
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10
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9
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10
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7
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3
3.8 190.04987 190.04899 -4.6
Indole-3-pyruvate C
11
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9
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3
4.0 204.06552 204.06533 -0.9
Xanthurenic acid C
10
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7
NO
4
4.1 206.04478 206.04428 -2.4
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H
12
N
2
O
2
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9
H
7
NO 4.2 146.06004 146.06047 2.9
3-methylindole C
9
H
9
N 4.3 132.08078 132.08066 -0.9
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H
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4.4 161.10732 161.10711 -1.3
Anthranilic acid C
7
H
7
NO
2
4.8 138.05496 138.05512 1.2
Oxindole C
8
H
7
NO 5.2 134.06004 134.06044 3.0
Tryptophol C
10
H
11
NO 5.8 162.09134 162.09151 1.0
Indole-3-acetic acid C
10
H
9
NO
2
5.8 176.07061 176.07033 -1.6
Indole-3-propionic acid C
11
H
11
NO
2
6.3 190.08626 190.08629 0.2
Indole C
8
H
7
N 6.8 118.06513 118.06488 -2.1
Table S2. Relative abundance as percentage of the 16S rRNA microbial analysis at family level.
Treatment Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO
Colon part AC AC AC AC AC AC TC TC TC TC TC TC DC DC DC DC DC DC
Donor 1 1 1 2 2 2 1 1 1 2 2 2 1 1 1 2 2 2
Acidaminococcaceae 0.12 0.13 0.10 0.11 0.11 0.12 0.22 0.17 0.19 0.24 0.18 0.12 0.29 0.14 0.14 0.22 0.12 0.12
Akkermansiaceae 0.77 0.32 0.66 0.26 0.47 0.84 16.23 2.83 2.40 4.39 1.83 3.30 10.71 4.62 2.65 5.04 1.68 3.21
Atopobiaceae 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.03 0.03 0.00 0.00 0.01 0.01 0.02 0.06
Bacillaceae 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00
Bacteroidaceae 30.85 19.67 15.64 19.49 18.80 23.27 17.16 30.32 31.44 23.30 20.63 33.57 30.34 38.65 27.39 32.08 27.11 27.51
Barnesiellaceae 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.02 0.03 0.01 0.01 0.00 0.02 0.02 0.02 0.00 0.01 0.00
Bifidobacteriaceae 9.59 9.11 7.33 20.05 15.22 12.89 5.99 6.52 8.07 13.54 10.80 12.02 7.31 8.12 11.48 16.81 14.55 14.87
Burkholderiaceae 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.06 0.03 0.04 0.08 0.05 0.04 0.05 0.05 0.04 0.09 0.08
Christensenellaceae 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.02 0.01 0.02 0.00 0.01 0.01
Clostridiaceae1 0.01 0.02 1.59 0.16 0.06 0.65 1.31 0.02 0.08 0.32 0.02 0.02 0.05 0.02 0.04 0.02 0.29 0.11
ClostridialesvadinBB60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00
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Table S2. Continued
Treatment Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO
Colon part AC AC AC AC AC AC TC TC TC TC TC TC DC DC DC DC DC DC
Donor 1 1 1 2 2 2 1 1 1 2 2 2 1 1 1 2 2 2
Coriobacteriaceae 0.41 0.51 0.35 0.53 0.48 0.36 0.44 0.77 0.76 0.40 0.73 0.60 0.48 0.91 1.05 0.45 0.95 0.98
Corynebacteriaceae 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Defluviitaleaceae 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Desulfovibrionaceae 0.07 0.07 0.13 0.14 0.12 0.14 0.24 0.43 0.40 0.79 1.18 1.10 0.40 0.61 0.73 1.09 1.54 1.29
Eggerthellaceae 0.01 0.02 0.12 0.02 0.02 0.04 0.09 0.07 0.04 0.03 0.07 0.06 0.03 0.02 0.04 0.04 0.05 0.06
Enterobacteriaceae 4.34 3.92 3.32 0.17 0.12 0.14 0.77 0.56 0.59 0.19 0.36 0.12 0.49 0.44 0.58 0.46 0.34 0.10
Enterococcaceae 0.00 0.00 0.06 0.01 0.00 0.02 0.04 0.02 0.01 0.01 0.09 0.01 0.00 0.01 0.01 0.00 0.03 0.01
Erysipelotrichaceae 0.01 0.09 0.20 0.08 0.05 0.16 0.07 0.07 0.21 0.09 0.04 0.08 0.11 0.06 0.37 0.02 0.30 0.19
FamilyXIII, Clostridiales 0.01 0.02 0.08 0.02 0.03 0.03 0.06 0.13 0.02 0.03 0.06 0.03 0.03 0.05 0.11 0.03 0.06 0.07
Fusobacteriaceae 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.01 0.00 0.01
Lachnospiraceae 5.59 4.88 12.15 4.26 4.31 7.10 9.13 12.12 12.41 7.35 12.49 11.23 7.76 10.35 13.93 7.88 12.37 12.12
Lactobacillaceae 0.01 0.00 0.04 0.01 0.00 0.04 0.03 0.01 0.01 0.02 0.09 0.02 0.01 0.02 0.01 0.01 0.02 0.01
Methanobacteriaceae 0.01 0.01 0.00 0.00 0.01 0.00 0.64 0.57 0.12 0.01 0.00 0.01 0.61 0.23 0.37 0.18 0.11 0.20
Microbacteriaceae 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.01
Muribaculaceae 0.08 0.42 1.15 0.34 0.56 1.21 0.70 0.99 0.73 0.64 0.32 1.05 0.36 0.34 1.12 0.52 0.93 1.49
Peptococcaceae 0.00 0.00 0.02 0.01 0.01 0.00 0.02 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.02
Peptostreptococcaceae 0.05 0.21 1.66 0.55 0.14 0.42 1.15 0.44 0.39 0.21 0.50 0.17 0.21 0.16 0.55 0.06 1.24 0.42
Planococcaceae 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Pseudomonadaceae 0.02 0.01 0.02 0.02 0.01 0.01 0.07 0.06 0.04 0.03 0.05 0.02 0.37 0.25 0.02 0.06 0.08 0.00
Rikenellaceae 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.03 0.05 0.03 0.02 0.03 0.05 0.04 0.05 0.03 0.03 0.02
Ruminococcaceae 0.61 0.78 6.24 2.09 1.58 3.30 5.39 3.32 3.38 6.54 6.82 4.46 3.87 1.97 3.07 7.22 8.60 5.86
Sanguibacteraceae 0.10 0.38 0.37 0.44 0.34 0.39 0.16 0.20 0.19 0.16 0.17 0.15 0.12 0.17 0.33 0.14 0.23 0.21
Staphylococcaceae 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Tannerellaceae 0.52 0.32 0.32 0.33 0.38 0.55 0.46 1.00 0.97 0.90 0.77 1.01 0.86 1.02 0.80 1.17 0.81 0.98
uncultured 0.00 0.00 0.01 0.02 0.00 0.01 0.01 0.00 0.00 0.09 0.72 0.10 0.00 0.00 0.00 0.06 0.36 0.03
unknown 0.05 0.18 0.02 0.16 0.03 0.01 0.32 0.70 0.14 0.14 0.22 0.03 0.07 0.48 0.05 0.05 0.29 0.15
Veillonellaceae 46.69 58.82 48.31 50.64 57.05 48.22 39.20 38.55 37.26 40.44 41.71 30.59 35.37 31.22 34.98 26.28 27.73 29.78
Victivallaceae 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
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Table S2. Continued
Treatment Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO Ctrl Trp WO
Colon part AC AC AC AC AC AC TC TC TC TC TC TC DC DC DC DC DC DC
Donor 1 1 1 2 2 2 1 1 1 2 2 2 1 1 1 2 2 2
Coriobacteriaceae 0.41 0.51 0.35 0.53 0.48 0.36 0.44 0.77 0.76 0.40 0.73 0.60 0.48 0.91 1.05 0.45 0.95 0.98
Corynebacteriaceae 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Defluviitaleaceae 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Desulfovibrionaceae 0.07 0.07 0.13 0.14 0.12 0.14 0.24 0.43 0.40 0.79 1.18 1.10 0.40 0.61 0.73 1.09 1.54 1.29
Eggerthellaceae 0.01 0.02 0.12 0.02 0.02 0.04 0.09 0.07 0.04 0.03 0.07 0.06 0.03 0.02 0.04 0.04 0.05 0.06
Enterobacteriaceae 4.34 3.92 3.32 0.17 0.12 0.14 0.77 0.56 0.59 0.19 0.36 0.12 0.49 0.44 0.58 0.46 0.34 0.10
Enterococcaceae 0.00 0.00 0.06 0.01 0.00 0.02 0.04 0.02 0.01 0.01 0.09 0.01 0.00 0.01 0.01 0.00 0.03 0.01
Erysipelotrichaceae 0.01 0.09 0.20 0.08 0.05 0.16 0.07 0.07 0.21 0.09 0.04 0.08 0.11 0.06 0.37 0.02 0.30 0.19
FamilyXIII, Clostridiales 0.01 0.02 0.08 0.02 0.03 0.03 0.06 0.13 0.02 0.03 0.06 0.03 0.03 0.05 0.11 0.03 0.06 0.07
Fusobacteriaceae 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.01 0.00 0.01
Lachnospiraceae 5.59 4.88 12.15 4.26 4.31 7.10 9.13 12.12 12.41 7.35 12.49 11.23 7.76 10.35 13.93 7.88 12.37 12.12
Lactobacillaceae 0.01 0.00 0.04 0.01 0.00 0.04 0.03 0.01 0.01 0.02 0.09 0.02 0.01 0.02 0.01 0.01 0.02 0.01
Methanobacteriaceae 0.01 0.01 0.00 0.00 0.01 0.00 0.64 0.57 0.12 0.01 0.00 0.01 0.61 0.23 0.37 0.18 0.11 0.20
Microbacteriaceae 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.01
Muribaculaceae 0.08 0.42 1.15 0.34 0.56 1.21 0.70 0.99 0.73 0.64 0.32 1.05 0.36 0.34 1.12 0.52 0.93 1.49
Peptococcaceae 0.00 0.00 0.02 0.01 0.01 0.00 0.02 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.02
Peptostreptococcaceae 0.05 0.21 1.66 0.55 0.14 0.42 1.15 0.44 0.39 0.21 0.50 0.17 0.21 0.16 0.55 0.06 1.24 0.42
Planococcaceae 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Pseudomonadaceae 0.02 0.01 0.02 0.02 0.01 0.01 0.07 0.06 0.04 0.03 0.05 0.02 0.37 0.25 0.02 0.06 0.08 0.00
Rikenellaceae 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.03 0.05 0.03 0.02 0.03 0.05 0.04 0.05 0.03 0.03 0.02
Ruminococcaceae 0.61 0.78 6.24 2.09 1.58 3.30 5.39 3.32 3.38 6.54 6.82 4.46 3.87 1.97 3.07 7.22 8.60 5.86
Sanguibacteraceae 0.10 0.38 0.37 0.44 0.34 0.39 0.16 0.20 0.19 0.16 0.17 0.15 0.12 0.17 0.33 0.14 0.23 0.21
Staphylococcaceae 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Tannerellaceae 0.52 0.32 0.32 0.33 0.38 0.55 0.46 1.00 0.97 0.90 0.77 1.01 0.86 1.02 0.80 1.17 0.81 0.98
uncultured 0.00 0.00 0.01 0.02 0.00 0.01 0.01 0.00 0.00 0.09 0.72 0.10 0.00 0.00 0.00 0.06 0.36 0.03
unknown 0.05 0.18 0.02 0.16 0.03 0.01 0.32 0.70 0.14 0.14 0.22 0.03 0.07 0.48 0.05 0.05 0.29 0.15
Veillonellaceae 46.69 58.82 48.31 50.64 57.05 48.22 39.20 38.55 37.26 40.44 41.71 30.59 35.37 31.22 34.98 26.28 27.73 29.78
Victivallaceae 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
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Abstract
Broccoli is rich in glucosinolates, which can be converted upon chewing and processing into 
various metabolites, including Aryl hydrocarbon Receptor (AhR) ligands. Activation of AhR 
plays an important role in overall gut homeostasis but the role of broccoli processing on the 
generation of AhR ligands is still largely unknown. In this study, the effects of temperature, 
cooking method (steaming versus boiling), gastric pH and further digestion of broccoli on AhR 
activation were investigated in vitro and in ileostomy subjects. For the in vitro study, broccoli 
florets were divided into 5 treatment groups: raw, steamed (t = 3 min and t = 6 min) and boiled 
(t = 3 min and t  =  6  min) and then digested in vitro with different gastric pH. In the in vivo 
ileostomy study, 8 subjects received a broccoli soup or a broccoli soup plus myrosinase source. 
AhR activation was measured in both in vitro and in vivo samples by using HepG2-Lucia™ AhR 
reporter cells. Cooking broccoli reduced the AhR activation measured after gastric digestion in 
vitro, but no effect of gastric pH was found. Indole AhR ligands were not detected or detected at 
very low levels both after intestinal in vitro digestion and in the ileostomy patient samples, which 
resulted in no AhR activation. AhR activation by glucosinolate derivatives present in broccoli is 
modulated by several factors including cooking method, cooking time and digestion. Broccoli 
consumption resulted in AhR activation after the oral and gastric phase in vitro. In contrast, after 
the small intestinal phase of both in vitro and in vivo samples, no AhR activation was found. This 
suggests that the evaluation of the relevance of dietary glucosinolates for AhR modulation in 
the gut cannot prescind from the way broccoli is processed, and that broccoli consumption does 
not necessarily produce substantial amounts of AhR ligands in the large intestine. 
Keywords: Aryl hydrocarbon Receptor, Broccoli, in vitro digestion, ileostomy, thermal treatment
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1 Introduction
Health benefits of consuming broccoli and cabbage, which belong to the genus Brassica, have 
been partly attributed to phytochemicals such as glucosinolates1. Recently, broccoli (Brassica 
oleracea) consumption was shown to alter the microbiota2, and attenuate chemically induced 
colitis in mice through an Aryl hydrocarbon Receptor (AhR)-dependent pathway3. Intestinal 
sources of AhR play an important role in immune function in the gut by recruiting intraepithelial 
lymphocytes to the epithelium, enhancing the gut defences, triggering anti-inflammatory 
pathways and controlling microbial load and composition through innate lymphoid cell 
production of IL-224-6.
Brassica vegetables are rich in glucosinolates, which can be converted into AhR ligands by 
myrosinase in the vegetal tissues4,7. Myrosinase is a plant enzyme that can enzymatically 
hydrolyse the chemically stable glucosinolates8. Myrosinase and glucosinolates are physically 
separated from each other in intact vegetable tissues, but mastication in the oral cavity allows 
them to come into contact with each other, promoting enzymatic hydrolysis of glucosinolates 
into a variety of breakdown products (BP)9. Glucosinolate hydrolysis is influenced by many 
endogenous factors like pH, ascorbic acid concentration, and exogenous factors like storage and 
processing conditions, which can affect myrosinase activity and breakdown product formation8. 
At low pH, nitriles are the main BP from glucosinolates. Additionally, nitriles can be produced 
during autolysis of fresh plant material. When ascorbic acid is present at a pH between 4 and 7, 
ascorbigen and thiocyanates will be the main BP of indole glucosinolates. At pH 6-7, the main 
BP are isothiocyanates (ITC), however, although some are stable, ITC products of glucosinolates 
containing an indole moiety as side chain or a β-hydroxylated side chain, like glucobrassicin, 
are unstable. β-hydroxy-ITCs spontaneously cyclise to oxazolidine-2-thiones, while indole ITCs 
undergo lysis, resulting in the formation of a corresponding alcohol, like indole-3-carbinol (I3C)8. 
The latter subsequently condenses in di-, tri- and tetramers, such as indolo-[3,2b]carbazole (ICZ), 
cyclic triindole (CT) and 3,3’-diindolylmethane (DIM) under relatively mild acidic conditions10,11. 
Besides, indole-3-acetonitrile (I3N) can be formed as another BP of glucobrassicin, depending on 
the amount of epithiospecifier protein (ESP)12. The biological functions of I3C include reducing 
DNA-adduct formation, inducing apoptosis and inhibiting tumour growth13,14. It is also a weak 
AhR ligand, while the products of the acid-catalyzed oligomerization DIM and ICZ have a high 
AhR binding capacity15. 
Recent studies have shown that broccoli consumption improves intestinal immune functioning 
and can alter the host’s microbiota, which might affect the production of BP and related 
condensation products from glucobrassicin and modulate AhR activation3,5,13. Broccoli is 
commonly cooked before consumption, which influences glucosinolate degradation and 
conversion into AhR ligands. The formation of AhR ligands is influenced by gastric pH16. The 
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gastric pH can be influenced by fasted or fed state, but also by different food products when 
combined in a meal, which can act as buffer in the gastric environment16-18. 
The aim of this research was to investigate the effect of broccoli processing and consumption 
on in vitro and in vivo AhR activation. We investigated the effect of temperature, cooking method 
(boiling versus steaming) and gastric pH on AhR activation by glucosinolate derivatives from 
broccoli in vitro. To investigate AhR activation in humans and the effect of absorption, which is 
lacking in in vitro systems, we also measured AhR activity in the ileal fluid samples collected from 
ileostomy subjects after consumption of a broccoli soup with or without supplementation of an 
exogenous source of active myrosinase.
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2 Materials and Methods 
2.1 Sample preparation and thermal treatments
2.1.1 Broccoli preparation and thermal treatments for in vitro study
One batch of broccoli was purchased at the local supermarket (The Netherlands). The stems of 
the broccoli were removed and the florets were cut into pieces of approximately 3 x 3 x 3 cm. The 
florets were equally divided into 5 groups and treated as follows: raw (group 1), boiled for 3 min 
(group 2), boiled for 6 min (group 3), steamed for 3 min (group 4) and steamed for 6 min (group 
5). Broccoli (265 g) was boiled in 1.4 L water (groups 2 and 3), or 240 g broccoli was steamed in 
a steam oven (groups 4 and 5), for 3 or 6 min. Thereafter, the broccoli was drained of water for 
5 min, immediately frozen by liquid nitrogen and freeze-dried. The trays used for freeze-drying 
were weighed before and after freeze-drying to determine the loss in water content of the 
samples. After freeze-drying, the samples were milled (2 min cooling time, 7 min milling time) 
into a fine powder, using a freeze miller (SpexEuropa, SPEX SamplePrep) and stored at -20 ºC 
until further analysis.
2.1.2 Broccoli preparation and thermal treatments for in vivo study
Beneforte super broccoli was supplied by Staples Vegetables Ltd (Boston, Lincolnshire, UK) 
and mustard seeds were sourced from a local supermarket (UK). Broccoli florets were cut 
(around 4 to 5 cm from top) and combined thoroughly. Fifty gram portions were placed and 
vacuum-packed in flexible polyethylene bags (LDPE) with dimensions of 24 × 24 cm to stop 
glucoraphanin leaching into the processing water. Using a thermostatic water bath, broccoli 
was cooked at 100 °C for 12 min. Mustard seeds were ground and added as a powder as source 
of myrosinase (at 2 % w/w) at the end of the soup preparation process (~ 60 °C). All samples of 
raw and cooked super broccoli were frozen in dry ice before storage at -80 °C. Following this, 
samples were lyophilized (VirTis SP Scientific, UK), ground using a coffee grinder and sieved 
(30 mesh). Samples were stored at -20 °C until soup preparation.
The preparation of the soups included the following steps (Table 1): broccoli powder was added 
to boiling water (400 mL) and cooked for 2 min. The rest of the ingredients, except mustard seed 
powder, were dissolved in 300 mL cold water and then added to the boiling soup. The soup was 
boiled for 3 additional min to inactivate ESP12. Afterwards, the soup was left to cool down to 
60 ˚C, followed by addition of the mustard seed powder. The soup was left in the water bath at 
60 ˚C for no more than two hours until serving of 200 mL per subject. 
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Table 1. Ingredients of 200 mL broccoli soup. 
Broccoli soup (200 mL) Gram 
Broccoli powder 11
Cheese powder (parmesan cheese) 5
Sauce mix1 11
Salt 0.3
Mustard seed powder 0.16
1Wheat flour, cheddar cheese powder (16 %), cheese powder (16 %), maize 
starch, skimmed milk powder, salt, yeast extract, flavouring, maltodextrin, 
whey powder, mustard powder, colours (curcumin, paprika extract). 
2.2 Determination of glucosinolate content and myrosinase activity
Glucosinolates of the thermally treated broccoli samples were extracted according to Oliviero 
et al.19 with and without the pre-addition of water to estimate the myrosinase activity. To 
determine the glucosinolates concentrations, 0.1 g freeze dried broccoli was mixed with 2.4 mL 
100 % methanol (75 °C) and 200 µL 3 mM glucotropaeolin (Sigma-Aldrich), after which the 
samples were incubated in a water bath at 75 °C for 5 min. The samples were centrifuged at 
1363 g for 10 min and the supernatants were collected, while the pellets were re-extracted twice 
by adding 2 mL 70% methanol (75 °C). All supernatants were combined and stored at -20 °C 
until desulphation. Glucosinolates were converted into desulphoglucosinolates according to 
Oerlemans et al.20. The extracted desulphated glucosinolates were separated using an Ultimate 
3000 U-HPLC (Thermo Scientific, Bremen, Germany) with Licospher 100 RP 18 column (125 x 
4 mm) with an injection volume of 20 µL and a flow rate of 1 mL/min. Two eluents were used, 
eluent A (100 % milliQ) and eluent B (100 % Acetonitrile). The HPLC ran for 25 min with a 
gradient elution of 100 % A for 2 min, 92 % A for 5.5 min, 75 % A for 10.5 min and back to 100 
% A for 2 min. The peaks were measured with a UV detector at a wavelength of 229 nm. The 
glucosinolates were identified by means of their absorption spectra and quantified by comparing 
their area to the area of a standard glucosinolate; glucotropaeolin (benzylglucosinolate).
In order to estimate myrosinase activity, the thermally treated broccoli samples were 
pre-incubated with water for 5 min, after which the glucobrassicin concentration was measured 
as described above. The myrosinase activity was expressed as percent of glucobrassicin reduction 
where the glucobrassicin concentration with and without water addition was compared.
2.3 Digestion: in vitro and in vivo
2.3.1 INFOGEST in vitro digestion
To simulate complete human digestion, the protocol of Minekus et al., (2014) was used with some 
modifications21. In short, 0.5 g freeze dried broccoli (samples from group 1 to 5) was added to 
4.5 g milliQ and incubated for 5 min at 37 °C while rotating to simulate the oral phase. This was 
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mixed with 3.5 mL simulated salivary fluid (1.475 mL milliQ, 25 µL 0.3 M CaCl
2
) and incubated 
for 2 min at 37 °C while rotating at speed 10 (Salm en Kipp B.V.). Subsequently, the oral bolus 
went to the gastric phase where the pH was decreased to pH 3 with HCl and mixed with 7.5 mL 
simulated gastric fluid (5 µL 0.3 M CaCl
2
, milliQ and 1.6 mL 2000 U/mL pepsin, Sigma-Aldrich), 
this mixture was incubated for 2 hours at 37 °C while rotating. Subsequently, the food bolus 
went to the intestinal phase where the pH was increased to pH 7 using NaOH and mixed with 
11 mL simulated intestinal fluid (40 µL 0.3 M CaCl
2
, milliQ and pancreatin; based on trypsin 
activity of 100 U/mL in final mixture (Sigma-Aldrich)). Again, this was incubated for 2 hours at 
37 °C while rotating. Samples were taken after the gastric and intestinal phases and centrifuged 
at 9000 g for 12 min. The supernatants were stored at -20 °C until further analysis.
2.3.2 In vitro gastric digestion of broccoli samples
To simulate human gastric digestion and vary the gastric pH, a simplified in vitro digestion method 
was used. Freeze-dried broccoli powder (0.5 g samples from groups 1-5) was added to 4.5 mL 
milliQ and incubated for 5 min at 37 °C while rotating. Subsequently, 5 mL dichloromethane 
(Actu-All Chemicals) was added and incubated for 2 min at room temperature while shaking, 
followed by centrifugation at 2670 g for 5 min. This procedure was repeated twice. Supernatant 
was collected and dichloromethane was evaporated using N
2
, after which 1 mL acetonitrile 
(Actu-All Chemicals) was added to re-dissolve the active compounds. This was mixed with 6.5 
mL milliQ, and the pH was decreased to either pH 2, 3 or 5 using HCl. Subsequently, milliQ was 
added to reach a final volume of 10 mL with the correct pH and the samples were incubated for 
2 hours at 37 °C while rotating. After incubation, the pH was increased to pH 7 using NaOH 
and the samples were centrifuged for 12 min at 4816 g. The supernatants were stored at -20 °C 
until further analysis. 
2.3.3 In vivo dietary intervention study with ileostomy patients
To compare the in vitro broccoli digestion with in vivo digestion, ileostomy patients were used. 
Ileostomy studies provide insight into the processes of biotransformation and absorption in the 
upper gastrointestinal tract that impact the phytochemicals in the ingested plant material, in the 
case of broccoli potentially influencing AhR bioactivity and health benefits22. Ethical approval 
(14/SC/1326) for the ileostomy feeding study was received from South Central - Hampshire 
Research Ethics Committee and Ulster University. All participants gave written informed 
consent and the study was conducted in accordance with the Helsinki Declaration. Participants 
were recruited between January 2015 and February 2015 from clinics at Altnagelvin Hospital. 
The intervention study ran between March 2015 and April 2015. The study was registered at 
clinicaltrials.gov (Identifier: NCT04113928). The study was conducted in 11 ileostomy subjects 
(7 males, 4 females) age range 32-63 years, who had undergone terminal ileostomies, were at 
least 1.5 years post-operative prior to the study and were non-smokers. 
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The study was an acute randomised, single-blind, placebo-controlled crossover feeding trial 
with a 1-week washout period. After obtaining informed consent, participants were randomly 
assigned, in blocks of four using a random-number generator (www.randomization.com), to 
either the intervention or the control. In total, 12 participants were randomised to 2 groups. One 
participant subsequently withdrew from the study prior to sampling. Participants were asked 
to follow a restriction diet, avoiding dark green leafy vegetable and mustard-like vegetables 
especially broccoli, cabbage, Brussel sprouts, watercress, rocket, spinach, onions, spring onions, 
radish, horseradish for 48 h before each clinic visit. Following an overnight fast, the participants 
provided an ileal fluid sample (T 0 h) then consumed 200 mL of freshly prepared broccoli soup 
(described above) with or without addition of mustard seed (containing myrosinase). A second 
ileal fluid sample was collected 4 hours post consumption (T 4 h). The ileal fluid samples were 
collected and processed as described in McDougall et al.23. Weights and pH of the ileal fluid 
were recorded, before dilution with ice cold distilled water as required dependent on viscosity, 
before being homogenised in a chilled Waring blender for 30 seconds, and storage of aliquots 
at -80 °C in preparation for subsequent analysis. A random subset of 8 participants were used 
to assess AhR activation, where 4 subjects started with the broccoli soup and the other 4 with 
the broccoli soup + mustard seeds.
Freeze-dried ileostomy sample (0.5 g) was extracted using dichloromethane as described 
in section 2.3.2. After evaporation, the compounds were redissolved in 2 mL MEM growth 
medium (Gibco, USA) and centrifuged at 3000 g for 5 min. The supernatant was added in a 
1 % final concentration to HepG2-Lucia™ AhR reporter cells (InvivoGen, France) to measure 
AhR activation (section 2.5). In addition, cytotoxicity was measured using the CytoTox 96 Non-
Radioactive Cytotoxicity Assay according to the manufacturers instructions (Promega, USA).
Samples were further processed using solid phase extraction (SPE), using Strata-E C18 reversed 
phase columns (Phenomenex), in order to clean up for quantification. The columns were 
conditioned with 1 mL methanol and equilibrated with 1 mL milliQ. Pre-extracted ileostomy 
sample (100 µL) was loaded, after which 1 mL 5 % methanol in milliQ was loaded. The column 
was dried under vacuum for 5 min and the sample was eluted with 1 mL methanol. Afterwards, 
the methanol was evaporated and samples were redissolved in 150 µL milliQ until quantification 
using LC-MS/MS (2.6).
2.4 AhR activation
HepG2-Lucia™ AhR reporter cells (InvivoGen) were grown according to the manufactures 
instructions in Minimum Essential Medium Eagle - Alpha Modification (α-MEM; Gibco USA), 
10% (v/v) heat inactivated fetal calf serum (Gibco), 1x non-essential amino acids (Gibco), 
Penicillin-Streptomycin (100 U/mL-100 µg/mL; Gibco), 100 µg/ mL Normocin™ (InvivoGen) 
and 100 µg/mL Zeocin™ (InvivoGen). To measure AhR activation, 20 µl sample was added 
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in triplicate to a 96-wells plate (Corning, USA). Thereafter, 180 µl cell suspension (~20,000 
cells/well) was added to each well and the plate was incubated for 48 hours at 37 °C in a CO
2
 
incubator. After incubation, 20 µL stimulated cell supernatant was transferred into a white 
walled clear bottom 96-wells plate (Corning), followed by addition of 50 µL QUANTI-Luc™ 
(InvivoGen). Luminescence was measured immediately using a Spectramax M5 (Molecular 
devices, USA). AhR activation was expressed as percentage of the activity of the positive 
control (5 µM β-naphthoflavone in DMSO). Results of AhR activation were corrected for their 
corresponding negative controls, either DMSO or medium. 
2.5 Detection of I3C and DIM
To detect I3C and DIM in the ileostomy samples, the samples were extracted by the procedure 
described previously by Domingues-Perles et al., with some modifications24. Briefly, the frozen 
ileal fluid samples were thawed and vortexed, and duplicate 5.0 ± 0.1 g samples were weighed 
into 15 mL centrifuge tubes. These samples were extracted using 2 mL methanol: water (80:20, 
v/v) with 1 % formic acid. The tubes were vortexed for 3 × 30 s and then sonicated in a water 
bath for 1 min. All procedures were carried out at 5 °C. After centrifugation (4000 g, 15 min, 
4 °C), the supernatants were transferred into new tubes. The pellets were extracted twice using 
3 mL of the same solution and the supernatants combined and vortexed. The extracts were 
further extracted using SPE Strata-X cartridges (33u Polymeric Strong Cation), following the 
manufacturer´s instructions. Cartridges were conditioned with 2 mL of MeOH and equilibrated 
with 2 mL ultrapure water/formic acid (98:2, v/v). After this step, the extracted ileal simples were 
applied to the column. Then, the SPE cartridges were washed with water/formic acid (98:2, v/v) 
and aspirated until dryness. The target analytes including I3C and DIM, were eluted with 2 mL 
of MeOH/formic acid (98:2, v/v) and dried using a Speed Vac concentrator. The extract was 
reconstituted with 200 µL of solvent A/B (90:10, v/v) until analysis. 
The targeted analysis of I3C and DIM was performed on an Ultra High Performance Liquid 
Chromatography Photo Diode Array mass spectrometer system (UHPLC-PDA-MS; Thermo 
Scientific, USA) comprising of a UHPLC pump, a PDA detector scanning from 200 to 600 nm, and 
an autosampler operating at 4 ºC (Dionex Ultimate 3000 RS, Thermo Corporation). Separations 
of I3C and DIM were based on a 100 x 2.1 mm i.d. 1.8 µm Zorbax SB-C18 RRHD column (Agilent, 
Santa Clara, CA) preceded with a precolumn with the same stationary phase (Waters, Spain) 
which was maintained at 40 ºC and eluted using two mobile phases: A: deionized water with 13 
mM of ammonium acetate (pH 4.0 with acetic acid) and B: acetonitrile with 1 % acetic acid, over 
the course of 20 min at 0.2 mL/min. The gradient started with 3 % of B rising 20 % B in 5 min, 
then rising 52 % B in 3 min following 95 % of B after 4.5 min, maintained for 2.5 min and finally 
return to 3 % B in 1 min and maintained during 4 min to equilibrate the column to the initial 
conditions. After passing through the flow cell of the PDA detector, the eluate went directly to 
an Exactive Orbitrap mass spectrometer (Thermo Scientific) fitted with a Heated Electrospray 
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Ionization Probe (HESI) operating in positive ionization mode. Full scans were recorder in m/z 
range from 100 to 800 with a resolution of 50.000 Hz and with a full AGC target of 100000 
charges, using 2 microscans. Analyses were also based on scans with in-source collision-induced 
dissociation (CID) at 25.0 eV. MS experiment condition with HESI in positive ionization mode 
was: capillary temperature 325 ºC, heater temperature 300 ºC, sheath gas 18 units, auxiliary 
gas 2 units, and the spray voltage 4.0 kv. Targeted identifications of I3C and DIM were achieved 
by comparing the exact mass and the retention time with available standards. Quantification of 
the compounds was carried out by selecting the theoretical exact mass of the molecular ion by 
reference to standard curves prepared in diluted ileal fluid extract. 
2.6  Detection of indole derivatives
To detect indole derivatives in the ileostomy samples, a Thermo UltiMate 3000 U-HPLC system 
coupled to a TSQ Quantum triple quadrupole mass spectrometer (Thermo Fisher Scientific, 
Germany) was used. Chromatography was carried out with a Phenomenex Kinetex 1.7 µm EVO 
C18 100 Å LC column (100 × 2.1 mm) maintained at 45 ºC. Mobile phases consisted of milliQ 
(A) and methanol (B) at a flow rate of 0.3 mL/min with the following gradient: 0-2 min, 0.1 % B; 
2-6 min, 0.1-25 % B; 6-10 min, 25-80 % B; 10-12 min, 80-90 % B; 12-15 min, 90 % B; 15-16 
min, 90-0.1 % B; then re-equilibration for 10 min. The samples were kept at 5 ºC in an auto 
sampler (WPS-3000 TRS, Thermo Fisher Scientific) throughout the run and 10 µL per sample 
was injected for analysis under positive mode. The electrospray sources parameters were set 
as follows: spray voltage, 4.5 kV; capillary temperature, 275 ºC; sheath gas, 40 arbitrary units; 
auxiliary gas, 0 arbitrary units. Table S1 (supplementary material) listed the exact mass precursor 
ions, exact mass product ions, retention time (RT), collision energy (CE), and tube lens (TL) for 
each metabolite. Data analysis was performed using Thermo Xcalibur 4.0 software (Thermo 
Fisher Scientific).
2.7  Statistical analysis
All statistical analyses were performed using Graphpad Prism 5 (La Jolla, USA). Results were 
expressed as mean ± standard error of the mean (SEM). Differences were considered significant 
when p < 0.05. Differences in glucosinolates were tested using a one-way ANOVA followed by a 
Tukey post-hoc test. AhR activation among the differently treated broccoli, were tested using a 
one-way ANOVA followed by a Tukey post-hoc analysis. AhR activation among different pH was 
tested using a repeated measures ANOVA followed by a Bonferroni post-hoc test. The samples 
before and after in vitro digestion were tested using a one-way repeated measures ANOVA 
followed by a Bonferroni post-hoc test. Letters above bars represent classes of statistically 
significant different responses compared to each sample. Each graph bar with the same letter 
is not statistically significant different.
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3 Results and Discussion
3.1 Glucobrassicin concentration and myrosinase activity
We quantified the level of glucobrassicin in the raw and thermally treated broccoli samples 
(Figure 1a). Glucobrassicin is the only glucosinolate responsible for AhR activation as it can be 
converted into AhR ligands DIM and ICZ via I3C3,15,25,26. The glucobrassicin concentration in the 
3 min steamed broccoli was the highest, with 466 µmol/100 g, which was significantly higher 
than the raw brocolli (280 µmol/100 g, p < 0.05) and boiled broccoli samples (293 and 199 
µmol/100 g after 3 and 6 min boiling, p < 0.05 and p < 0.01 respectively). The concentration of 
glucobrassicin is highly dependent on the type and batch of broccoli, and our values lie within 
the previously reported ranges such as those reported by Oliviero et al., and Vallejo et al.19,27. 
The loss of total glucosinolates during heating has been previously reported and attributed 
to leaching of glucosinolates into the cooking water (up to 90 %)27-32, and a time-dependent 
glucosinolate loss by thermal treatment19,33,34. A lower amount of glucobrassicin was measured 
in raw broccoli compared to steamed broccoli (3 min, p < 0.05), due to an increased extractability 
in the thermally treated broccoli matrix, as reported previously19,35,36.
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Figure 1. Effect of cooking method. (a) Glucobrassicin concentration (µmol / 100 g freeze dried broccoli) 
for raw, steamed (3 or 6 min) and boiled (3 or 6 min) broccoli (n = 2). (b) Glucobrassicin reduction (%) 
with addition of water before extraction compared to no addition of water before extraction (n =3). A 
one-way ANOVA followed by a Tukey post-hoc test was used. Letters above bars represent classes of 
statistically significant different responses compared to each sample. Each graph bar with the same letter 
is not statistically significant different. 
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To estimate the myrosinase activity in the thermally treated samples, extraction was performed 
with pre-incubation of water, in order to facilitate hydrolysis of glucosinolates by myrosinase. 
Figure 1b shows the glucobrassicin reduction in the thermally treated samples after the addition 
of water. The raw broccoli had the highest myrosinase activity, as there was no glucobrassicin 
found after incubation with water (p < 0.05). All thermal treatments reduced the myrosinase 
activity, with no significant differences between the treatments. Myrosinase was not completely 
inactivated, but a reduction of ≥ 50 % was observed. From this we can conclude that the thermal 
treatments retained a significant myrosinase activity and that there were no differences 
observed among the thermal treatments.
3.2  AhR activation by undigested broccoli
Before testing the AhR activation of DIM and I3C in the differently treated broccoli samples, 
we checked for AhR activation of I3C and DIM in a range of concentrations using a newly 
developed AhR reporter cell line (Figure 2a and 2b). DIM gave higher AhR activation at a lower 
concentration compared to I3C, namely 75 % of the β-naphthoflavone positive control, in the 
concentration range 25 to 500 µM, while I3C only reached this level of activation when cells 
were stimulated with concentrations ranging from 100 to 250 µM. This implies that DIM is a 
more potent AhR ligand, which is confirmed by literature3,11, but also I3C can activate AhR in a 
dose-dependent manner. Beside DIM and I3C, also indole-3-acetonitrile (I3N) was previously 
shown to be a weak AhR ligand, together with ICZ, the latter being the most potent AhR ligand 
among those obtained from glucobrassicin breakdown37,38. 
Figure 2. AhR activation measured using HepG2-Lucia™ AhR cells, with luciferase production as read out, 
expressed as percentage of positive control (β-naphthoflavone, 5 µM). a) 3,3’-Di-indolylmethane (DIM), 
b) Indole-3-carbinol (I3C). c) undigested raw, 3 and 6 min steamed, and 3 and 6 min boiled broccoli (1 
mg/mL). Data is expressed as mean ± SEM, n = 3. A one-way ANOVA followed by a Tukey post-hoc test 
was used. Letters above bars represent classes of statistically significant different responses compared 
to each sample. Each graph bar with the same letter is not statistically different.
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When undigested broccoli samples were tested, activation of AhR was relatively low but the 
highest AhR activation was observed in the raw broccoli and broccoli steamed for 3 min. The 
thermal treatments reduced the AhR activation considerably (p < 0.1), with a general trend 
of AhR activation decreasing as the intensity of the thermal treatment increases (Figure 2c). 
However, in line with the results above, steaming for 3 min and raw broccoli showed the same 
level of AhR activation. Boiling is known to result in significant losses of glucosinolates in the 
cooking water, as can be seen in Figure 1 by comparing the glucobrassicin content of broccoli 
steamed and boiled for a comparable time. The loss of glucosinolates by cooking meant that 
less glucosinolates were available to be hydrolysed into AhR ligands. Loss of myrosinase activity 
can decrease glucosinolate hydrolysis during mastication and digestion, which decreases AhR 
activation28,39. Besides the amount of glucosinolates present and the residual myrosinase 
activity, AhR activation in broccoli can be modulated by the residual epithiospecifier protein 
(ESP) activity12. 
ESP is a myrosinase co-factor, that can favour the formation of nitriles over isothiocyanates 
in an iron-dependent manner12. In addition, presence of the epithiospecifier modifier protein 
(ESM1), can inhibit the ESP mediated nitrile formation leading to an increase in ITC40. Although 
I3C and I3N both are AhR ligands38, only I3C can be further metabolised into the more potent 
AhR ligands DIM and ICZ41. Compared with raw broccoli, a mild steaming can inactivate ESP 
leaving enough myrosinase activity to produce I3C, whereas in raw broccoli the largely intact 
ESP activity may direct glucobrassicin mostly towards I3N12. The impact of ESP on the AhR 
activation from broccoli products is difficult to predict, mostly because the relative potency of 
I3C and I3N as AhR ligands has never been compared. Our results show that light steaming did 
not decrease AhR activation and that a partial inactivation of myrosinase does not necessarily 
compromise formation of AhR ligands from glucobrassicin in broccoli. Therefore, we hypothesise 
that the lower AhR activation observed after more intense thermal treatments is likely the result 
of loss of glucosinolates rather than of myrosinase activity (Figure 2c). 
3.3  The effect of gastric pH on AhR activation
In a separate set of experiments, we sought to investigate the effect of gastric pH on the 
formation of AhR ligands and therefore potential AhR ligand activation by broccoli. Therefore, 
all samples were digested by a simplified in vitro gastric digestion with various pHs (pH 2, 3 
and 5). As reported in Figure 3, raw and 3 min steamed broccoli show significantly higher AhR 
activation at pH 2 and 3 compared to 3 and 6 min boiled and 6 min steamed broccoli (p < 0.01). 
At pH 5, the only significant difference was between raw and boiled broccoli, while steamed 
broccoli did not show a higher activation compared to boiled broccoli. These results are in line 
with the AhR activation of the undigested samples (Figure 2), where it was observed that raw 
and 3 min steaming results in the highest AhR activation.
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The different pH tested did not significantly influence AhR activation suggesting that in vivo 
the gastric pH will not affect the formation of AhR ligands in the stomach. Previous research 
showed that ITC formation is favoured at neutral pH (pH 4-7), while nitrile formation is 
favoured at acidic pH8,10,16,42,43. DIM and ICZ are more potent AhR ligands than I3C and I3N38. 
As DIM and ICZ are formed from I3C, one could conclude that AhR activation should be 
highest at neutral pH8,15,41. However, De Kruif et al., (1991) found that the highest amount of 
DIM formed was found at pH 4-517, whereas Grose & Bjeldanes, (1992) found that the highest 
amount of ICZ formed was found at pH close to neutrality44. In our study, we might have 
favoured the conversion of isothiocyanates by including an oral phase at neutral pH. Overall, 
it is difficult to correlate the expected effect of pH on glucobrassicin breakdown products to 
AhR activation because the observed level of activation is a complex balance of relative levels 
of I3C, I3N, DIM and ICZ. 
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Figure 3. Effect of gastric pH. AhR activation measured using HepG2-Lucia™ AhR cells, with luciferase 
production as read out, expressed as percentage of positive control (β-naphthoflavone, 5 µM) in raw 
broccoli, steamed broccoli (t = 3 min, t = 6 min) and boiled broccoli (t = 3 min, t = 6 min), digested at 
different pH. Data is expressed as mean ± SEM, n = 4 biological replicates and n = 3 biological replicates 
for 6 min steamed broccoli at pH 5. A one-way repeated measures ANOVA followed by a Bonferroni 
post-hoc test was used. Letters above bars represent classes of statistically significant different responses 
compared to each sample. Each graph bar with the same letter is not statistically different.
Brassica vegetables are normally consumed as part of a meal. The effect of digestion on 
glucosinolates and AhR activation may therefore also be influenced by the composition of the 
meal. Although in our study pH showed no significant effect, the presence of ferrous ions at 
acidic pH increases nitrile formation and could therefore indirectly decrease the formation 
of DIM and ICZ. Additionally, ascorbic acid is a co-factor of myrosinase and directs hydrolysis 
towards thiocyanates and ascorbigen formation, which decreases I3C formation and possibly 
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decreases AhR activation8,16,42,45. As mentioned previously, formation of AhR ligands is 
theoretically higher at neutral pH, although the literature is not completely in agreement. The 
pH in an empty stomach can be less than 2, but when food enters the stomach, the buffering 
effect exerted by food components, primarily by proteins, can increase the pH to 5 or even 
higher17,46. This would imply that it could be beneficial to consume raw broccoli in combination 
with a protein rich product, like meat, although in our study no clear effects of gastric pH were 
observed, contradicting previous studies. 
3.4   In vitro digestion: gastric and small intestinal effects on AhR
To study the effect of the intestinal digestion on AhR activation, all broccoli samples were 
digested using the INFOGEST standard in vitro digestion protocol with a pH of 3 during 
the gastric phase. In Figure 4, we report the AhR activation of the digesta supernatant, 
i.e. the activation resulting from AhR ligands formed in the broccoli matrix and released 
from the matrix during the gastric phase. This would represent the AhR ligands available 
for absorption or activation in the small intestine. AhR activation of raw broccoli during 
standard digestion was significantly higher after the gastric phase (p < 0.001) than the 
cooked broccoli. Also, 3 min steamed broccoli had a higher AhR activation than both 3 and 
6 min boiled (p < 0.05). After the intestinal phase, no AhR activation was observed in any of 
the samples (data not shown). Results in Figure 4 confirm the effect of thermal treatment 
on formation of AhR ligands from broccoli. However, when results in Figure 4 and Figure 
2c are compared (AhR activation by broccoli before digestion), it appears that the gastric 
step has activated raw broccoli more than the thermally treated broccoli and this can only 
be related to different initial levels of I3C after the treatment. The results in Figure 2c only 
show the AhR activation by broccoli in a concentration of 1 mg/mL, whereas the digested 
samples were diluted with digestive fluids. Therefore, the AhR activation after the gastric 
phase might be underestimated. Besides, part of the ligands may have remained entrapped 
in the broccoli matrix and are possibly released upon fermentation of the polysaccharide 
matrix in the gut. 
To explain the absence of AhR activation after the intestinal phase, despite the absence of an 
absorption step in our static model of digestion, we tested the degradation or further conversion 
of I3C and DIM at the neutral pH of the small intestine (Figure 5). Results show that there is a 
degradation of both I3C and DIM during 2 hours incubation at pH 7 at 37 ºC, ranging from 20 % 
at a low concentration to 5 % at a higher concentration. 
We also tested the possible interference of digesta fluids on the cells by testing the AhR 
activation of I3C spiked in pancreatin. Results showed that AhR activation was completely absent 
when 40 µM I3C was mixed with pancreatin, probably due to cell growth inhibition, which could 
partially explain the lack of AhR activation found in samples from the in vitro intestinal phase. 
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Of course, the dilution of gastric digesta with simulated intestinal fluids during in vitro digestion 
also needs to be considered but does not account for the complete loss of AhR activation that 
was observed. On the other hand, AhR ligands may be slowly released from the broccoli matrix 
during the 2 hours of the intestinal phase, resulting in a lack of AhR activation.
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Figure 4. Effect of gastric digestion. AhR activation measured with HepG2-Lucia™ AhR cells, using 
luciferase production as read out, expressed as percentage of positive control (β-naphthoflavone, 5 
µM). The bioaccessible fraction (supernatant) of glucobrassicin-derived AhR ligands from raw broccoli, 
steamed broccoli (t = 3 min, t = 6 min) and boiled broccoli (t = 3 min, t = 6 min) after the gastric phase 
using in vitro digestion were tested. Data is expressed as mean ± SEM with n = 3 for the raw and steamed 
and n = 2 for the boiled broccoli. A one-way ANOVA followed by a Tukey post-hoc test was used. Letters 
above bars represent classes of statistically significant different responses compared to each sample. 
Each graph bar with the same letter is not statistically different.
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Figure 5. Degradation (%) of different concentrations of I3C and DIM at pH 7 at 37 ºC for 2 hours to 
simulate the in vitro small intestine. Results expressed as mean ± SEM, n = 3. 
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3.5  In vivo digestion: ileal fluids and its effects on AhR activation
In order to confirm our in vitro data, ileal fluid samples from ileostomy patients were tested 
for AhR activation. This was the first time that ileal fluid has been tested for their potential 
to activate AhR. Therefore, these samples may provide useful information on the presence 
and transformation of AhR ligands during small intestinal digestion, and thus on the potential 
activation of AhR in the colon. Results show that none of the ileal samples from the 8 ileostomy 
subjects, who consumed either a broccoli soup (with inactivated myrosinase) or a broccoli soup 
plus mustard seeds (containing an exogenous source of myrosinase to convert glucobrassicin 
into I3C), contained AhR ligands in amounts that were high enough to activate AhR in our 
reporter cell line (data not shown). Probably, the AhR ligands are either broken down, diluted 
too much or absorbed in the very first part of the duodenum. In order to rule out interference 
from the pancreatic juice on the AhR assay, we spiked one ileostomy sample with I3C which was 
then tested for AhR activation. Results showed that spiking an ileostomy sample with an amount 
of I3C, which produced a final concentration of 77 µM in the AhR assay, led to an AhR activation 
that reached 57 % of the positive control, while in the non-spiked sample only 1 % AhR activation 
was found. In relation to Figure 2b, this implies that the extraction method is effective for I3C 
and besides, if there had been any AhR ligand present in the ileostomy samples, there would 
have been an AhR response. Indole AhR ligands were detected in the ileal fluid samples (Table 
2), but I3C was only found in very limited amount (ranging from 0 - 71 ng/g wet weight ileal 
fluid, data not shown) and DIM was not detected at all. Although DIM was not detected, we did 
detect other indole derivatives. Kynurenine is a product of endogenous tryptophan metabolism, 
while the others (tryptamine, indole-3-aldehyde, indole-3-acetic acid and indole-3-lactic acid) 
are reported as products of bacterial tryptophan metabolism and possibly produced by the ileal 
microbiota from dietary tryptophan47. However, their concentrations were too low to trigger a 
significant AhR activation in our reporter assay48. 
Overall, the data from the ileostomy study indicate that the concentration of indole derivatives 
arriving in the ileum level after broccoli soup consumption was too low to produce a significant 
increase in the AhR activation with the in vitro assay used herein. This may be due to a limited 
formation of AhR ligands from glucobrassicin or their absorption through the small intestinal 
epithelium8,49. It is possible that after preparation of the broccoli soup there is not enough 
glucobrassicin present to produce a measurable AhR activation, or that the exogenous 
myrosinase activity provided with mustard seeds was insufficient to hydrolyse glucobrassicin 
efficiently. It must be considered that glucosinolates can also reach the colon intact as reported 
by Maskell (1990)50. Elfoul et al., (2001) reported that 55 % of the initial dose of glucosinolates 
was still intact in the colon of rats51. The role played by intact glucobrassicin reaching the colon 
is not known. Microbiota present in the colon can hydrolyse glucosinolates with a myrosinase 
activity which is about 10 % of the activity present in broccoli, possibly resulting in AhR ligand 
formation8,41,52,53. The formation of sulforaphane from glucoraphanin by colonic microbiota 
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has been demonstrated, but not the formation of I3C or its further cyclization into AhR 
ligands53. Therefore, it might be that the broccoli particles entering the colon, still containing 
glucosinolates, can be converted into AhR ligands by colonic microbiota and generate AhR 
activation in the slightly acidic conditions of the ascending colon. Nonetheless, AhR is highly 
expressed in, for example, intraepithelial lymphocytes and T-helper 17 cells, which are more 
abundant in the small intestine6,54. Therefore, it is important that most AhR ligands at least reach 
the small intestine, as no AhR are present in the stomach. In this in vitro study, we show that there 
was AhR activation after the gastric phase, indicating the presence of AhR ligands available for 
the small intestine. After the small intestine however, in both the ileostomy and in vitro samples, 
no AhR activation was measured anymore and the fate of AhR ligands and reason for lack of 
activity in the small intestine unfortunately remain unknown. 
Table 2. Indole derivatives detected by LC-MS/MS in freeze-dried ileal fluid samples after subjects 
consumed either a broccoli soup or a broccoli soup + mustard seeds (200 mL). T1 is before ingestion 
and T2 is 4 hours after ingestion. n = 8 donors. Data is expressed as µg or ng per g dry weight ileostomy 
sample ± SEM.
Broccoli soup Broccoli soup + Mustard 
T1 T2 T1 T2
Tryptophan (µg) 60.8 ± 3.3 117.5 ± 23.2 79.2 ± 9.9 133.7 ± 18.0
Kynurenine (ng) 87.6 ± 29.5 99.5 ± 17.7 67.8 ± 24.2 42.8 ± 11.5
Tryptamine (ng) 155.8 ± 96.5 11.7 ± 5.2 111.6 ± 87.0 13.2 ± 4.6
Indole-3-lactic acid (ng) 412.5 ± 150.5 88.6 ± 9.9 1098.6 ± 848.1 308.8 ± 99.6
Indole-3-aldehyde (ng) 13.0 ± 8.4 34.4 ± 12.1 21.5 ± 15.1 103.9 ± 12.8
Indole-3-acetic acid (ng) 50.9 ± 30.7 18.2 ± 12.6 87.8 ± 58.5 28.0 ± 17.5
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4 Concluding remarks
This research showed that activation of AhR from consumption of broccoli can be modulated 
by the thermal treatments during domestic cooking or industrial processing. In general, cooking 
broccoli decreased AhR activation and raw broccoli showed the highest AhR activation. 
However, a thermal treatment is not necessarily deleterious for the generation of AhR ligands, 
because mild thermal treatments, like steaming, preserve glucobrassicin and myrosinase activity. 
Furthermore, AhR activation after the gastric phase was higher for raw broccoli but not for 
the steamed or boiled broccoli, and pH in the gastric phase had no significant effect on AhR 
activation. However, no AhR activation was found after in vitro digestion or in ileal fluid samples 
from ileostomy subjects after consumption of broccoli soup, which could be due to processing 
of the broccoli, uptake of all AhR ligands in the small intestine or interference with the digestive 
enzymes used in the in vitro assay. Overall, it can be concluded that broccoli consumption resulted 
in AhR activation after the oral and gastric phase, with the highest AhR activation measured 
using raw broccoli. In the ileal fluid samples, the concentration of AhR ligands at ileum level was 
too low to induce significant AhR activation on our cell-assay, but production of AhR ligands in 
the stomach and their absorption by the small intestine epithelium could have beneficial effects 
on health.
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1. The gut way to health
This thesis entitled ‘The gut way to health: in vitro studies on immunomodulatory food compounds’, 
describes the relationship between diet, metabolites produced by the gut microbiota and the immune 
system, during in vitro digestion and fermentation. We aimed at highlighting the importance of the 
food matrix and the interaction with the microbiota in modulating the health effects of single food 
compounds, which is often neglegted1-7. By applying a unique approach using whole foods, rather 
than single components, we created a more physiologically relevant, but also a more complex model 
system. In this way, the role of the food matrix and the influence of food processing and fermentation 
or microbial metabolism is taken into account. This approach leads to more knowledge regarding the 
fate and immune-activating capacity of food compounds when consumed as part of a food product. 
Furthermore, starting from the obvious observation that dietary compounds can be transformed 
during their passage through the small or large intestine, we studied the fate of immuno-modulating 
compounds during digestion and how this modulates their biological activities on host cells in vitro. 
Our in vitro results can serve as a basis to design in vivo experiments by showing insights in the 
relationship between food, microbiota and the immune system.
We focused on both direct (by parent compounds) and indirect (by metabolites) 
immune-modulation of food. We investigated binding of dietary fibres on binding to dendritic 
cells and induced cytokine secretion, as well as ligand activation of the Aryl hydrocarbon Receptor 
(AhR), which is involved in the establishment and maintenance of intestinal homeostasis8-10. 
We hypothesized that food preparation, digestion and fermentation all have an effect on the 
capacity of immunomodulatory food compounds to modulate the immune system. Therefore, 
we ought to obtain more insight into the importance of food compounds during digestion and 
fermentation.
In Chapter 2, the fibre linear arabinan (LA), an oligosaccharide that is part of the complex 
structure of pectin, was shown to bind to dendritic cells and induce cytokine secretion through 
a calcium and spleen tyrosine kinase (SYK)-dependent mechanism. We ruled out interaction 
of LA with several C-type Lectin Receptors (CLR). Additionally, we showed that human colonic 
fermentation of natural plant matrices containing LA (apple and sugar beet) led to immune-
stimulatory activity. 
In Chapter 3, oregano was selected as a source of polyphenols, and its potential in activating 
AhR during in vitro fermentation was studied. Fermentation of oregano released modest 
amounts of dietary polyphenols. The microbiota made a major contribution to AhR activation 
in the colon through the metabolism of tryptophan into indoles. Chapter 4 further explores 
the relationships between tryptophan supplementation, AhR activation and the evolution of 
tryptophan metabolites produced by gut microbiota.
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Finally, in Chapter 5 the contribution of another category of known AhR dietary ligands, 
i.e. glucosinolates, was studied. We specifically investigated the effects of different cooking 
methods of broccoli on AhR activation during in vitro and in vivo digestion. 
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2. Immune stimulation by food compounds
The immune system is highly influenced by the intestinal microbiota11-13. Immune cells are 
known to bind parts of bacteria and viruses through pattern recognition receptors (PRRs), but 
they are also known to detect food compounds14. Dietary fibres, phytochemicals and microbial 
metabolites of tryptophan are gaining more attention due to their interaction with host 
receptors such as PRRs and AhR15-19. The relevance of these compounds is better understood 
in the small intestine compared to the colon, where microbial fermentation or metabolism can 
greatly influence their biological activities. 
2.1  Dietary fibres
Non-digestible dietary fibres (DF) are fermented by the colonic microbiota resulting in the 
production of short-chain fatty acids (SCFA), mainly consisting of acetate, propionate and 
butyrate19. Butyrate has been shown to be beneficial for intestinal functioning, improvement of 
gut barrier function by stimulation of mucin formation, and it has anti-inflammatory effects20,21. 
Besides the indirect immunomodulatory effect exerted by fibres through the products of their 
fermentation (SCFAs), specific glycan structures can directly bind to immune cells. A typical 
example is fungal β-glucan, which was found to bind the CLR Dectin-122,23. Furthermore, it was 
recently shown that also other polysaccharides can induce cytokine production by binding to 
dendritic cells in mice19. It was recently reported that LA could activate mouse bone marrow-
derived dendritic cells from TLR2/4 knockout mice19, but LPS contamination prevented studies 
on human immune cells14. Therefore, in Chapter 2 we investigated the potential of linear arabinan 
(LA) from sugar beet to bind and activate human dendritic cells leading to cytokine secretion. By 
purifying LA free of Microbe-associated molecular patterns (MAMPs), e.g. lipopolysaccharide 
(LPS), we could demonstrate specific binding and activation of LA to human dendritic cells 
(DC). Immune activation of human DC was calcium-dependent and SYK-dependent, suggesting 
interaction of LA with a CLR containing an ITAM or hemi-ITAM motif. Experiments with siRNAs 
and blocking antibodies failed to identify a role for the most well-characterised ITAM-containing 
CLRs i.e. Mincle, DC-SIGN, Dectin-1 and Dectin-2. Identification of this receptor through reverse 
genetics or siRNA inhibition of other CLRs in the human genome will enable investigation of its 
possible expression in intestinal epithelial cells and different immune cells. Ultimately this will 
lead to more insights into the role of this receptor in human biology. 
Furthermore, as LA does not occur in food as isolated compound but as part of the pectin 
backbone within a complex plant cell wall, we investigated the potential of LA-containing 
pectin and plant matrices (apple and sugar beet) to induce cytokine production during human 
in vitro fermentation. Fermentation of apple and sugar beet by human microbiota indeed led 
to immune activation of BMDCs from TLR4/TLR2 knockout mice. However, extracted sugar 
beet pectin did not induce immune activation of DCs, even when the arabinan was present in 
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relatively higher amounts than in apple or sugar beet. Particulate LA induced a higher immune 
response by DCs than soluble LA19, which resulted in a lower cytokine production in our study 
by the use of supernatant. Investigating the bacterial pellet, including particulate arabinans, 
would therefore be an interesting addition to our study. In any case, these results indicate that 
the supramolecular organisation of the pectin molecule and the solubilisation of ligands from 
the matrix must be taken into account when judging the immunomodulatory effect of linear 
arabinans in real foods. 
2.2  Polyphenols
In Chapter 3, we performed an intensive screening to test the capacity of isolated polyphenols 
to activate AhR in the Chemical Activated Luciferase gene eXpression (CALUX) assay. 
Several studies have reported conflicting results on the capacity of polyphenols to activate 
AhR1,24-27, most likely due to the use of different cell types in the reporter assay28. Our results 
showed that luteolin, baicalein, and 4-O-caffeoylquinic acid dose-dependently activated 
AhR, while quercetin reduced AhR activation when presented to the cells in combination 
with luteolin, suggesting an antagonistic effect of quercetin on AhR activation. This indicates 
that the in vivo biological effect can be difficult to predict when using foods or whole diets, 
because polyphenols typically occur as complex mixtures of chemical structures at varying 
concentrations. Based on our screening we selected oregano, a rich source of luteolin, to 
study the effect of the food matrix on the fate of luteolin during in vitro fermentation and its 
capacity to activate AhR.
In the colon polyphenols might be directly absorbed or metabolised by bacteria into smaller 
compounds, typically phenyl acetic acid and phenyl propionic acid derivatives. Therefore, it 
is important to know the kinetics of polyphenol degradation in the colon, because this has 
an impact on the pharmacokinetics of their distribution and ultimately on their bioactivity. 
By using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) fermentation 
model, we were able to study the fate of polyphenolic AhR ligands in each part of the colon, 
which is not possible using a simpler in vitro batch fermentation system or through in vivo 
studies. Our results showed limited breakdown of luteolin in the ascending colon, whereas 
luteolin was completely converted to other metabolites by the microbiota in the transverse 
colon. This indicates that the microbiota in the ascending colon is unable to metabolise 
polyphenols, allowing them to remain in that part of the colon for a longer time. This longer 
time may be sufficient for transport in the ascending colon and AhR activation in the mucosa 
and other tissues. 
We furthermore showed that oregano could increase AhR activation in the ascending colon, but 
the microbial derived tryptophan metabolites were more abundant than the polyphenols from 
oregano, clearly contributing majorly to AhR activation in the gut. There was a high AhR activating 
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capacity by tryptophan metabolites, indicating that the relevance of polyphenols as AhR ligands 
may be rather limited. Furthermore, the in vivo biological effects will depend on transport across 
the colonic epithelium and this has yet to be studied for metabolites like polyphenols.
2.3  Tryptophan metabolites
To gain more insight into the potential of tryptophan metabolites to activate AhR, we studied 
tryptophan (Trp) and its derivatives during in vitro fermentation in Chapter 4. For the first time, 
an intestinal model of the human microbiota ecosystem has been used to investigate the effect of 
Trp supplementation on the profile of Trp metabolites generated in different parts of the colon. 
The duration of the fermentation experiment was 3 weeks, of which the first week was control 
feeding, followed by one week of Trp supplementation, and finally another one-week wash-out 
period with control feeding. Trp supplementation increased the amount of Trp metabolites in 
the fermenter supernatants. Most Trp metabolites were produced in the transcending colon 
(TC), where also the largest effect of Trp on the microbiota composition was observed. In the 
TC the relative abundance of AhR ligand producers Enterococcus faecalis, Lactobacillus reuteri 
and Lactobacillus murinus were increased as a result of Trp supplementation. Overall, these 
findings indicate that Trp supplementation can increase Trp metabolism and consequently the 
production of AhR agonists. However, when the AhR activation of the supernatants collected 
at different days of treatment was measured, the overall AhR activation of supernatants was 
lower during the Trp supplementation period than during the control period. We hypothesized 
that this was due to an antagonistic effect exerted by Trp, which does not activate AhR in our in 
vitro cell assay, and which concentration in the supernatants was highly negatively correlated to 
the AhR activation. This hypothesis was proven by measuring AhR activation of mixtures of Trp 
and tryptamine, where results showed that the presence of Trp reduced AhR activation induced 
by tryptamine. Again, this highlights the difficulty in predicting overall in vivo biological effects 
using isolated compounds rather than mixtures. 
As only a small fraction of Trp is converted into AhR ligands, the presence of large amounts of 
Trp in the cellular environment may limit the efficacy of Trp metabolites in activating AhR. This 
depends on the relative transport of Trp through the colon epithelium compared to that of Trp 
metabolites. To investigate the transport of Trp and its derivative tryptamine (Trm) across the 
intestinal epithelium, we performed a pilot study using colonic pig organoids (Figure 1). The 
organoids were grown as polarised monolayers on Transwell filters according to the method of 
van der Hee et al., 201829 and were stimulated with a mixture of Trp and Trm (both 20 µM) for 
30 and 120 minutes at either the apical or basolateral side, and both apical and basolateral sides 
were sampled after incubation. The trans-epithelial resistance of the monolayers was monitored 
during the incubation to check for integrity of the monolayer as previously described29. 
Afterwards, the concentration of tryptophan and tryptamine were determined using LC/MS-
MS as described in Chapter 5.
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Figure 1. Preliminary results on trans-epithelial transport of tryptophan (Trp) and tryptamine (Trm) 
across an intact monolayer of colon organoid cells. Trp and Trm were added to either apical or basolateral 
compartments and samples from both compartments were taken after 30 and 120 minutes incubation. 
The concentrations of Trp and Trp were determined using LC-MS/MS.
The results show that Trp was transported from apical to basolateral side after already 
30 minutes (around 7 %) while Trm transport occurred at a slower rate (4 % after 120 min). 
Furtheremore, there was some transport from the basolateral side towards the apical side, 
so back into the lumen, of both Trp and Trm with respectively 1.5 and 2 % transported after 
30 min, and 6 and 7 % transported after 120 min. Furthermore, the concentration of Trp 
transported from apical to basolateral side did not increase over time. This might be due to 
organoid metabolism, or uptake by the organoids without excretion to the basolateral side. 
Although the amounts transported in vitro seem relatively small, the total amounts transported 
in vivo would be substantial considering the surface area of the intestine. Combined with the 
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previously found antagonistic effects of Trp on AhR, these data indicate that Trp and Trm can 
be absorbed by intestinal immune cells simultaneously, possibly at a similar ratio as observed 
in our in vitro fermentation system. Therefore, when aiming for in vivo AhR activation in the 
colon induced by AhR ligands like Trm, the balance between agonists and antagonists should 
be carefully determined.
Colonic protein fermentation is usually seen as detrimental for the host health30. However, 
as shown in our results, depending on the type of protein and metabolites formed, protein 
fermentation might also have beneficial effects on intestinal functioning. This also relates to 
the microbiota, since we showed that several beneficial species in the colon increased after 
Trp supplementation (Chapter 4). The recent findings that Trp metabolites can improve gut 
barrier function are in conflict with studies on protein fermentation and increased inflammatory 
responses (Figure 2)31. There must be a paradigm shift when it comes to the effects of protein 
fermentation in the colon towards a re-evaluation of the physiological relevance of protein 
metabolites on host health. Furthermore, the role of protein fermentation in colonic health 
may be confounded by the harmful effects exerted by other compounds found in e.g. grilled or 
processed meat.
Figure 2. Abundant proteolytic fermentation generates compounds that may promote inflammatory 
responses and proliferation of colonocytes, whereas fibre fermentation and short-chain fatty acid 
production together with tryptophan metabolism have a protective role. Adjusted from Diether et al.31.
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2.4  Glucosinolates and AhR activation
In Chapter 5, we tested another class of dietary phytochemicals that are reported to be precursors 
of AhR ligands, namely glucosinolates and in particular, glucobrassicin, of which broccoli is a 
very rich source. We first tested the glucobrassicin derivatives 3,3'-Diindolylmethane (DIM) 
and Indole-3-Carbinol (I3C), using HepG2-Lucia™ AhR reporter cells, and we found that DIM 
induced a higher AhR activation than I3C. This confirms that DIM is a more potent AhR ligand, 
which was confirmed by other studies18,32. However, the magnitude of AhR activation measured 
with the HepG2-Lucia™ AhR cell line was different compared to what has been reported with 
other assays. 
We tested the effect of different cooking methods on the capacity of broccoli to activate AhR. 
Several factors affect AhR activation by glucosinolate derivatives present in broccoli, including 
cooking method, cooking time and digestion. In particular the way broccoli is processed at 
industrial or, more frequently, domestic scale, can affect the residual myrosinase activity, which 
is crucial for the breakdown of glucobrassicin into the breakdown products I3C and DIM. This 
obvious notion has not yet been explored in the scientific literature despite the interest in the 
health effects of broccoli and its potential to activate AhR. Broccoli consumption resulted in 
AhR activation after the oral and gastric phase in vitro (Chapter 5). In general, raw broccoli 
showed the highest AhR activation and cooking broccoli decreased AhR activation. However, 
a thermal treatment is not necessarily deleterious for the generation of AhR ligands, because 
mild thermal treatments, such as steaming, preserves glucobrassicin and myrosinase activity 
(Chapter 5). Furthermore, we showed that the breakdown products of glucobrassicin, i.e. I3C, 
was only present in very small amounts and DIM was not present in ileostomy samples of 
patients that received a broccoli soup, even after addition of an exogenous source of myrosinase. 
This suggests that the way broccoli is processed is highly important for the magnitude of its 
effect on AhR activation. The fact that glucosinolate breakdown products do not reach the colon 
may depend on their absorption during the passage through the small intestine. A fraction of 
intact glucosinolates do reach the colon and is metabolised by the microbiota33. Whereas it has 
been shown that the gut microbiota possesses myrosinase-like activity and that it can produce 
sulforaphane from glucoraphanin, the hydrolysis of glucobrassicin and potential production of 
AhR ligands in the large intestine has not yet been proven. Therefore, the relevance of dietary 
glucosinolates to AhR activation in the gut may strongly depend on the way food is processed.
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3. Methodological aspects
3.1  AhR activation measurements in cell cultures
To measure AhR activation, three methods were used in this thesis: the CALUX assay (Chapter 
3 and 4), qPCR measuring gene expression (Chapter 3), and the recently developed human 
HepG2-Lucia™ AhR reporter cells (Chapter 5). In literature, many different methods to measure 
AhR activation are used, such as in vitro cell assays and in vivo experiments using mice34-36. We 
can argue what the best method is, considering the various outcomes of similar compounds 
when different methods are used. The CALUX assay has the advantage of being a very stable 
cell line, and can be used as a high throughput method. The recently developed HepG2-Lucia 
AhR reporter cells could also be used as high throughput. However, this cell line has the practical 
disadvantage that the quality is only guaranteed for 20 passages by the company (Invivogen), 
whereas the CALUX cell line cells can be passaged up to 200 times. The main difference between 
the CALUX and the HepG2-Lucia AhR reporter cells is the origin of the cells. The CALUX cells 
used in this thesis originate from rat liver cells, whereas the Lucia cells originate from human 
liver cells. Both cell lines originate from the liver, and even though we study colonic samples, 
we did not choose to use the human HT29-Lucia-AhR (colonic cells) cells because these might 
also express drug transporter proteins originating from the small intestinal epithelia. In order 
to avoid interference with drug transporters, we used the liver cells to study AhR activating 
capacity by ligands.
It is known that rodent AhR respond differently to the same ligands compared to the human 
AhR, although in general AhR is evolutionary conserved across species37-41. For example, indole 
derivatives bind with a higher affinity to human AhR than mice AhR40. In Chapters 3 and 4 we 
used the CALUX assay, thus rat liver cells. Therefore, AhR activation induced by tryptophan 
derivatives in humans might be higher than we reported. In Chapter 5, in which we studied the 
indole derivatives from glucobrassicin, we used human HepG2-Lucia cells, and indeed we found 
a higher AhR activation induced by DIM than in the CALUX assay (p < 0.0001; Figure 3a). In 
contrast, dioxins like 2,3,7,8-tetrachloordibenzo-p-dioxin (TCDD) have a 10-fold higher affinity 
for mice AhR compared to human AhR41. 
Also β-naphthoflavone (positive control used for the AhR activation measurements) gives 
a different relative light unit (RLU) value for both reporter cell lines, even 1.5 times higher 
in the CALUX assay (p < 0.0001; Figure 3b). The AhR activation in this thesis was expressed 
as a percentage of the positive control and therefore, it becomes difficult to compare the 
results from the different studies. It is important to put results into perspective of its cell 
type origin and to use the activation results only as an indication of which compounds 
activate AhR and which are more or less potent in a cell type of specific origin. In order 
to compare the outcomes from different labs, there is need for a standardisation of the 
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methods. Furthermore, studies that use rodents as a model to measure AhR activation in 
human should be carefully interpreted and human studies (in vivo or at least ex vivo) are 
necessary to confirm results. 
Figure 3. AhR activation using two different cell assays: the Chemical Activated Luciferase gene 
eXpression (CALUX, white) and the HepG2-Lucia AhR reporter cells (black). a) expressed as percent 
of the positive control β-naphthoflavone (5 µM) for indole-3-carbinol (I3C) and 3,3'-Diindolylmethane 
(DIM), n = 3 and b) expressed as relative light units (RLU), medium, 1 % DMSO in medium, and 5 µM 
β-naphthoflavone (β-naph) using n = 6. **** p < 0.0001, ANOVA with Bonferroni post-hoc test.
3.2  Digestion studies
In this thesis, we used an in vitro approach to get a mechanistic understanding of processes in the 
body. This would not be possible using in vivo studies, because of limitations in sampling location 
and ethical concerns. Naturally, it is challenging to simulate the highly complex physiological and 
chemical processes of the human body42, but in vitro models are developed to reflect the in vivo 
conditions as much as possible. 
In order to compare results obtained in different labs across the globe, an in vitro small intestinal 
digestion method was developed, called INFOGEST43. This method is claimed to reflect the in 
vivo digestion conditions better than other methods, and it includes all steps starting from the 
oral cavity to the small intestinal phase. When using an in vitro digestion model, inter-individual 
differences are eliminated. This has the advantage that there is less variability between replicates 
and differences due to treatments are easier to interpret and normally less replicates are needed 
than in vivo. Inter-individual differences exist in, for example, isothiocyanate absorption, chewing 
time and therefore the amount of saliva, and enzyme activity44-46. These individual differences 
were taken into account in the ileostomy study (Chapter 5), as we used multiple subjects. All in 
all, there is need to validate the in vitro models with in vivo data, which has been done only to a 
limited extent with the INFOGEST protocol.
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Although the INFOGEST in vitro digestion method has the advantages described above (used in 
Chapter 5), there are also some limitations. Firstly, the method is not yet validated for specific 
food matrices and some compounds, and some parameters might be different in vivo, depending 
on the amount and mixture with other foods. Furthermore, due to the static nature of the 
method, it does not reproduce the dynamic changes in some physiological conditions in the 
small intestine, like the gradual change of pH in the gastric compartment, the gradual emptying 
of the stomach, not to mention the actual mixing and flowing regime as in vivo. There is also a 
lack of chewing during the oral phase of the INFOGEST method. Instead of chewing, milling was 
performed in our study (Chapter 5), which might result in an increased surface area, thereby 
possibly changing the glucosinolate hydrolysis47. Additionally, the oral phase takes longer during 
in vitro digestion than during in vivo digestion, which could also result in increased glucosinolate 
hydrolysis43. Studies that make use of ileostomy subjects as we described in Chapter 5, could 
provide us with some answers regarding inter-individual differences. However, as mentioned 
before, human intervention studies are costly, labour intensive and have ethical constraints. 
Human interventions should be carefully designed, taking into account intestinal passage time 
and inter-individual variation therein, as well as the initial dosage and the limit of detection of 
the techniques used for the quantification of the relevant biomarkers (e.g. HPLC/MS-MS). 
3.3  Fermentation studies
In the other chapters in this thesis, we used simulated in vitro fermentation methods. The 
advantage of using such in vitro models is that the system is automated so that the changes in 
microbial population and metabolism can be studied upon long-term feeding. Furthermore, the 
colon is divided into 3 parts, each with a distinctive microbiota so that the metabolism dynamics 
in these 3 macro-areas can be studied. The use of the SHIME has allowed us to understand the 
complex dynamics of formation of immunomodulating food compounds during fermentation in 
the three separate colon parts, such as LA in sugar beet and apple, polyphenols from oregano 
and tryptophan with its metabolites. These results would have been impossible to obtain with in 
vivo studies or only partially possible with other (semi)-dynamic systems (e.g. TIM-2). However, 
it is questionable whether the same dynamics of the metabolites evolution is observed in vivo. 
The in vitro fermentation model used in this thesis also has some limitations. First of all, the 
SHIME is semi-dynamic fermentation, i.e. batches in series rather than plug-flow. Furthermore, 
under its conventional set-up, the system cannot reproduce absorption in the colon. When 
metabolites are not removed by the system, the dynamics of metabolite interconversion can be 
biased and the accumulation of e.g. SCFA may change the microbial metabolism. This limitation 
can be partly overcome with a system where dialysis is implemented48. In addition to the lack of 
absorption in the colon, the lack of an absorption step in the small intestinal phase of the in vitro 
system must be considered to realistically reproduce what enters the colon after digestion of 
real diets. This is of course strongly dependent on the type of compounds that are studied and 
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is, for example, of little importance for polyphenols (limited absorption in the small intestine) 
but very important for Trp (almost completely absorbed in the small intestine). In our studies, 
we fed the microbiota pre-digested material, which must also be considered in other studies.
Another point of discussion is whether or not to pool the faecal inoculum used for in vitro 
fermentation studies49. The microbial community is a complex mixture of many species with 
high inter-individual variation and possibly distinct enterotypes50,51. Microbes will compete 
with each other until a microbial balance is settled. This microbial balance can be disturbed by 
various factors, such as pathogens and dietary changes. It is debatable how many individual 
faecal samples should be mixed when pooling. Furthermore, even when an average microbiota 
is reached49, this might still represent only one (other) individual. Therefore, we decided to 
use individual faecal samples rather than to pool them, as also recommended by the SHIME 
manufacturer ProDigest48. However, pooling has the advantage that experiments can be 
repeated using the same microbial subset, but also the individual inoculum can be frozen52, 
thereby facilitating repetition possibilities.
In our fermentation studies, we observed large inter-individual microbiota variation and 
different changes in species after tryptophan supplementation (Chapter 4). However, AhR 
activation induced by fermenter supernatants did not vary much between donors (Chapters 
3 and 4). This implies that, even though individuals in our study had different microbiota, the 
functionality linked to AhR activation was similar. A similar function of different microbiota is 
also proven in other studies where a functional overlap of the microbiota of different individuals 
was found, probably due to metabolic cross-feeding53-56. As a result, different individuals might 
have a comparable benefit from certain bioactives, even though they might have a substantially 
different microbiota composition. It must be noted though, that our fermentation protocol 
comprises a stabilization period of 2 weeks before the start of the experiments and during this 
period microbiota from different donors are fed with a standardized diet. This may have reduced 
the inter-individual variation in the microbiota (Chapters 3 and 4).
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4. Future perspectives
Possible avenues for continuing this research are shown in Figure 4. We studied the capacity 
of LA to bind human DCs, thereby aiming to obtain more information regarding the human 
relevance over mice . LA showed to induce cytokine production in human DCs, however, it 
still remains unknown whether the optimal effect can only be produced in vivo by purified LA 
preparations or whether the same effect can be obtained from plant sources of LA and pectin. 
Furthermore, the relative contribution on immune activation by direct binding to immune cells 
by DFs next to the production of SCFAs should be evaluated. It is important to identify the 
receptor involved in the arabinan binding to DCs as it can provide new insights into the function 
of this receptor in humans. Possible approaches are immune-precipitation of the receptor with 
LA antibody and its detection by proteomics, or studies of receptor-LA binding in the Biacore 
apparatus. In a preliminary study, we bound C-type lectin fusion proteins made by Mayer et 
al.57 on a G-protein chip, after which we used the Biacore to measure potential binding of LA to 
any of the C-type lectin fusion proteins. Follow-up studies are needed because so far we only 
observed weak non-specific binding.
The relevance of AhR activation in humans has not been studied to date and should be 
carried out in the future. Studying the binding of potential AhR ligands to human cells in vitro, 
unfortunately does not gives information of its relevance in vivo. Using in vitro studies, both AhR 
binding assays and digestion/fermentation studies, a selection of compounds of interest should 
be made and the results can serve as a base for in vivo trials. Based on our results, phytochemicals 
like polyphenols and glucobrassicin are potent AhR ligands, but these should be provided in 
relatively high amounts to see an effect on AhR activation. It would be interesting to study a 
mixture of several AhR ligands from phytochemicals, which could be present in a normal diet. 
Such studies might explain the fact that oregano supplementation resulted in increased AhR 
activation in the ascending colon, while the AhR ligand luteolin was present in amounts that 
were too low to activate AhR. 
Furthermore, researching the capacity of gut microbiota to produce AhR ligands from metabolism 
of I3C, DIM and ICZ from intact glucosinolates can give insight in their relevance for colonic 
functioning and AhR activation. A first start would be the supplementation of glucobrassicin to 
the gut microbiota in vitro, followed by measurements of possible production of I3C and DIM. To 
make the study more realistic, in vitro digested broccoli could be added to an in vitro fermenter or, 
possibly more relevant, samples from ileal subjects who received a relatively high dose of cooked 
broccoli in a meal could be added to the colonic fermenter. Furthermore, an in vivo intervention 
with differently cooked broccoli, also including raw broccoli, may validate our findings and clarify 
the role of thermal treatments on AhR activation in the human intestine. The major difficulty is 
how to measure AhR activation in vivo58. Either ex vivo AhR measurements, or obtaining biopic 
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material from colonic cells after which gene expression is measured, are probably reliable, but 
invasive options58.
A more potent way to increase AhR activation could be supplementation of Trp, which showed 
to increase the amount of AhR ligands produced in the colon. As we showed that excessive Trp 
might play an antagonistic role regarding AhR activation (Chapter 4), an in vivo study using 
AhR active Trp derivatives is worth investigating in the future. It is not clear whether we can 
modulate the amount of AhR ligands from Trp through the diet or food design, or by e.g. microbial 
transplantation. Future research could focus on the role of food design on the formation of 
immunomodulatory food compounds and their place of action in the gut. If Trp is proven to have 
beneficial effect in humans in vivo, the role of protein fermentation on human health should be 
re -evaluated. A schematic overview of the possible future research directions is presented in 
Figure 4. The results in this thesis gave us more insight towards the gut way to health.
Figure 4. Schematic overview of the thesis with future research directions: food design, cooking methods, 
protein fermentation and human relevance. 
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Summary 
Recent insights have shown that there is a triangular relationship between the diet, immune 
system and intestinal microbiome, in which the gut microbiota is a substantial contributor to 
human metabolism and health. A better understanding of the relationship between dietary 
components, including food processing, and the activity of metabolites produced by the gut 
microbiota on the host, is an essential step in designing food that benefits human health. The 
nutrient composition of a diet is obviously of importance to health, but the way food is designed 
also plays an important role in how much reaches the colon, where it is metabolised by the 
microbiota. Food design, both industrial food processing and domestic food preparation, can 
therefore be a tool to influence the nutrients that reach the lower gut and impact on intestinal 
health. However, more insight is needed into the modulatory effect of digestion and microbial 
fermentation on the interactions between dietary components and the gut immune system. 
Therefore, this thesis describes the effects of different dietary components (fibre, tryptophan, 
glucosinolates and polyphenols) on immune modulation, mainly focussing on activation of the Aryl 
hydrocarbon Receptor (AhR), during human digestion and fermentation. The results presented 
in this thesis give insight into the effects of food preparation and microbial fermentation on the 
potential health properties of food compounds.
Chapter 2 describes the ability of the dietary fibre arabinan to bind to human dendritic cells, and 
studies the effects of a (food) matrix during fermentation of arabinan containing sugar beet and apple. 
Dietary fibres such as pectin-derived arabinans are fermented in the colon resulting in bacterial 
production of short-chain fatty acids (SCFAs), which play a role in gut homeostasis. Additionally, 
linear arabinan (LA) originating from sugar beet has been reported to strongly activate mouse 
dendritic cells in a Spleen Tyrosine Kinase (SYK)-dependent manner, suggesting involvement of 
ITAM-containing C-type lectin receptors (CLR). The aim of this study was to investigate whether 
LA was immune-stimulatory for human dendritic cells (DCs) and to identify the CLR involved. 
Purified LPS-free LA bound specifically to human DCs, in a calcium dependent manner, with 
involvement of SYK. Stimulation of human DCs with LA resulted in strong induction of IL-6, IL-10 
and TNFα and these responses were reduced after SYK-inhibition. Using different approached, 
we ruled out the involvement of Dectin-1, Dectin-2, DC-SIGN, Mincle and the Mannose Receptor 
in immune activation by LA. Additionally, we fermented sugar beet, apple and sugar beet pectin 
with human faecal microbiota in vitro to investigate the potential biological relevance of pectin 
fermentation and immune activity of the glycans in vivo. Filtered supernatants from sugar beet 
and apple fermentation increased production of IL-6 and TNFα in BMDCs from TLR4/2 knockout 
mice. However, fermentation of isolated sugar beet pectin only had a small effect on the immune 
stimulatory activity compared to sugar beet, suggesting an important role for the natural matrix. In 
conclusion, LA is immune-stimulatory for human DCs in a calcium and SYK-dependent manner, which 
suggests involvement of a CLR other than the CLRs targeted in this study.
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Besides the immune activation by dietary fibres showed in Chapter 2, many dietary 
phytochemicals have been reported to promote gut health. Specific dietary phytochemicals, 
such as luteolin, as well as specific microbial metabolites of tryptophan are ligands of the Aryl 
hydrocarbon Receptor (AhR), which plays a role in immunity and homeostasis of the gut barrier. 
In Chapter 3, the effects of oregano, containing the polyphenol luteolin, on AhR activation during 
in vitro fermentation were studied. We studied the fate of luteolin during colonic fermentation 
and the contribution of tryptophan metabolites to AhR activity in different parts of the colon. 
Several polyphenols were screened for AhR activation and oregano, containing the ligand 
luteolin, was added to batch cultures of human microbiota from the distal colon. Luteolin was 
rapidly metabolised, with no measurable increase in AhR activity. In the second experiment 
using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME), not all luteolin 
was metabolized in the ascending colon, but disappeared rapidly in the transverse colon. The 
greatest AhR activity was due to microbiota-derived metabolites of tryptophan, particularly 
in the descending colon. Luteolin in food was rapidly metabolized in the transverse colon. We 
concluded that tryptophan metabolism by the microbiota in the colon contributes substantially 
to the pool of lumen metabolites that can activate the AhR.
As a continuation, Chapter 4 describes the importance of microbial metabolites from tryptophan 
on AhR activation during in vitro fermentation. The gut microbiome has been shown to influence 
metabolic pathways in mice and humans. Some microbial metabolites of tryptophan are known 
AhR agonists. The aim of this study was to assess the impact of tryptophan supplementation 
on the formation of tryptophan metabolites, AhR activation and microbiota composition in the 
SHIME. AhR activation, microbial composition, and tryptophan metabolites were compared 
during high tryptophan supplementation and control and wash-out periods. During tryptophan 
supplementation, the concentration of several tryptophan metabolites was increased 
compared to the control and wash-out period, but AhR activation by fermenter supernatant 
was significantly decreased. This was due to the higher levels of tryptophan, which was found 
to be an antagonist of AhR signalling. Tryptophan supplementation induced most microbial 
changes in the transverse colon including increased relative abundance of Lactobacillus, which 
are known to produce AhR agonists by metabolising tryptophan. We conclude that tryptophan 
supplementation leads to increased formation of AhR agonists in the colon. Although tryptophan 
itself was found to be an antagonist of AhR activation its impact on AhR activation in vivo is 
unknown due to uptake and transport by intestinal epithelial cells. 
In Chapter 5, broccoli derived AhR ligands were investigated. Broccoli is rich in glucosinolates, 
which can be converted upon chewing and processing into various metabolites, including AhR 
ligands. In this study, the effects of temperature, cooking method (steaming versus boiling), 
gastric pH and further digestion of broccoli on AhR activation were investigated in vitro and in 
ileostomy subjects. For the in vitro study, broccoli florets were divided into different treatment 
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groups: raw, steamed and boiled followed by an in vitro digestion with different gastric pH. In 
the in vivo ileostomy study, subjects received a broccoli soup or a broccoli soup plus myrosinase 
source. AhR activation was measured in both in vitro and in vivo samples by using HepG2-Lucia™ 
AhR reporter cells. Cooking broccoli reduced the AhR activation measured after gastric digestion 
in vitro, but gastric pH did not have an effect. Indole AhR ligands were not detected or detected 
at very low levels both after intestinal in vitro digestion and in the ileostomy samples, which 
resulted in no AhR activation. AhR activation by glucosinolate derivatives present in broccoli is 
modulated by several factors including cooking method, cooking time and digestion. Broccoli 
consumption resulted in AhR activation after the oral and gastric phase in vitro. In contrast, after 
the small intestinal phase of both in vitro and in vivo samples, no AhR activation was found. This 
suggests that the evaluation of the relevance of dietary glucosinolates for AhR modulation in 
the gut cannot prescind from the way broccoli is processed and that broccoli consumption does 
not necessarily produce substantial amounts of AhR ligands in the large intestine. 
Finally, Chapter 6 discusses the results of the different research chapters, as well as some 
limitations in the methods used and future research opportunities.
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